Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Pathways
Variants search result for Homo sapiens
(View Results for all Objects and Ontologies)


1003 records found for search term Ptpn11
Refine Term:
Assembly:
    Chr  
Sort By:
           Export CSV TAB Print

RGD IDSymbolVariant TypeNameTraitClinical SignificanceChrStartStopSpeciesAnnotationsMatch
150408211CV1194610single nucleotide variantNM_002834.5(PTPN11):c.*6C>Tnot provided [RCV001572564]likely benign12112504770112504770Humanname
401797506CV2742275single nucleotide variantNM_002834.5(PTPN11):c.-7G>Anot specified [RCV003324456]uncertain significance12112419105112419105Humanname
597706544CV3585021single nucleotide variantNM_002834.5(PTPN11):c.-2A>CCardiovascular phenotype [RCV004989443]uncertain significance12112419110112419110Humanname
150508823CV1244927single nucleotide variantNM_002834.5(PTPN11):c.-33G>Anot provided [RCV001659178]benign12112419079112419079Humanname
150482150CV1261574single nucleotide variantNM_002834.5(PTPN11):c.*48C>Tnot provided [RCV001686177]benign12112505840112505840Humanname
8692575CV142544single nucleotide variantNM_002834.5(PTPN11):c.-45T>Gnot specified [RCV000127655]benign12112419067112419067Humanname
8692578CV142547single nucleotide variantNM_002834.3(PTPN11):c.*13A>Gnot specified [RCV000127658]benign|likely benign|conflicting interpretations of pathogenicity12112504777112504777Humanname
8692579CV142548single nucleotide variantNM_002834.5(PTPN11):c.*50C>TLEOPARD syndrome 1 [RCV000385112]|Metachondromatosis [RCV000270635]|Noonan syndrome 1 [RCV000328023]|PTPN11-related disorder [RCV004532530]|not specified [RCV000127659]benign|likely benign|uncertain significance12112505842112505842Human5name , alternate_id
13527611CV503884single nucleotide variantNM_002834.5(PTPN11):c.-13G>Anot specified [RCV000599819]likely benign|conflicting interpretations of pathogenicity12112419099112419099Humanname
28867250CV869294single nucleotide variantNM_002834.5(PTPN11):c.-77G>ALEOPARD syndrome 1 [RCV001111690]|Metachondromatosis [RCV001111691]|Noonan syndrome 1 [RCV001111692]uncertain significance12112419035112419035Human3name
28867252CV869295single nucleotide variantNM_002834.5(PTPN11):c.-71C>TLEOPARD syndrome 1 [RCV001112155]|Metachondromatosis [RCV001111693]|Noonan syndrome 1 [RCV001111694]uncertain significance12112419041112419041Human3name
28867510CV869296single nucleotide variantNM_002834.5(PTPN11):c.*64C>GLEOPARD syndrome 1 [RCV001109583]|Metachondromatosis [RCV001111863]|Noonan syndrome 1 [RCV001111864]uncertain significance12112505856112505856Human3name
151739507CV1490405single nucleotide variantNM_002834.5(PTPN11):c.14+6G>ARASopathy [RCV001985100]uncertain significance12112419131112419131Human1name
152030742CV1632297single nucleotide variantNM_002834.5(PTPN11):c.14+9C>ARASopathy [RCV002124406]likely benign12112419134112419134Human1name
405059842CV2968438single nucleotide variantNM_002834.5(PTPN11):c.14+9C>TRASopathy [RCV003655668]likely benign12112419134112419134Human1name
405062706CV3022762single nucleotide variantNM_002834.5(PTPN11):c.14+8G>CRASopathy [RCV003656077]likely benign12112419133112419133Human1name
11599642CV316040single nucleotide variantNM_002834.5(PTPN11):c.-273G>ALEOPARD syndrome 1 [RCV000362097]|Metachondromatosis [RCV000321361]|Noonan syndrome 1 [RCV000267451]|Noonan syndrome 1 [RCV002504067]|RASopathy [RCV001514462]|not provided [RCV000680648]benign|likely benign12112418839112418839Human5name
11649843CV316041single nucleotide variantNM_002834.5(PTPN11):c.-139G>ALEOPARD syndrome 1 [RCV000289513]|Metachondromatosis [RCV000407773]|Noonan syndrome 1 [RCV000352648]uncertain significance12112418973112418973Human3name
11602009CV316046single nucleotide variantNM_002834.5(PTPN11):c.*329T>CLEOPARD syndrome 1 [RCV000335302]|Metachondromatosis [RCV000287314]|Noonan syndrome 1 [RCV000373708]benign|likely benign|uncertain significance12112506121112506121Human3name
405260047CV3190182single nucleotide variantNM_002834.5(PTPN11):c.15-3A>CPTPN11-related disorder [RCV004534658]likely benign12112446273112446273Humanname , trait , alternate_id
11599382CV323298single nucleotide variantNM_002834.5(PTPN11):c.*325G>ALEOPARD syndrome 1 [RCV000264960]|Metachondromatosis [RCV000379260]|Noonan syndrome 1 [RCV000322269]|not provided [RCV003311745]benign|uncertain significance12112506117112506117Human3name
11598757CV323300single nucleotide variantNM_002834.5(PTPN11):c.*775G>ALEOPARD syndrome 1 [RCV000323449]|Metachondromatosis [RCV000260034]|Noonan syndrome 1 [RCV000380126]benign|likely benign|uncertain significance12112506567112506567Human3name
11613209CV329404single nucleotide variantNM_002834.3(PTPN11):c.-287G>CLEOPARD syndrome 1 [RCV000310699]|Metachondromatosis [RCV000266082]|Noonan syndrome 1 [RCV000365349]benign|likely benign|uncertain significance12112418825112418825Human3name
11616555CV329406single nucleotide variantNM_002834.4(PTPN11):c.-179G>CLEOPARD syndrome 1 [RCV000385402]|Metachondromatosis [RCV000330825]|Noonan syndrome 1 [RCV000295495]uncertain significance12112418933112418933Human3name
11648354CV329407deletionNM_002834.5(PTPN11):c.*656delMetachondromatosis [RCV000337777]|Noonan syndrome [RCV000281512]|Noonan syndrome with multiple lentigines [RCV000391697]uncertain significance12112506437112506437Human3name
11618374CV329458single nucleotide variantNM_002834.5(PTPN11):c.*670G>ALEOPARD syndrome 1 [RCV000351577]|Metachondromatosis [RCV000404053]|Noonan syndrome 1 [RCV000313164]benign|likely benign12112506462112506462Human3name
11645554CV329467single nucleotide variantNM_002834.5(PTPN11):c.*740C>TLEOPARD syndrome 1 [RCV000265964]|Metachondromatosis [RCV000310522]|Noonan syndrome 1 [RCV000358266]uncertain significance12112506532112506532Human3name
11616223CV329470single nucleotide variantNM_002834.5(PTPN11):c.*838G>ALEOPARD syndrome 1 [RCV000292522]|Metachondromatosis [RCV000317531]|Noonan syndrome 1 [RCV000374465]benign|likely benign|uncertain significance12112506630112506630Human3name
11648242CV330584single nucleotide variantNM_002834.3(PTPN11):c.-245C>GLEOPARD syndrome 1 [RCV000280439]|Metachondromatosis [RCV000374913]|Noonan syndrome 1 [RCV000317842]uncertain significance12112418867112418867Human3name
11652001CV330589single nucleotide variantNM_002834.5(PTPN11):c.14+8G>TLEOPARD syndrome 1 [RCV000346689]|Metachondromatosis [RCV000406530]|Noonan syndrome 1 [RCV000302391]uncertain significance12112419133112419133Human3name
11613850CV330591single nucleotide variantNM_002834.5(PTPN11):c.*687C>TLEOPARD syndrome 1 [RCV000307246]|Metachondromatosis [RCV000271962]|Noonan syndrome 1 [RCV000364128]uncertain significance12112506479112506479Human3name
14396267CV612030deletionNM_002834.5(PTPN11):c.15-4delNoonan syndrome [RCV000761126]|RASopathy [RCV001517426]|not specified [RCV003994107]benign|likely benign|uncertain significance12112446268112446268Human2name
14724183CV652408single nucleotide variantNM_002834.5(PTPN11):c.14+6G>TRASopathy [RCV000798291]uncertain significance12112419131112419131Human1name
28912067CV869289single nucleotide variantNM_002834.3(PTPN11):c.-317C>GLEOPARD syndrome 1 [RCV001111590]|Metachondromatosis [RCV001111592]|Noonan syndrome 1 [RCV001111591]uncertain significance12112418795112418795Human3name
28867815CV869290single nucleotide variantNM_002834.3(PTPN11):c.-291G>ALEOPARD syndrome 1 [RCV001112071]|Metachondromatosis [RCV001112069]|Noonan syndrome 1 [RCV001112070]uncertain significance12112418821112418821Human3name
28873450CV869291single nucleotide variantNM_002834.4(PTPN11):c.-176G>TLEOPARD syndrome 1 [RCV001115011]|Metachondromatosis [RCV001109368]|Noonan syndrome 1 [RCV001109367]uncertain significance12112418936112418936Human3name
28910656CV869292single nucleotide variantNM_002834.5(PTPN11):c.-161T>ALEOPARD syndrome 1 [RCV001109370]|Metachondromatosis [RCV001109371]|Noonan syndrome 1 [RCV001109369]uncertain significance12112418951112418951Human3name
28910658CV869293single nucleotide variantNM_002834.5(PTPN11):c.-151C>ALEOPARD syndrome 1 [RCV001109372]|Metachondromatosis [RCV001109374]|Noonan syndrome 1 [RCV001109373]uncertain significance12112418961112418961Human3name
28868215CV869297single nucleotide variantNM_002834.5(PTPN11):c.*474A>GLEOPARD syndrome 1 [RCV001112324]|Metachondromatosis [RCV001112325]|Noonan syndrome 1 [RCV001112326]uncertain significance12112506266112506266Human3name
28868217CV869298single nucleotide variantNM_002834.5(PTPN11):c.*673G>ALEOPARD syndrome 1 [RCV001112327]|Metachondromatosis [RCV001112328]|Noonan syndrome 1 [RCV001113679]uncertain significance12112506465112506465Human3name
28870690CV869299single nucleotide variantNM_002834.5(PTPN11):c.*682T>CLEOPARD syndrome 1 [RCV001113680]|Metachondromatosis [RCV001113682]|Noonan syndrome 1 [RCV001113681]uncertain significance12112506474112506474Human3name
28870695CV869300single nucleotide variantNM_002834.5(PTPN11):c.*684G>ALEOPARD syndrome 1 [RCV001113683]|Metachondromatosis [RCV001113684]|Noonan syndrome 1 [RCV001113685]uncertain significance12112506476112506476Human3name
28910930CV869301single nucleotide variantNM_002834.5(PTPN11):c.*720C>TLEOPARD syndrome 1 [RCV001109663]|Metachondromatosis [RCV001109662]|Noonan syndrome 1 [RCV001109664]uncertain significance12112506512112506512Human3name
28867659CV869302single nucleotide variantNM_002834.5(PTPN11):c.*799G>ALEOPARD syndrome 1 [RCV001111969]|Metachondromatosis [RCV001111967]|Noonan syndrome 1 [RCV001111968]uncertain significance12112506591112506591Human3name
28867664CV869303single nucleotide variantNM_002834.5(PTPN11):c.*801C>TLEOPARD syndrome 1 [RCV001111970]|Metachondromatosis [RCV001112422]|Noonan syndrome 1 [RCV001111971]benign|likely benign12112506593112506593Human3name
28868354CV869304single nucleotide variantNM_002834.5(PTPN11):c.*802G>ALEOPARD syndrome 1 [RCV001112425]|Metachondromatosis [RCV001112423]|Noonan syndrome 1 [RCV001112424]uncertain significance12112506594112506594Human3name
150451577CV1207234single nucleotide variantNM_002834.5(PTPN11):c.15-19C>ARASopathy [RCV002070443]|not specified [RCV001582363]likely benign|uncertain significance12112446257112446257Human1name
151833189CV1416469single nucleotide variantNM_002834.5(PTPN11):c.525+6T>ARASopathy [RCV002014509]uncertain significance12112453393112453393Human1name
152080146CV1579980single nucleotide variantNM_002834.5(PTPN11):c.643-9C>TNoonan syndrome 1 [RCV005008471]|RASopathy [RCV002076260]|not provided [RCV005232865]likely benign|uncertain significance12112455941112455941Human3name
152137913CV1580503single nucleotide variantNM_002834.5(PTPN11):c.15-16T>CRASopathy [RCV002156379]likely benign12112446260112446260Human1name
152164382CV1619859single nucleotide variantNM_002834.5(PTPN11):c.643-6G>TRASopathy [RCV002181526]likely benign12112455944112455944Human1name
152070538CV1650812single nucleotide variantNM_002834.5(PTPN11):c.15-20A>GRASopathy [RCV002148014]likely benign12112446256112446256Human1name
152118256CV1659003single nucleotide variantNM_002834.5(PTPN11):c.526-9T>CRASopathy [RCV002175222]likely benign12112454555112454555Human1name
152070390CV1660994single nucleotide variantNM_002834.5(PTPN11):c.14+11C>ANoonan syndrome 1 [RCV002494266]|RASopathy [RCV002129539]likely benign12112419136112419136Human3name
9693644CV178353single nucleotide variantNM_002834.5(PTPN11):c.15-38C>TNoonan syndrome [RCV000156972]benign12112446238112446238Human1name
156347946CV1893237single nucleotide variantNM_002834.5(PTPN11):c.14+12C>GRASopathy [RCV003090747]likely benign12112419137112419137Human1name
156333641CV1905790single nucleotide variantNM_002834.5(PTPN11):c.332+7A>TRASopathy [RCV003089942]likely benign12112450519112450519Human1name
156272835CV2046204single nucleotide variantNM_002834.5(PTPN11):c.643-5A>GRASopathy [RCV002770104]likely benign|uncertain significance12112455945112455945Human1name
156144438CV2052671single nucleotide variantNM_002834.5(PTPN11):c.933+8T>CRASopathy [RCV002801076]likely benign12112477738112477738Human1name
155954536CV2073525single nucleotide variantNM_002834.5(PTPN11):c.525+1G>ARASopathy [RCV002816446]likely pathogenic12112453388112453388Human1name
156121478CV2078071single nucleotide variantNM_002834.5(PTPN11):c.14+15G>ARASopathy [RCV002889580]likely benign12112419140112419140Human1name
156230257CV2115568single nucleotide variantNM_002834.5(PTPN11):c.643-8T>CRASopathy [RCV002932801]likely benign12112455942112455942Human1name
401870659CV2749394single nucleotide variantNM_002834.5(PTPN11):c.138-2A>Gnot provided [RCV003332522]likely pathogenic12112450316112450316Humanname
401919039CV2794737single nucleotide variantNM_002834.5(PTPN11):c.853+4A>Cnot specified [RCV003388411]uncertain significance12112473044112473044Humanname
405165374CV2930154single nucleotide variantNM_002834.5(PTPN11):c.14+12C>TRASopathy [RCV003540474]likely benign12112419137112419137Human1name
405056314CV2954721single nucleotide variantNM_002834.5(PTPN11):c.853+7A>GRASopathy [RCV003655569]uncertain significance12112473047112473047Human1name
405056540CV2958727single nucleotide variantNM_002834.5(PTPN11):c.933+7T>GRASopathy [RCV003655586]likely benign12112477737112477737Human1name
405062222CV3021457single nucleotide variantNM_002834.5(PTPN11):c.853+3A>GRASopathy [RCV003656038]uncertain significance12112473043112473043Human1name
405050327CV3051676single nucleotide variantNM_002834.5(PTPN11):c.525+6T>CRASopathy [RCV003654624]uncertain significance12112453393112453393Human1name
405203137CV3143937single nucleotide variantNM_002834.5(PTPN11):c.15-15G>ARASopathy [RCV003844727]likely benign12112446261112446261Human1name
11604446CV316051single nucleotide variantNM_002834.5(PTPN11):c.*1536T>GLEOPARD syndrome 1 [RCV000364343]|Metachondromatosis [RCV000405633]|Noonan syndrome 1 [RCV000309705]uncertain significance12112507328112507328Human3name
11598893CV316054single nucleotide variantNM_002834.5(PTPN11):c.*2731G>AMetachondromatosis [RCV000355768]|Noonan syndrome [RCV000300369]|Noonan syndrome with multiple lentigines [RCV000260944]uncertain significance12112508523112508523Human3name
11599781CV316057single nucleotide variantNM_002834.5(PTPN11):c.*3231T>GLEOPARD syndrome 1 [RCV000304892]|Metachondromatosis [RCV000353772]|Noonan syndrome 1 [RCV000268399]uncertain significance12112509023112509023Human3name
11599254CV316064single nucleotide variantNM_002834.5(PTPN11):c.*3244A>GLEOPARD syndrome 1 [RCV000359656]|Metachondromatosis [RCV000328468]|Noonan syndrome 1 [RCV000264022]uncertain significance12112509036112509036Human3name
11647807CV316065single nucleotide variantNM_002834.5(PTPN11):c.*4019C>TLEOPARD syndrome 1 [RCV000343019]|Metachondromatosis [RCV000278689]|Noonan syndrome 1 [RCV000390876]uncertain significance12112509811112509811Human3name
405254180CV3175019single nucleotide variantNM_002834.5(PTPN11):c.332+3C>TRASopathy [RCV003871471]uncertain significance12112450515112450515Human1name
402497525CV3179336single nucleotide variantNM_002834.5(PTPN11):c.756+6T>CRASopathy [RCV003877603]uncertain significance12112456069112456069Human1name
11650984CV323294single nucleotide variantNM_002834.5(PTPN11):c.853+8T>CLEOPARD syndrome 1 [RCV000296099]|Metachondromatosis [RCV000388132]|Noonan syndrome 1 [RCV000325441]uncertain significance12112473048112473048Human3name
11603033CV323301deletionNM_002834.5(PTPN11):c.*1006delMetachondromatosis [RCV000387928]|Noonan syndrome [RCV000349825]|Noonan syndrome and Noonan-related syndrome [RCV001813457]|Noonan syndrome with multiple lentigines [RCV000296025]likely benign12112506798112506798Human3name
11603356CV323304single nucleotide variantNM_002834.5(PTPN11):c.*1536T>CLEOPARD syndrome 1 [RCV000299094]|Metachondromatosis [RCV000390936]|Noonan syndrome 1 [RCV000356281]benign|likely benign|uncertain significance12112507328112507328Human3name
11646210CV323305single nucleotide variantNM_002834.5(PTPN11):c.*1588C>GLEOPARD syndrome 1 [RCV000370066]|Metachondromatosis [RCV000334209]|Noonan syndrome 1 [RCV000269703]uncertain significance12112507380112507380Human3name
11601950CV323306single nucleotide variantNM_002834.5(PTPN11):c.*1806G>ALEOPARD syndrome 1 [RCV000342107]|Metachondromatosis [RCV000286878]|Noonan syndrome 1 [RCV000378018]uncertain significance12112507598112507598Human3name
11603036CV323307single nucleotide variantNM_002834.5(PTPN11):c.*2928A>TLEOPARD syndrome 1 [RCV000345487]|Metachondromatosis [RCV000296301]|Noonan syndrome 1 [RCV000381456]uncertain significance12112508720112508720Human3name
11652116CV329471single nucleotide variantNM_002834.5(PTPN11):c.*1035A>GLEOPARD syndrome 1 [RCV000347631]|Metachondromatosis [RCV000303225]|Noonan syndrome 1 [RCV000406346]uncertain significance12112506827112506827Human3name
11615450CV329472single nucleotide variantNM_002834.5(PTPN11):c.*1374G>CLEOPARD syndrome 1 [RCV000343362]|Metachondromatosis [RCV000390938]|Noonan syndrome 1 [RCV000286100]benign|likely benign12112507166112507166Human3name
11647220CV329473single nucleotide variantNM_002834.5(PTPN11):c.*1729A>GLEOPARD syndrome 1 [RCV000330611]|Metachondromatosis [RCV000375829]|Noonan syndrome 1 [RCV000275387]uncertain significance12112507521112507521Human3name
11648716CV329475single nucleotide variantNM_002834.5(PTPN11):c.*1946G>ALEOPARD syndrome 1 [RCV000392581]|Metachondromatosis [RCV000347850]|Noonan syndrome 1 [RCV000283443]uncertain significance12112507738112507738Human3name
11645684CV329476single nucleotide variantNM_002834.5(PTPN11):c.*2907A>CLEOPARD syndrome 1 [RCV000266651]|Metachondromatosis [RCV000380020]|Noonan syndrome 1 [RCV000316069]uncertain significance12112508699112508699Human3name
11616092CV329477single nucleotide variantNM_002834.5(PTPN11):c.*2927T>ALEOPARD syndrome 1 [RCV000376468]|Metachondromatosis [RCV000321682]|Noonan syndrome 1 [RCV000291387]benign|likely benign12112508719112508719Human3name
11618237CV329478single nucleotide variantNM_002834.5(PTPN11):c.*3006G>ALEOPARD syndrome 1 [RCV000311755]|Metachondromatosis [RCV000351151]|Noonan syndrome 1 [RCV000407469]|not provided [RCV004703616]benign|likely benign|uncertain significance12112508798112508798Human3name
11616937CV329485single nucleotide variantNM_002834.5(PTPN11):c.*3043C>TLEOPARD syndrome 1 [RCV000298931]|Metachondromatosis [RCV000338505]|Noonan syndrome 1 [RCV000407473]|not provided [RCV004705237]benign|likely benign|uncertain significance12112508835112508835Human3name
11646446CV329521single nucleotide variantNM_002834.5(PTPN11):c.*3300T>CLEOPARD syndrome 1 [RCV000326046]|Metachondromatosis [RCV000270955]|Noonan syndrome 1 [RCV000364452]uncertain significance12112509092112509092Human3name
11615941CV330595single nucleotide variantNM_002834.5(PTPN11):c.*1015C>GLEOPARD syndrome 1 [RCV000290290]|Metachondromatosis [RCV000391805]|Noonan syndrome 1 [RCV000344064]uncertain significance12112506807112506807Human3name
11650211CV330611single nucleotide variantNM_002834.5(PTPN11):c.*1332G>ALEOPARD syndrome 1 [RCV000383763]|Metachondromatosis [RCV000291766]|Noonan syndrome 1 [RCV000339872]uncertain significance12112507124112507124Human3name
11612782CV330625single nucleotide variantNM_002834.5(PTPN11):c.*1805C>TLEOPARD syndrome 1 [RCV000372227]|Metachondromatosis [RCV000262330]|Noonan syndrome 1 [RCV000317559]|not provided [RCV003391085]benign|likely benign|uncertain significance12112507597112507597Human3name
11652876CV330626single nucleotide variantNM_002834.5(PTPN11):c.*2493C>TLEOPARD syndrome 1 [RCV000404816]|Metachondromatosis [RCV000307730]|Noonan syndrome 1 [RCV000343984]uncertain significance12112508285112508285Human3name
11646884CV330628single nucleotide variantNM_002834.5(PTPN11):c.*2540G>TLEOPARD syndrome 1 [RCV000368402]|Metachondromatosis [RCV000313683]|Noonan syndrome 1 [RCV000273408]uncertain significance12112508332112508332Human3name
11616574CV330630single nucleotide variantNM_002834.5(PTPN11):c.*3381A>GLEOPARD syndrome 1 [RCV000295611]|Metachondromatosis [RCV000331706]|Noonan syndrome 1 [RCV000389840]benign|likely benign|uncertain significance12112509173112509173Human3name
11648538CV330634single nucleotide variantNM_002834.5(PTPN11):c.*3720T>CLEOPARD syndrome 1 [RCV000337611]|Metachondromatosis [RCV000386164]|Noonan syndrome 1 [RCV000282547]uncertain significance12112509512112509512Human3name
405675712CV3386472deletionNM_002834.5(PTPN11):c.333-3delCardiovascular phenotype [RCV004516218]uncertain significance12112453190112453190Humanname
12843413CV371810single nucleotide variantNM_002834.5(PTPN11):c.138-4T>GRASopathy [RCV003654264]|not specified [RCV000436182]likely benign12112450314112450314Human1name
597887101CV3838999single nucleotide variantNM_002834.5(PTPN11):c.854-8T>CRASopathy [RCV005179084]likely benign12112477643112477643Human1name
597936428CV3862493single nucleotide variantNM_002834.5(PTPN11):c.138-9C>TRASopathy [RCV005207765]likely benign12112450309112450309Human1name
8602470CV40230single nucleotide variantNM_002834.5(PTPN11):c.643-2A>CMetachondromatosis [RCV000024260]pathogenic12112455948112455948Human1name
13477398CV442536duplicationNM_002834.5(PTPN11):c.643-6dupNoonan syndrome 1 [RCV002506264]|PTPN11-related disorder [RCV004541625]|RASopathy [RCV000520386]|not provided [RCV001712480]|not specified [RCV001193112]benign|likely benign12112455943112455944Human8name , alternate_id
8603031CV45370single nucleotide variantNM_002834.5(PTPN11):c.526-8C>ALEOPARD syndrome 1 [RCV001109477]|Metachondromatosis [RCV001109476]|Noonan syndrome 1 [RCV001109478]|Noonan syndrome [RCV000030388]|Noonan syndrome and Noonan-related syndrome [RCV001813213]|RASopathy [RCV000033495]|not provided [RCV000430276]|not specified [RCV000037650]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance12112454556112454556Human6name
13474862CV462423single nucleotide variantNM_002834.5(PTPN11):c.643-7C>TRASopathy [RCV000548455]likely benign12112455943112455943Human1name
9691227CV48948single nucleotide variantNM_002834.5(PTPN11):c.14+25G>CJuvenile myelomonocytic leukemia [RCV003315533]|Metachondromatosis [RCV005234823]|Noonan syndrome [RCV000157025]|not provided [RCV001538566]|not specified [RCV000244297]benign12112419150112419150Human4name
150507389CV48949single nucleotide variantNM_002834.5(PTPN11):c.14+42C>Tnot provided [RCV001596282]benign12112419167112419167Humanname
9691222CV48950single nucleotide variantNM_002834.5(PTPN11):c.14+54C>AJuvenile myelomonocytic leukemia [RCV003315534]|Metachondromatosis [RCV005234824]|Noonan syndrome [RCV000156975]|not provided [RCV001610305]benign12112419179112419179Human4name
8604480CV48981single nucleotide variantNM_002834.5(PTPN11):c.333-3T>CCardiovascular phenotype [RCV002316204]|PTPN11-related disorder [RCV004532487]|RASopathy [RCV000033488]|not provided [RCV003390717]|not specified [RCV000213919]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance12112453192112453192Human1name , alternate_id
13539897CV503886single nucleotide variantNM_002834.5(PTPN11):c.333-4T>Cnot specified [RCV000613907]likely benign12112453191112453191Humanname
13835506CV586765single nucleotide variantNM_002834.5(PTPN11):c.933+4A>Tnot provided [RCV000731329]uncertain significance12112477734112477734Humanname
15014897CV679454single nucleotide variantNM_002834.5(PTPN11):c.854-1G>CVentricular tachycardia [RCV000852441]likely pathogenic12112477650112477650Human2name
15167794CV690018single nucleotide variantNM_002834.5(PTPN11):c.756+9T>CRASopathy [RCV002064633]|not specified [RCV004702487]likely benign12112456072112456072Human1name
15170230CV759980single nucleotide variantNM_002834.5(PTPN11):c.757-5T>CCardiovascular phenotype [RCV002390912]|RASopathy [RCV001858576]likely benign|uncertain significance12112472939112472939Human1name
28870853CV869305single nucleotide variantNM_002834.5(PTPN11):c.*1038G>ALEOPARD syndrome 1 [RCV001113767]|Metachondromatosis [RCV001113768]|Noonan syndrome 1 [RCV001113769]uncertain significance12112506830112506830Human3name
28910993CV869306single nucleotide variantNM_002834.5(PTPN11):c.*1419G>ALEOPARD syndrome 1 [RCV001110540]|Metachondromatosis [RCV001109759]|Noonan syndrome 1 [RCV001109758]uncertain significance12112507211112507211Human3name
28911436CV869307single nucleotide variantNM_002834.5(PTPN11):c.*1520C>TLEOPARD syndrome 1 [RCV001110543]|Metachondromatosis [RCV001110541]|Noonan syndrome 1 [RCV001110542]uncertain significance12112507312112507312Human3name
28868489CV869308single nucleotide variantNM_002834.5(PTPN11):c.*1616C>TLEOPARD syndrome 1 [RCV001112519]|Metachondromatosis [RCV001112521]|Noonan syndrome 1 [RCV001112520]uncertain significance12112507408112507408Human3name
28911034CV869309single nucleotide variantNM_002834.5(PTPN11):c.*1830G>ALEOPARD syndrome 1 [RCV001109838]|Metachondromatosis [RCV001109839]|Noonan syndrome 1 [RCV001109840]uncertain significance12112507622112507622Human3name
28911035CV869310single nucleotide variantNM_002834.5(PTPN11):c.*2078G>ALEOPARD syndrome 1 [RCV001109841]|Metachondromatosis [RCV001110624]|Noonan syndrome 1 [RCV001110625]benign|likely benign12112507870112507870Human3name
28911481CV869311single nucleotide variantNM_002834.5(PTPN11):c.*2096T>GLEOPARD syndrome 1 [RCV001110626]|Metachondromatosis [RCV001110628]|Noonan syndrome 1 [RCV001110627]uncertain significance12112507888112507888Human3name
28911482CV869312single nucleotide variantNM_002834.5(PTPN11):c.*2150G>TLEOPARD syndrome 1 [RCV001110629]|Metachondromatosis [RCV001110631]|Noonan syndrome 1 [RCV001110630]uncertain significance12112507942112507942Human3name
28868625CV869313single nucleotide variantNM_002834.5(PTPN11):c.*2179C>TLEOPARD syndrome 1 [RCV001112614]|Metachondromatosis [RCV001112613]|Noonan syndrome 1 [RCV001112612]uncertain significance12112507971112507971Human3name
28871200CV869314single nucleotide variantNM_002834.5(PTPN11):c.*2608C>TLEOPARD syndrome 1 [RCV001113955]|Metachondromatosis [RCV001113954]|Noonan syndrome 1 [RCV001113953]uncertain significance12112508400112508400Human3name
28871205CV869315single nucleotide variantNM_002834.5(PTPN11):c.*2629A>GLEOPARD syndrome 1 [RCV001113956]|Metachondromatosis [RCV001113958]|Noonan syndrome 1 [RCV001113957]benign|likely benign12112508421112508421Human3name
28871209CV869316single nucleotide variantNM_002834.5(PTPN11):c.*2822A>GLEOPARD syndrome 1 [RCV001109922]|Metachondromatosis [RCV001109921]|Noonan syndrome 1 [RCV001113959]uncertain significance12112508614112508614Human3name
28911117CV869317single nucleotide variantNM_002834.5(PTPN11):c.*3971A>GLEOPARD syndrome 1 [RCV001110017]|Metachondromatosis [RCV001110018]|Noonan syndrome 1 [RCV001110016]uncertain significance12112509763112509763Human3name
38466172CV920310single nucleotide variantNM_002834.5(PTPN11):c.643-6G>ALEOPARD syndrome 1 [RCV001198119]|RASopathy [RCV002561060]likely benign|uncertain significance12112455944112455944Human2name
127246731CV1100856single nucleotide variantNM_002834.5(PTPN11):c.1448-4G>ACardiovascular phenotype [RCV004656594]|RASopathy [RCV001435492]likely benign12112489020112489020Human1name
127330590CV1122310single nucleotide variantNM_002834.5(PTPN11):c.1225-9C>TRASopathy [RCV001470949]likely benign12112486466112486466Human1name
150423961CV1184623single nucleotide variantNM_002834.5(PTPN11):c.525+78A>Gnot provided [RCV001556021]likely benign12112453465112453465Humanname
150427100CV1187836single nucleotide variantNM_002834.5(PTPN11):c.642+41T>Gnot provided [RCV001560478]likely benign12112454721112454721Humanname
150437719CV1201298single nucleotide variantNM_002834.5(PTPN11):c.137+42A>Gnot provided [RCV001583110]likely benign12112446440112446440Humanname
150472777CV1217236deletionNM_002834.5(PTPN11):c.643-62delnot provided [RCV001615531]benign12112455872112455872Humanname
150475760CV1239784single nucleotide variantNM_002834.5(PTPN11):c.525+34A>Gnot provided [RCV001651961]benign12112453421112453421Humanname
150441339CV1246717single nucleotide variantNM_002834.5(PTPN11):c.934-24A>Gnot provided [RCV001666371]benign12112477833112477833Humanname
150469506CV1268109deletionNM_002834.5(PTPN11):c.333-19delnot provided [RCV001694972]|not specified [RCV003317519]benign12112453171112453171Humanname
151352169CV1325125single nucleotide variantNM_002834.5(PTPN11):c.1380-5C>TCardiovascular phenotype [RCV002386575]|Noonan syndrome and Noonan-related syndrome [RCV001813681]|RASopathy [RCV002077267]|not provided [RCV005232668]likely benign|uncertain significance12112488438112488438Human1name
151712344CV1334405duplicationNM_002834.5(PTPN11):c.643-62dupnot provided [RCV001840879]likely benign12112455871112455872Humanname
151840503CV1423593single nucleotide variantNM_002834.5(PTPN11):c.1448-2A>TRASopathy [RCV001977628]likely pathogenic12112489022112489022Human1name
151886722CV1441649single nucleotide variantNM_002834.5(PTPN11):c.525+11A>GRASopathy [RCV001942229]likely benign12112453398112453398Human1name
152092571CV1567804single nucleotide variantNM_002834.5(PTPN11):c.854-20G>ARASopathy [RCV002212930]likely benign12112477631112477631Human1name
152117890CV1601091single nucleotide variantNM_002834.5(PTPN11):c.1600-8A>TRASopathy [RCV002097745]likely benign12112502136112502136Human1name
152118548CV1602594single nucleotide variantNM_002834.5(PTPN11):c.1224+7A>TRASopathy [RCV002117533]likely benign12112482212112482212Human1name
152171044CV1612733single nucleotide variantNM_002834.5(PTPN11):c.332+18G>TRASopathy [RCV002183366]likely benign12112450530112450530Human1name
152123165CV1613675single nucleotide variantNM_002834.5(PTPN11):c.1092+9C>TRASopathy [RCV002081840]likely benign12112478024112478024Human1name
152094551CV1617427single nucleotide variantNM_002834.5(PTPN11):c.854-18G>CRASopathy [RCV002114529]|not specified [RCV005239268]likely benign12112477633112477633Human1name
152161754CV1619520single nucleotide variantNM_002834.5(PTPN11):c.526-20T>CRASopathy [RCV002159762]likely benign12112454544112454544Human1name
9689135CV175542single nucleotide variantNM_002834.5(PTPN11):c.1225-7A>GRASopathy [RCV003539799]|not specified [RCV000154569]likely benign|uncertain significance12112486468112486468Human1name
9693654CV178354single nucleotide variantNM_002834.5(PTPN11):c.137+35G>ANoonan syndrome [RCV000156999]benign12112446433112446433Human1name
9693653CV178355single nucleotide variantNM_002834.5(PTPN11):c.933+25T>CNoonan syndrome [RCV000156998]likely benign12112477755112477755Human1name
9833398CV179452single nucleotide variantNM_002834.5(PTPN11):c.934-12C>Tnot specified [RCV000159039]benign12112477845112477845Humanname
155716178CV1847952single nucleotide variantNM_002834.5(PTPN11):c.1093-3C>TCardiovascular phenotype [RCV002448260]|RASopathy [RCV005058776]uncertain significance12112482071112482071Human1name
156305361CV1868125single nucleotide variantNM_002834.5(PTPN11):c.1379+9T>ARASopathy [RCV003062159]likely benign12112486638112486638Human1name
156325208CV1871141single nucleotide variantNM_002834.5(PTPN11):c.333-11A>GRASopathy [RCV003063353]likely benign12112453184112453184Human1name
156256708CV1875351single nucleotide variantNM_002834.5(PTPN11):c.642+19T>GRASopathy [RCV003060216]likely benign12112454699112454699Human1name
156387941CV1875725single nucleotide variantNM_002834.5(PTPN11):c.853+18G>TRASopathy [RCV003051022]likely benign12112473058112473058Human1name
156410152CV1888236single nucleotide variantNM_002834.5(PTPN11):c.642+17G>ARASopathy [RCV003071953]likely benign12112454697112454697Human1name
156197338CV1897174single nucleotide variantNM_002834.5(PTPN11):c.854-17G>ARASopathy [RCV002574623]likely benign12112477634112477634Human1name
156153693CV1926048single nucleotide variantNM_002834.5(PTPN11):c.853+19C>TNoonan syndrome 1 [RCV005002969]|RASopathy [RCV002624098]likely benign|uncertain significance12112473059112473059Human3name
156444325CV1938181single nucleotide variantNM_002834.5(PTPN11):c.934-10A>GRASopathy [RCV003115249]likely benign12112477847112477847Human1name
156254087CV1981642single nucleotide variantNM_002834.5(PTPN11):c.643-17C>TRASopathy [RCV002645991]|not specified [RCV003988014]likely benign12112455933112455933Human1name
156209574CV2036782single nucleotide variantNM_002834.5(PTPN11):c.854-15C>TRASopathy [RCV002790191]likely benign12112477636112477636Human1name
156270730CV2055958single nucleotide variantNM_002834.5(PTPN11):c.1599+5C>TRASopathy [RCV002806651]uncertain significance12112489180112489180Human1name
156050524CV2060029single nucleotide variantNM_002834.5(PTPN11):c.853+14T>GRASopathy [RCV002796752]likely benign12112473054112473054Human1name
156002878CV2074734single nucleotide variantNM_002834.5(PTPN11):c.1448-7T>GRASopathy [RCV002843491]likely benign12112489017112489017Human1name
156298548CV2075747single nucleotide variantNM_002834.5(PTPN11):c.1599+7G>CRASopathy [RCV002857057]likely benign12112489182112489182Human1name
156023687CV2077870single nucleotide variantNM_002834.5(PTPN11):c.138-12G>ARASopathy [RCV002866729]uncertain significance12112450306112450306Human1name
156048727CV2093413single nucleotide variantNM_002834.5(PTPN11):c.1712+9T>GRASopathy [RCV002867712]likely benign12112502265112502265Human1name
156324428CV2101315single nucleotide variantNM_002834.5(PTPN11):c.1599+6A>CRASopathy [RCV002899526]uncertain significance12112489181112489181Human1name
156022499CV2111143single nucleotide variantNM_002834.5(PTPN11):c.1599+7G>TRASopathy [RCV002909680]likely benign12112489182112489182Human1name
156392421CV2123481single nucleotide variantNM_002834.5(PTPN11):c.1379+6A>CRASopathy [RCV002944044]uncertain significance12112486635112486635Human1name
156287134CV2172336single nucleotide variantNM_002834.5(PTPN11):c.525+16A>TRASopathy [RCV003027531]likely benign12112453403112453403Human1name
11096475CV230260single nucleotide variantNM_002834.5(PTPN11):c.1380-4G>TRASopathy [RCV001439592]|not specified [RCV000223627]likely benign12112488439112488439Human1name
11093807CV230261single nucleotide variantNM_002834.5(PTPN11):c.1713-5T>ARASopathy [RCV002057175]|not specified [RCV000220247]likely benign|uncertain significance12112504690112504690Human1name
11544086CV254414single nucleotide variantNM_002834.5(PTPN11):c.526-17T>CNoonan syndrome 1 [RCV002503939]|RASopathy [RCV002058126]|not specified [RCV000243321]benign|likely benign|conflicting interpretations of pathogenicity12112454547112454547Human3name
405157801CV2866909single nucleotide variantNM_002834.5(PTPN11):c.1447+1G>ARASopathy [RCV003539611]likely pathogenic12112488511112488511Human1name
405159223CV2870494single nucleotide variantNM_002834.5(PTPN11):c.333-18A>TRASopathy [RCV003539607]likely benign12112453177112453177Human1name
405158359CV2871810single nucleotide variantNM_002834.5(PTPN11):c.757-12C>GRASopathy [RCV003539653]likely benign12112472932112472932Human1name
405162335CV2881932single nucleotide variantNM_002834.5(PTPN11):c.525+19A>GRASopathy [RCV003540048]likely benign12112453406112453406Human1name
405160995CV2886846single nucleotide variantNM_002834.5(PTPN11):c.756+18T>CRASopathy [RCV003540113]likely benign12112456081112456081Human1name
405164740CV2928942single nucleotide variantNM_002834.5(PTPN11):c.1447+6T>CRASopathy [RCV003540419]uncertain significance12112488516112488516Human1name
405164873CV2931009single nucleotide variantNM_002834.5(PTPN11):c.756+19G>ARASopathy [RCV003540378]likely benign12112456082112456082Human1name
405055737CV2939248single nucleotide variantNM_002834.5(PTPN11):c.756+16A>GRASopathy [RCV003655525]likely benign12112456079112456079Human1name
405061344CV3015497single nucleotide variantNM_002834.5(PTPN11):c.526-14G>ARASopathy [RCV003655967]likely benign12112454550112454550Human1name
405048006CV3019503single nucleotide variantNM_002834.5(PTPN11):c.1599+9C>TRASopathy [RCV003654453]likely benign12112489184112489184Human1name
405047722CV3024307single nucleotide variantNM_002834.5(PTPN11):c.1225-9C>GRASopathy [RCV003654504]likely benign12112486466112486466Human1name
405049394CV3048371single nucleotide variantNM_002834.5(PTPN11):c.853+12T>CRASopathy [RCV003654635]likely benign12112473052112473052Human1name
405052464CV3073642deletionNM_002834.5(PTPN11):c.934-12delRASopathy [RCV003654853]likely benign12112477844112477844Human1name
405052117CV3078586single nucleotide variantNM_002834.5(PTPN11):c.1224+7A>GRASopathy [RCV003654824]likely benign12112482212112482212Human1name
404983910CV3180060single nucleotide variantNM_002834.5(PTPN11):c.756+16A>TRASopathy [RCV003880862]likely benign12112456079112456079Human1name
402509095CV3182123single nucleotide variantNM_002834.5(PTPN11):c.1225-7A>CRASopathy [RCV003878776]likely benign12112486468112486468Human1name
407573249CV3499050single nucleotide variantNM_002834.5(PTPN11):c.1447+7C>Tnot specified [RCV004700021]uncertain significance12112488517112488517Humanname
597706559CV3585025single nucleotide variantNM_002834.5(PTPN11):c.1599+3A>GCardiovascular phenotype [RCV004989446]uncertain significance12112489178112489178Humanname
597670396CV3713703single nucleotide variantNM_002834.5(PTPN11):c.643-20C>ANoonan syndrome 1 [RCV005004823]uncertain significance12112455930112455930Human2name
12833233CV371821single nucleotide variantNM_002834.5(PTPN11):c.853+17C>TRASopathy [RCV002065015]|not specified [RCV000418124]likely benign|conflicting interpretations of pathogenicity12112473057112473057Human1name
12843312CV372556single nucleotide variantNM_002834.5(PTPN11):c.137+49A>Tnot specified [RCV000436005]likely benign12112446447112446447Humanname
597830543CV3743080single nucleotide variantNM_002834.5(PTPN11):c.934-18T>ARASopathy [RCV005062088]likely benign12112477839112477839Human1name
597830581CV3743118single nucleotide variantNM_002834.5(PTPN11):c.853+19C>GRASopathy [RCV005062126]likely benign12112473059112473059Human1name
597842418CV3752985single nucleotide variantNM_002834.5(PTPN11):c.526-15T>ARASopathy [RCV005086714]likely benign12112454549112454549Human1name
597840616CV3756112single nucleotide variantNM_002834.5(PTPN11):c.853+18G>ARASopathy [RCV005086384]likely benign12112473058112473058Human1name
597955776CV3787198single nucleotide variantNM_002834.5(PTPN11):c.756+19G>CRASopathy [RCV005122083]likely benign12112456082112456082Human1name
597869651CV3839272single nucleotide variantNM_002834.5(PTPN11):c.526-16G>ARASopathy [RCV005176383]likely benign12112454548112454548Human1name
597943407CV3847669single nucleotide variantNM_002834.5(PTPN11):c.1380-4G>ARASopathy [RCV005188397]likely benign12112488439112488439Human1name
597878574CV3860428single nucleotide variantNM_002834.5(PTPN11):c.1380-8G>ARASopathy [RCV005198637]likely benign12112488435112488435Human1name
597919048CV3861641single nucleotide variantNM_002834.5(PTPN11):c.138-17C>ARASopathy [RCV005204797]likely benign12112450301112450301Human1name
598245627CV3896470single nucleotide variantNM_002834.5(PTPN11):c.934-59T>ANoonan syndrome with multiple lentigines [RCV005365827]likely pathogenic12112477798112477798Human1name
8602472CV40232single nucleotide variantNM_002834.5(PTPN11):c.1093-1G>TMetachondromatosis [RCV000024262]pathogenic12112482073112482073Human1name
13506302CV481137single nucleotide variantNM_002834.5(PTPN11):c.1599+4C>ACardiovascular phenotype [RCV003159973]|LEOPARD syndrome 1 [RCV000577953]|Metachondromatosis [RCV000578031]|Noonan syndrome 1 [RCV000578108]|Noonan syndrome 1 [RCV005004256]|RASopathy [RCV001860000]|not provided [RCV001558688]likely benign|uncertain significance12112489179112489179Human8name
13521776CV487580single nucleotide variantNM_002834.5(PTPN11):c.1379+6A>GLEOPARD syndrome 1 [RCV001113594]|Metachondromatosis [RCV001113592]|Noonan syndrome 1 [RCV001113593]|not provided [RCV000590231]uncertain significance12112486635112486635Human3name
8604479CV48979single nucleotide variantNM_002834.5(PTPN11):c.332+17T>GRASopathy [RCV000033486]|not provided [RCV003736548]|not specified [RCV000157684]benign12112450529112450529Human1name
150432250CV48980single nucleotide variantNM_002834.5(PTPN11):c.332+29C>Gnot provided [RCV001642102]benign12112450541112450541Humanname
8604485CV48986single nucleotide variantNM_002834.5(PTPN11):c.525+12G>CCardiovascular phenotype [RCV002336105]|Juvenile myelomonocytic leukemia [RCV003315536]|LEOPARD syndrome 1 [RCV001115113]|Metachondromatosis [RCV001115114]|Noonan syndrome 1 [RCV001115112]|RASopathy [RCV000523314]|not provided [RCV000680298]|not specified [RCV000037649]benign|likely benign|conflicting interpretations of pathogenicity12112453399112453399Human8name
9691224CV48987single nucleotide variantNM_002834.5(PTPN11):c.757-69T>CNoonan syndrome [RCV000157003]|not provided [RCV001711140]benign12112472875112472875Human1name
150453885CV48999single nucleotide variantNM_002834.5(PTPN11):c.853+80C>Tnot provided [RCV001681071]benign12112473120112473120Humanname
8604497CV49000single nucleotide variantNM_002834.5(PTPN11):c.854-32A>CNoonan syndrome [RCV000157019]|RASopathy [RCV000521102]|not provided [RCV000680300]|not specified [RCV000251132]benign|conflicting interpretations of pathogenicity|uncertain significance12112477619112477619Human2name
8604498CV49001single nucleotide variantNM_002834.5(PTPN11):c.854-30T>CNoonan syndrome [RCV000157029]|not provided [RCV001682721]|not specified [RCV000033511]benign12112477621112477621Human1name
8604499CV49002single nucleotide variantNM_002834.5(PTPN11):c.854-21C>TJuvenile myelomonocytic leukemia [RCV003315537]|Metachondromatosis [RCV005234825]|Noonan syndrome [RCV000157028]|not provided [RCV001711141]|not specified [RCV000033512]benign12112477630112477630Human4name
8604504CV49007single nucleotide variantNM_002834.5(PTPN11):c.933+11C>TRASopathy [RCV000033520]benign12112477741112477741Human1name
8604509CV49012single nucleotide variantNM_002834.5(PTPN11):c.1093-9C>AJuvenile myelomonocytic leukemia [RCV003315541]|LEOPARD syndrome 1 [RCV000390906]|Metachondromatosis [RCV000341657]|Noonan syndrome 1 [RCV000157023]|Noonan syndrome and Noonan-related syndrome [RCV001813254]|RASopathy [RCV000033525]|not provided [RCV001811233]|not specified [RCV000037605]benign|likely benign|conflicting interpretations of pathogenicity12112482065112482065Human8name
13592611CV497629single nucleotide variantNM_002834.5(PTPN11):c.1448-5C>TCardiovascular phenotype [RCV002395546]|RASopathy [RCV001478592]|not specified [RCV000603401]likely benign|uncertain significance12112489019112489019Human1name
13530888CV503555single nucleotide variantNM_002834.5(PTPN11):c.526-11T>CRASopathy [RCV005091664]|not specified [RCV000600868]likely benign12112454553112454553Human1name
13534490CV503897single nucleotide variantNM_002834.5(PTPN11):c.854-19T>GRASopathy [RCV002063127]|not specified [RCV000607335]likely benign12112477632112477632Human1name
13539960CV503899single nucleotide variantNM_002834.5(PTPN11):c.1448-8C>Tnot specified [RCV000614013]likely benign12112489016112489016Humanname
34896354CV917491single nucleotide variantNM_002834.5(PTPN11):c.642+19T>Cnot specified [RCV001193711]uncertain significance12112454699112454699Humanname
38470275CV940244single nucleotide variantNM_002834.5(PTPN11):c.1448-1G>ARASopathy [RCV001207607]likely pathogenic12112489023112489023Human1name
41407644CV980344single nucleotide variantNM_002834.5(PTPN11):c.854-14T>ANoonan syndrome 1 [RCV001280892]uncertain significance12112477637112477637Human1name
8641003CV99988deletionNM_002834.4(PTPN11):c.333-7delAnot provided [RCV000080035]other|not provided12112453188112453188Humanname
127295976CV1143173single nucleotide variantNM_002834.5(PTPN11):c.1447+10C>TRASopathy [RCV001497376]likely benign12112488520112488520Human1name
150412760CV1177546duplicationNM_002834.5(PTPN11):c.333-262dupnot provided [RCV001547600]likely benign12112452924112452925Humanname
150413733CV1177547deletionNM_002834.5(PTPN11):c.525+275delnot provided [RCV001547891]likely benign12112453647112453647Humanname
150427000CV1187834deletionNM_002834.5(PTPN11):c.138-216delnot provided [RCV001560330]likely benign12112450087112450087Humanname
150428422CV1187839single nucleotide variantNM_002834.5(PTPN11):c.*32+267C>Tnot provided [RCV001562249]likely benign12112505063112505063Human3name
150428422CV1187839single nucleotide variantNM_002834.5(PTPN11):c.*32+267C>Tnot provided [RCV001562249]likely benign12112505063112505064Human3name
150420301CV1194611deletionNM_002834.5(PTPN11):c.*33-144delnot provided [RCV001570059]likely benign12112505657112505657Humanname
150441564CV1204570duplicationNM_002834.5(PTPN11):c.525+275dupnot provided [RCV001583677]likely benign12112453646112453647Humanname
150446271CV1215633deletionNM_002834.5(PTPN11):c.642+159delnot provided [RCV001611226]benign12112454819112454819Humanname
150505402CV1222882single nucleotide variantNM_002834.5(PTPN11):c.1447+26G>Anot provided [RCV001621816]benign12112488536112488536Humanname
150474796CV1234503duplicationNM_002834.5(PTPN11):c.642+159dupnot provided [RCV001651823]benign12112454818112454819Humanname
150466208CV1240369duplicationNM_002834.5(PTPN11):c.138-216dupnot provided [RCV001650130]benign12112450086112450087Humanname
150481554CV1244121single nucleotide variantNM_002834.5(PTPN11):c.1600-11C>GRASopathy [RCV003771816]|not provided [RCV001652967]|not specified [RCV001806245]likely benign|uncertain significance12112502133112502133Human1name
150461008CV1253188single nucleotide variantNM_002834.5(PTPN11):c.525+272T>Gnot provided [RCV001669517]benign12112453659112453659Humanname
150481719CV1258968single nucleotide variantNM_002834.5(PTPN11):c.*33-151A>Cnot provided [RCV001686098]benign12112505674112505674Humanname
150496256CV1272837single nucleotide variantNM_002834.5(PTPN11):c.*33-152A>Cnot provided [RCV001688760]benign12112505673112505673Humanname
150521210CV1290891duplicationNM_002834.5(PTPN11):c.*33-144dupnot provided [RCV001732524]benign12112505656112505657Humanname
150535879CV1312081single nucleotide variantNM_002834.5(PTPN11):c.1447+28C>Tnot provided [RCV001779892]likely benign12112488538112488538Humanname
8692573CV142542single nucleotide variantNM_002834.5(PTPN11):c.1379+20C>TCardiovascular phenotype [RCV002381441]|Juvenile myelomonocytic leukemia [RCV003315856]|Metachondromatosis [RCV005235034]|Noonan syndrome 1 [RCV002505096]|RASopathy [RCV002055762]|not provided [RCV001812106]|not specified [RCV000127653]benign|likely benign|conflicting interpretations of pathogenicity12112486649112486649Human8name
152126487CV1528012single nucleotide variantNM_002834.5(PTPN11):c.1600-14C>TRASopathy [RCV002098890]likely benign12112502130112502130Human1name
152160628CV1555133single nucleotide variantNM_002834.5(PTPN11):c.1599+17T>ARASopathy [RCV002103728]likely benign12112489192112489192Human1name
152112325CV1558951single nucleotide variantNM_002834.5(PTPN11):c.1599+20C>ARASopathy [RCV002134642]likely benign12112489195112489195Human1name
152103873CV1569888single nucleotide variantNM_002834.5(PTPN11):c.1093-12G>TRASopathy [RCV002195889]likely benign12112482062112482062Human1name
152078051CV1602027single nucleotide variantNM_002834.5(PTPN11):c.1447+16G>TRASopathy [RCV002148949]likely benign12112488526112488526Human1name
152132212CV1631248single nucleotide variantNM_002834.5(PTPN11):c.1092+10A>GRASopathy [RCV002119234]benign12112478025112478025Human1name
152093993CV1648793single nucleotide variantNM_002834.5(PTPN11):c.1599+18G>ARASopathy [RCV002078089]likely benign12112489193112489193Human1name
9693657CV178357single nucleotide variantNM_002834.5(PTPN11):c.1599+26G>ANoonan syndrome [RCV000157026]benign12112489201112489201Human1name
9693646CV178358single nucleotide variantNM_002834.5(PTPN11):c.1599+33A>GNoonan syndrome [RCV000156978]benign12112489208112489208Human1name
156359293CV1925384single nucleotide variantNM_002834.5(PTPN11):c.1092+18C>ARASopathy [RCV002651519]likely benign12112478033112478033Human1name
156444589CV1948317single nucleotide variantNM_002834.5(PTPN11):c.1379+18C>TRASopathy [RCV003115513]likely benign12112486647112486647Human1name
156351191CV2018939single nucleotide variantNM_002834.5(PTPN11):c.1712+11C>TRASopathy [RCV002720193]likely benign12112502267112502267Human1name
156106453CV2061862duplicationNM_002834.5(PTPN11):c.1713-14dupRASopathy [RCV002824749]benign12112504676112504677Human1name
156354306CV2066257single nucleotide variantNM_002834.5(PTPN11):c.1448-16G>ARASopathy [RCV002812019]likely benign12112489008112489008Human1name
156008857CV2075368single nucleotide variantNM_002834.5(PTPN11):c.1600-17A>GRASopathy [RCV002843761]likely benign12112502127112502127Human1name
155933705CV2129341single nucleotide variantNM_002834.5(PTPN11):c.1092+16T>CRASopathy [RCV002970782]likely benign12112478031112478031Human1name
156147237CV2130968single nucleotide variantNM_002834.5(PTPN11):c.1224+14C>TRASopathy [RCV002982526]likely benign12112482219112482219Human1name
11094126CV230259single nucleotide variantNM_002834.5(PTPN11):c.1224+15G>ALEOPARD syndrome 1 [RCV001197715]|Noonan syndrome 1 [RCV002500700]|RASopathy [RCV002057140]|not specified [RCV000220650]benign|likely benign12112482220112482220Human4name
11547189CV254418single nucleotide variantNM_002834.5(PTPN11):c.1448-38G>Cnot specified [RCV000247441]benign12112488986112488986Humanname
405157668CV2865596single nucleotide variantNM_002834.5(PTPN11):c.1447+17G>ARASopathy [RCV003539551]likely benign12112488527112488527Human1name
405055691CV2945775deletionNM_002834.5(PTPN11):c.1447+20delRASopathy [RCV003655522]likely benign12112488529112488529Human1name
405059500CV2994649single nucleotide variantNM_002834.5(PTPN11):c.1712+15A>TRASopathy [RCV003655844]likely benign12112502271112502271Human1name
405061530CV3013018single nucleotide variantNM_002834.5(PTPN11):c.1380-11T>CRASopathy [RCV003655982]likely benign12112488432112488432Human1name
405051227CV3068874single nucleotide variantNM_002834.5(PTPN11):c.1599+17T>CRASopathy [RCV003654754]likely benign12112489192112489192Human1name
11647433CV316045deletionNM_002834.5(PTPN11):c.*41_*46delMetachondromatosis [RCV000276544]|Noonan syndrome [RCV000315032]|Noonan syndrome with multiple lentigines [RCV000362740]|PTPN11-related disorder [RCV004537730]|not specified [RCV000486749]likely pathogenic|likely benign|uncertain significance12112505831112505836Human3name , alternate_id
402464799CV3177130single nucleotide variantNM_002834.5(PTPN11):c.1448-13G>ARASopathy [RCV003872761]likely benign12112489011112489011Human1name
402490378CV3182300single nucleotide variantNM_002834.5(PTPN11):c.1448-17T>CRASopathy [RCV003876786]likely benign12112489007112489007Human1name
597941316CV3785764single nucleotide variantNM_002834.5(PTPN11):c.1225-10T>CRASopathy [RCV005133656]likely benign12112486465112486465Human1name
597918823CV3789803single nucleotide variantNM_002834.5(PTPN11):c.1093-11A>GRASopathy [RCV005129898]likely benign12112482063112482063Human1name
597885695CV3800010single nucleotide variantNM_002834.5(PTPN11):c.1713-14T>CRASopathy [RCV005150489]likely benign12112504681112504681Human1name
597948684CV3801220single nucleotide variantNM_002834.5(PTPN11):c.1600-13T>CRASopathy [RCV005135400]likely benign12112502131112502131Human1name
597910872CV3806565single nucleotide variantNM_002834.5(PTPN11):c.1599+16C>TRASopathy [RCV005154132]likely benign12112489191112489191Human1name
597970549CV3832446single nucleotide variantNM_002834.5(PTPN11):c.1224+10T>CRASopathy [RCV005166525]likely benign12112482215112482215Human1name
597869209CV3835130single nucleotide variantNM_002834.5(PTPN11):c.1448-19C>TRASopathy [RCV005176306]likely benign12112489005112489005Human1name
597956006CV3838114single nucleotide variantNM_002834.5(PTPN11):c.1447+18C>GRASopathy [RCV005191489]likely benign12112488528112488528Human1name
597862504CV3860555single nucleotide variantNM_002834.5(PTPN11):c.1600-16C>TRASopathy [RCV005196083]likely benign12112502128112502128Human1name
598127655CV3882802single nucleotide variantNM_002834.5(PTPN11):c.1600-15T>Cnot provided [RCV005234333]likely benign12112502129112502129Humanname
616934366CV4012364single nucleotide variantNM_002834.5(PTPN11):c.1379+10C>Tnot specified [RCV005409400]likely benign12112486639112486639Humanname
8603029CV45368single nucleotide variantNM_002834.5(PTPN11):c.1380-14C>GRASopathy [RCV003654178]|not specified [RCV005237431]likely benign|uncertain significance12112488429112488429Human1name
9691225CV49039single nucleotide variantNM_002834.5(PTPN11):c.1600-95C>TNoonan syndrome [RCV000157011]|not provided [RCV001642533]benign12112502049112502049Human1name
13796753CV552669single nucleotide variantNM_002834.5(PTPN11):c.138-181G>Cnot provided [RCV000680735]benign12112450137112450137Humanname
13797064CV552671single nucleotide variantNM_002834.5(PTPN11):c.333-223A>Gnot provided [RCV000680938]benign12112452972112452972Humanname
13797603CV552675single nucleotide variantNM_002834.5(PTPN11):c.643-340T>Cnot provided [RCV000681335]likely benign12112455610112455610Humanname
13797068CV552679single nucleotide variantNM_002834.5(PTPN11):c.854-223C>Tnot provided [RCV000680941]likely benign12112477428112477428Humanname
150404434CV1194609single nucleotide variantNM_002834.5(PTPN11):c.1379+308C>Tnot provided [RCV001571152]likely benign12112486937112486937Humanname
150438379CV1264815single nucleotide variantNM_002834.5(PTPN11):c.1712+289G>Cnot provided [RCV001678808]benign12112502545112502545Humanname
401932434CV2816882duplicationNM_002834.5(PTPN11):c.1713-482dupnot provided [RCV003392037]benign12112504206112504207Humanname
150500239CV49042single nucleotide variantNM_002834.5(PTPN11):c.1713-146G>Anot provided [RCV001718352]benign12112504549112504549Human4name
150500239CV49042single nucleotide variantNM_002834.5(PTPN11):c.1713-146G>Anot provided [RCV001718352]benign12112504549112504550Human4name
13797547CV552681single nucleotide variantNM_002834.5(PTPN11):c.1379+273G>Anot provided [RCV000681306]benign12112486902112486902Human3name
13797547CV552681single nucleotide variantNM_002834.5(PTPN11):c.1379+273G>Anot provided [RCV000681306]benign12112486902112486903Human3name
13797155CV552684single nucleotide variantNM_002834.5(PTPN11):c.1599+229G>Anot provided [RCV000680991]likely benign12112489404112489404Humanname
13797479CV552685single nucleotide variantNM_002834.5(PTPN11):c.1599+293C>Tnot provided [RCV000681250]benign12112489468112489468Humanname
11651128CV323302microsatelliteNM_002834.5(PTPN11):c.*1157ATG[17]Metachondromatosis [RCV000360287]|Noonan syndrome [RCV000390604]|Noonan syndrome with multiple lentigines [RCV000297210]|not provided [RCV003391084]likely benign|uncertain significance12112506946112506947Humanname
11647201CV323303microsatelliteNM_002834.5(PTPN11):c.*1157ATG[16]Metachondromatosis [RCV000367541]|Noonan syndrome [RCV000332732]|Noonan syndrome with multiple lentigines [RCV000275293]uncertain significance12112506946112506947Humanname
11649560CV330605microsatelliteNM_002834.5(PTPN11):c.*1157ATG[13]Metachondromatosis [RCV000288283]|Noonan syndrome [RCV000326849]|Noonan syndrome with multiple lentigines [RCV000389650]uncertain significance12112506947112506952Humanname
11612750CV330607microsatelliteNM_002834.5(PTPN11):c.*1157ATG[14]Metachondromatosis [RCV000354481]|Noonan syndrome [RCV000319453]|Noonan syndrome with multiple lentigines [RCV000261988]likely benign12112506947112506949Humanname
401932431CV2816880deletionNM_002834.5(PTPN11):c.921_933+11delnot provided [RCV003392035]uncertain significance12112477715112477738Humanname
127322221CV1143171single nucleotide variantNM_002834.5(PTPN11):c.6A>G (p.Thr2=)Cardiovascular phenotype [RCV002368535]|RASopathy [RCV001505031]likely benign12112419117112419117Human1name
150488226CV1251635microsatelliteNM_002834.5(PTPN11):c.525+102TTTA[8]not provided [RCV001674307]benign12112453488112453489Humanname
151797406CV1470488deletionNM_002834.5(PTPN11):c.1713-6_1730delRASopathy [RCV001898746]uncertain significance12112504689112504712Human1name
152056787CV1588332deletionNM_002834.5(PTPN11):c.14+25_14+41delRASopathy [RCV002190063]likely benign12112419142112419158Human1name
155959624CV2138248duplicationNM_002834.5(PTPN11):c.14+15_14+31dupRASopathy [RCV002972319]likely benign12112419139112419140Human1name
405056774CV2962723deletionNM_002834.5(PTPN11):c.15-15_15-12delRASopathy [RCV003655604]likely benign12112446260112446263Human1name
597706612CV3585038single nucleotide variantNM_002834.5(PTPN11):c.6A>T (p.Thr2=)Cardiovascular phenotype [RCV004989457]likely benign12112419117112419117Humanname
152110389CV1665405single nucleotide variantNM_002834.5(PTPN11):c.10C>A (p.Arg4=)RASopathy [RCV002080167]likely benign12112419121112419121Human1name
597950406CV3798095single nucleotide variantNM_002834.5(PTPN11):c.15A>G (p.Arg5=)RASopathy [RCV005135875]uncertain significance12112446276112446276Human1name
598181369CV3904794single nucleotide variantNM_002834.5(PTPN11):c.12G>A (p.Arg4=)Cardiovascular phenotype [RCV005265188]likely benign12112419123112419123Humanname
151781876CV1422183deletionNM_002834.5(PTPN11):c.18del (p.Trp6fs)RASopathy [RCV001972154]pathogenic12112446278112446278Human1name
152049046CV1615892deletionNM_002834.5(PTPN11):c.526-18_526-17delRASopathy [RCV002166630]likely benign12112454546112454547Human1name
152032133CV1643005single nucleotide variantNM_002834.5(PTPN11):c.99T>C (p.Pro33=)RASopathy [RCV002204907]likely benign12112446360112446360Human1name
9833399CV179457deletionNM_002834.5(PTPN11):c.*33-17_*33-13delnot provided [RCV001840208]benign|likely benign12112505804112505808Humanname
156095019CV1980872deletionNM_002834.5(PTPN11):c.756+22_756+36delRASopathy [RCV002621997]likely benign12112456081112456095Human1name
11547672CV254413deletionNM_002834.5(PTPN11):c.526-33_526-31delnot provided [RCV001582851]|not specified [RCV000248072]likely benign12112454529112454531Humanname
8599381CV28388single nucleotide variantNM_002834.5(PTPN11):c.5C>T (p.Thr2Ile)LEOPARD syndrome 1 [RCV004795408]|Metachondromatosis [RCV000988912]|Noonan syndrome 1 [RCV000014277]|Noonan syndrome 1 [RCV002496356]|Noonan syndrome [RCV000211847]|RASopathy [RCV000694389]|See cases [RCV003156060]|not provided [RCV000033445]pathogenic|likely pathogenic12112419116112419116Human6name
405062602CV3018713single nucleotide variantNM_002834.5(PTPN11):c.42G>A (p.Val14=)RASopathy [RCV003656068]likely benign12112446303112446303Human1name
405050531CV3057527single nucleotide variantNM_002834.5(PTPN11):c.60G>A (p.Leu20=)RASopathy [RCV003654701]likely benign12112446321112446321Human1name
405222529CV3154852microsatelliteNM_002834.5(PTPN11):c.854-13_854-12delRASopathy [RCV003847347]likely benign12112477635112477636Humanname
597670359CV3707172single nucleotide variantNM_002834.5(PTPN11):c.2T>G (p.Met1Arg)Noonan syndrome 1 [RCV005004819]likely pathogenic12112419113112419113Human2name
8607429CV53775single nucleotide variantNM_002834.5(PTPN11):c.48A>G (p.Ala16=)Cardiovascular phenotype [RCV002336132]|LEOPARD syndrome 1 [RCV000305683]|Metachondromatosis [RCV000359447]|Noonan syndrome 1 [RCV000390713]|Noonan syndrome and Noonan-related syndrome [RCV001813329]|RASopathy [RCV000520646]|not provided [RCV000587695]|not specified [RCV000037648]benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance12112446309112446309Human6name
8607433CV53779single nucleotide variantNM_002834.5(PTPN11):c.66A>G (p.Thr22=)Cardiovascular phenotype [RCV005259986]|RASopathy [RCV000654980]|not specified [RCV000037655]likely benign12112446327112446327Human1name
15169910CV753101single nucleotide variantNM_002834.5(PTPN11):c.36T>C (p.Thr12=)Cardiovascular phenotype [RCV004986689]|RASopathy [RCV002065819]|not specified [RCV001818837]likely benign12112446297112446297Human1name
21075906CV791197deletionNM_002834.5(PTPN11):c.643-61_643-38delMetachondromatosis [RCV000988914]likely benign12112455889112455912Human1name
150487758CV1262790single nucleotide variantNM_002834.5(PTPN11):c.114T>G (p.Pro38=)not provided [RCV001687188]likely benign12112446375112446375Humanname
155720052CV1830673single nucleotide variantNM_002834.5(PTPN11):c.156C>T (p.Thr52=)Cardiovascular phenotype [RCV002405629]likely benign12112450336112450336Humanname
155684808CV1841281single nucleotide variantNM_002834.5(PTPN11):c.108T>C (p.Ser36=)Cardiovascular phenotype [RCV002457459]|RASopathy [RCV003539459]likely benign12112446369112446369Human1name
155665976CV1855495single nucleotide variantNM_002834.5(PTPN11):c.285C>A (p.Val95=)Cardiovascular phenotype [RCV002435451]|PTPN11-related disorder [RCV004545325]likely benign12112450465112450465Humanname , alternate_id
156250121CV2041011single nucleotide variantNM_002834.5(PTPN11):c.279A>T (p.Gly93=)RASopathy [RCV002805977]likely benign|uncertain significance12112450459112450459Human1name
156147188CV2188411single nucleotide variantNM_002834.5(PTPN11):c.294T>G (p.Leu98=)RASopathy [RCV003056401]likely benign12112450474112450474Human1name
11641217CV264573single nucleotide variantNM_002834.5(PTPN11):c.10C>G (p.Arg4Gly)not provided [RCV000353023]likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112419121112419121Humanname
11636476CV271467single nucleotide variantNM_002834.5(PTPN11):c.132C>T (p.Ser44=)Cardiovascular phenotype [RCV002379138]|PTPN11-related disorder [RCV004543100]|RASopathy [RCV001428636]|not provided [RCV000589141]|not specified [RCV001175376]likely benign|conflicting interpretations of pathogenicity|uncertain significance12112446393112446393Human1name , alternate_id
401769143CV2734639single nucleotide variantNM_002834.5(PTPN11):c.18G>C (p.Trp6Cys)Cardiovascular phenotype [RCV003283491]uncertain significance12112446279112446279Humanname
405158498CV2858299single nucleotide variantNM_002834.5(PTPN11):c.198T>C (p.Tyr66=)Cardiovascular phenotype [RCV004985381]|RASopathy [RCV003539534]likely benign12112450378112450378Human1name
405160929CV2893458single nucleotide variantNM_002834.5(PTPN11):c.11G>A (p.Arg4Gln)RASopathy [RCV003540107]likely pathogenic|uncertain significance12112419122112419122Human1name
405162240CV2903076single nucleotide variantNM_002834.5(PTPN11):c.210A>G (p.Lys70=)RASopathy [RCV003540215]likely benign12112450390112450390Human1name
405055491CV2941818single nucleotide variantNM_002834.5(PTPN11):c.18G>T (p.Trp6Cys)Cardiovascular phenotype [RCV005264464]|RASopathy [RCV003655507]uncertain significance12112446279112446279Human1name
405059125CV2987024single nucleotide variantNM_002834.5(PTPN11):c.228G>A (p.Glu76=)RASopathy [RCV003655817]likely benign12112450408112450408Human1name
597706581CV3585031single nucleotide variantNM_002834.5(PTPN11):c.204G>A (p.Gly68=)Cardiovascular phenotype [RCV004989451]likely benign12112450384112450384Humanname
597706593CV3585033single nucleotide variantNM_002834.5(PTPN11):c.171G>A (p.Gln57=)Cardiovascular phenotype [RCV004989453]likely benign12112450351112450351Humanname
597706598CV3585034single nucleotide variantNM_002834.5(PTPN11):c.291G>A (p.Glu97=)Cardiovascular phenotype [RCV004989454]likely benign12112450471112450471Humanname
598181370CV3904795single nucleotide variantNM_002834.5(PTPN11):c.183T>C (p.Asp61=)Cardiovascular phenotype [RCV005265189]likely benign12112450363112450363Humanname
598181403CV3904805single nucleotide variantNM_002834.5(PTPN11):c.156C>A (p.Thr52=)Cardiovascular phenotype [RCV005265199]likely benign12112450336112450336Humanname
598181473CV3904828single nucleotide variantNM_002834.5(PTPN11):c.264A>G (p.Leu88=)Cardiovascular phenotype [RCV005265222]likely benign12112450444112450444Humanname
616937590CV4011199single nucleotide variantNM_002834.5(PTPN11):c.234C>G (p.Val78=)not specified [RCV005405045]likely benign12112450414112450414Humanname
8603030CV45369single nucleotide variantNM_002834.5(PTPN11):c.255C>T (p.His85=)Cardiovascular phenotype [RCV000250837]|Hereditary cancer-predisposing syndrome [RCV005251046]|Juvenile myelomonocytic leukemia [RCV003315517]|LEOPARD syndrome 1 [RCV000273664]|Metachondromatosis [RCV000356750]|Noonan syndrome 1 [RCV001094232]|Noonan syndrome [RCV000030387]|Noonan syndrome and Noonabenign|likely benign|conflicting interpretations of pathogenicity|conflicting data from submitters12112450435112450435Human9name
8604454CV48953single nucleotide variantNM_002834.5(PTPN11):c.132C>A (p.Ser44=)Cardiovascular phenotype [RCV004984650]|not provided [RCV001719719]benign|likely benign12112446393112446393Humanname
13527253CV510343single nucleotide variantNM_002834.5(PTPN11):c.162C>T (p.Ile54=)Cardiovascular phenotype [RCV000619629]likely benign12112450342112450342Humanname
15171633CV768892single nucleotide variantNM_002834.5(PTPN11):c.117A>C (p.Gly39=)RASopathy [RCV002545958]likely benign12112446378112446378Human1name
38465881CV918373single nucleotide variantNM_002834.5(PTPN11):c.231G>A (p.Leu77=)not specified [RCV001195206]likely benign12112450411112450411Humanname
38458135CV926467single nucleotide variantNM_002834.5(PTPN11):c.222G>A (p.Leu74=)Cardiovascular phenotype [RCV004986969]|Noonan syndrome 1 [RCV002491699]|RASopathy [RCV001222471]likely benign|uncertain significance12112450402112450402Human8name
126911172CV1053471single nucleotide variantNM_002834.5(PTPN11):c.324C>A (p.Thr108=)not provided [RCV001570061]|not specified [RCV001375510]likely benign12112450504112450504Humanname
127244235CV1100853single nucleotide variantNM_002834.5(PTPN11):c.498A>G (p.Lys166=)RASopathy [RCV001434983]likely benign12112453360112453360Human1name
127280486CV1100854single nucleotide variantNM_002834.5(PTPN11):c.507T>C (p.His169=)RASopathy [RCV001446464]likely benign12112453369112453369Human1name
127335460CV1122309single nucleotide variantNM_002834.5(PTPN11):c.312T>C (p.Cys104=)RASopathy [RCV001474311]likely benign12112450492112450492Human1name
127288198CV1152484single nucleotide variantNM_002834.5(PTPN11):c.80G>A (p.Gly27Asp)not provided [RCV001508340]uncertain significance12112446341112446341Humanname
150417775CV1180935duplicationNM_002834.5(PTPN11):c.642+158_642+159dupnot provided [RCV001550293]likely benign12112454818112454819Humanname
150452073CV1220948microsatelliteNM_002834.5(PTPN11):c.1448-15_1448-13delRASopathy [RCV002072906]|not provided [RCV001612042]|not specified [RCV003226482]benign|likely benign12112489006112489008Humanname
150439077CV1247671deletionNM_002834.5(PTPN11):c.642+158_642+159delnot provided [RCV001666038]benign12112454819112454820Humanname
150546725CV1291627single nucleotide variantNM_002834.5(PTPN11):c.363A>G (p.Glu121=)RASopathy [RCV002539827]|not specified [RCV001733382]likely benign12112453225112453225Human1name
150549871CV1299702single nucleotide variantNM_002834.5(PTPN11):c.957C>T (p.Asn319=)Cardiovascular phenotype [RCV002386529]|Noonan syndrome 1 [RCV002477970]|RASopathy [RCV003539405]|not provided [RCV001752628]|not specified [RCV004699460]likely benign|uncertain significance12112477880112477880Human8name
151740243CV1386472single nucleotide variantNM_002834.5(PTPN11):c.34A>G (p.Thr12Ala)RASopathy [RCV001893199]uncertain significance12112446295112446295Human1name
8688321CV138851single nucleotide variantNM_002834.5(PTPN11):c.53A>G (p.Asn18Ser)Cardiovascular phenotype [RCV002345428]|LEOPARD syndrome 1 [RCV000318336]|Metachondromatosis [RCV000261129]|Noonan syndrome 1 [RCV000353569]|Noonan syndrome and Noonan-related syndrome [RCV001813381]|PTPN11-related disorder [RCV004530030]|RASopathy [RCV000521827benign|likely benign|uncertain significance|not provided12112446314112446314Human6name , alternate_id
151713704CV1464312single nucleotide variantNM_002834.5(PTPN11):c.793C>A (p.Arg265=)Cardiovascular phenotype [RCV005262615]|RASopathy [RCV001964799]likely benign|uncertain significance12112472980112472980Human1name
152161409CV1531107single nucleotide variantNM_002834.5(PTPN11):c.768A>G (p.Gln256=)Cardiovascular phenotype [RCV004982919]|RASopathy [RCV002123263]|not specified [RCV004700653]likely benign12112472955112472955Human1name
152143274CV1607543single nucleotide variantNM_002834.5(PTPN11):c.376T>C (p.Leu126=)Cardiovascular phenotype [RCV004982903]|RASopathy [RCV002101073]likely benign12112453238112453238Human1name
152162404CV1608859single nucleotide variantNM_002834.5(PTPN11):c.915C>T (p.Ile305=)RASopathy [RCV002104048]likely benign12112477712112477712Human1name
152145214CV1661523single nucleotide variantNM_002834.5(PTPN11):c.567T>C (p.Ser189=)Cardiovascular phenotype [RCV004656860]|RASopathy [RCV002157326]likely benign12112454605112454605Human1name
152156337CV1668516duplicationNM_002834.5(PTPN11):c.*33-145_*33-144dupnot provided [RCV002222798]likely benign12112505656112505657Humanname
152981234CV1676705single nucleotide variantNM_002834.5(PTPN11):c.28A>C (p.Asn10His)Metachondromatosis [RCV002247769]uncertain significance12112446289112446289Human1name
155265256CV1704715single nucleotide variantNM_002834.5(PTPN11):c.91G>T (p.Ala31Ser)not provided [RCV002284931]uncertain significance12112446352112446352Humanname
9689320CV175395single nucleotide variantNM_002834.5(PTPN11):c.558G>T (p.Arg186=)Cardiovascular phenotype [RCV000617423]|Juvenile myelomonocytic leukemia [RCV003315942]|LEOPARD syndrome 1 [RCV001109481]|Metachondromatosis [RCV001109479]|Noonan syndrome 1 [RCV001109480]|Noonan syndrome 1 [RCV002498744]|Noonan syndrome and Noonan-related syndrome [RCV001813400]|RASopathy [RCV00051benign|likely benign|conflicting interpretations of pathogenicity12112454596112454596Human8name
155721541CV1817286single nucleotide variantNM_002834.5(PTPN11):c.864C>G (p.Thr288=)Cardiovascular phenotype [RCV002449630]likely benign12112477661112477661Humanname
155705268CV1824115single nucleotide variantNM_002834.5(PTPN11):c.843C>T (p.Asn281=)Cardiovascular phenotype [RCV002445937]likely benign12112473030112473030Humanname
155996847CV1875942single nucleotide variantNM_002834.5(PTPN11):c.342T>C (p.His114=)RASopathy [RCV003076385]likely benign12112453204112453204Human1name
156406138CV1894746single nucleotide variantNM_002834.5(PTPN11):c.354T>G (p.Ser118=)RASopathy [RCV003070247]likely benign12112453216112453216Human1name
156090696CV1919727single nucleotide variantNM_002834.5(PTPN11):c.351C>G (p.Leu117=)Cardiovascular phenotype [RCV005264364]|RASopathy [RCV002591900]likely benign12112453213112453213Human1name
156377088CV1930600single nucleotide variantNM_002834.5(PTPN11):c.912C>T (p.Tyr304=)RASopathy [RCV002633929]likely benign12112477709112477709Human1name
156237124CV1952840single nucleotide variantNM_002834.5(PTPN11):c.528A>G (p.Glu176=)Cardiovascular phenotype [RCV003365739]|RASopathy [RCV002576095]likely benign12112454566112454566Human1name
156353596CV1962201single nucleotide variantNM_002834.5(PTPN11):c.654G>A (p.Thr218=)Cardiovascular phenotype [RCV004983014]|RASopathy [RCV002581233]likely benign12112455961112455961Human1name
156055786CV2003363single nucleotide variantNM_002834.5(PTPN11):c.696A>G (p.Glu232=)RASopathy [RCV002659516]likely benign12112456003112456003Human1name
156363941CV2003422single nucleotide variantNM_002834.5(PTPN11):c.570G>A (p.Leu190=)RASopathy [RCV002676431]likely benign12112454608112454608Human1name
155955287CV2069862single nucleotide variantNM_002834.5(PTPN11):c.645C>G (p.Pro215=)RASopathy [RCV002816483]likely benign12112455952112455952Human1name
156080556CV2138165single nucleotide variantNM_002834.5(PTPN11):c.29A>G (p.Asn10Ser)RASopathy [RCV002979245]|not provided [RCV004763497]uncertain significance12112446290112446290Human1name
156349182CV2191571single nucleotide variantNM_002834.5(PTPN11):c.384A>G (p.Glu128=)RASopathy [RCV003048199]likely benign12112453246112453246Human1name
10767798CV222205single nucleotide variantNM_002834.5(PTPN11):c.624A>G (p.Thr208=)Cardiovascular phenotype [RCV004020525]|RASopathy [RCV000205330]|not specified [RCV000615915]likely benign|uncertain significance12112454662112454662Human1name
11090443CV230258single nucleotide variantNM_002834.5(PTPN11):c.831T>C (p.Asn277=)not specified [RCV000216054]likely benign12112473018112473018Humanname
11345078CV236790single nucleotide variantNM_002834.5(PTPN11):c.642G>A (p.Gln214=)Cardiovascular phenotype [RCV000248716]|Noonan syndrome 1 [RCV002494609]|RASopathy [RCV000538418]|not provided [RCV000680327]|not specified [RCV000223920]uncertain significance12112454680112454680Human8name
156435686CV2402976single nucleotide variantNM_002834.5(PTPN11):c.501G>C (p.Val167=)Noonan syndrome 1 [RCV003126404]uncertain significance12112453363112453363Human1name
243059782CV2413599single nucleotide variantNM_002834.5(PTPN11):c.849G>T (p.Leu283=)Cardiovascular phenotype [RCV004246051]|not provided [RCV003135160]likely benign|uncertain significance12112473036112473036Humanname
329381401CV2423770single nucleotide variantNM_002834.5(PTPN11):c.555A>G (p.Glu185=)Cardiovascular phenotype [RCV003188014]likely benign12112454593112454593Humanname
329381405CV2423772single nucleotide variantNM_002834.5(PTPN11):c.762A>G (p.Leu254=)Cardiovascular phenotype [RCV003188016]|RASopathy [RCV005101174]likely benign12112472949112472949Human1name
11548223CV254412single nucleotide variantNM_002834.5(PTPN11):c.381T>C (p.Thr127=)RASopathy [RCV002058125]|not specified [RCV000248803]likely benign12112453243112453243Human1name
11545385CV254415single nucleotide variantNM_002834.5(PTPN11):c.540C>T (p.Asp180=)Cardiovascular phenotype [RCV002347958]|RASopathy [RCV001482261]|not provided [RCV001668484]|not specified [RCV000245064]likely benign12112454578112454578Human1name
401756909CV2729576single nucleotide variantNM_002834.5(PTPN11):c.456C>T (p.Arg152=)Cardiovascular phenotype [RCV003297537]likely benign12112453318112453318Humanname
401756912CV2734638single nucleotide variantNM_002834.5(PTPN11):c.813A>G (p.Gln271=)Cardiovascular phenotype [RCV003297538]likely benign12112473000112473000Humanname
401855223CV2764072single nucleotide variantNM_002834.5(PTPN11):c.28A>T (p.Asn10Tyr)Cardiovascular phenotype [RCV003339290]|not provided [RCV004784143]uncertain significance12112446289112446289Humanname
401888054CV2781895single nucleotide variantNM_002834.5(PTPN11):c.984T>C (p.Ile328=)Cardiovascular phenotype [RCV003367462]|RASopathy [RCV003655422]likely benign12112477907112477907Human1name
401932430CV2816879single nucleotide variantNM_002834.5(PTPN11):c.432T>C (p.Pro144=)Cardiovascular phenotype [RCV005264412]|RASopathy [RCV005100020]|not provided [RCV003392034]likely benign12112453294112453294Human1name
405157617CV2856602single nucleotide variantNM_002834.5(PTPN11):c.29A>C (p.Asn10Thr)RASopathy [RCV003539596]|not provided [RCV005220744]uncertain significance12112446290112446290Human1name
405157500CV2863014single nucleotide variantNM_002834.5(PTPN11):c.32T>C (p.Ile11Thr)RASopathy [RCV003539587]uncertain significance12112446293112446293Human1name
405157697CV2877463single nucleotide variantNM_002834.5(PTPN11):c.697C>T (p.Leu233=)RASopathy [RCV003539602]likely benign12112456004112456004Human1name
405159355CV2887502single nucleotide variantNM_002834.5(PTPN11):c.882T>C (p.Asp294=)Cardiovascular phenotype [RCV005264436]|RASopathy [RCV003539730]likely benign12112477679112477679Human1name
405054344CV2936493single nucleotide variantNM_002834.5(PTPN11):c.861T>C (p.His287=)Cardiovascular phenotype [RCV004985453]|RASopathy [RCV003655437]likely benign12112477658112477658Human1name
405055372CV2938714single nucleotide variantNM_002834.5(PTPN11):c.636C>A (p.Leu212=)RASopathy [RCV003655499]likely benign12112454674112454674Human1name
405057967CV2966677single nucleotide variantNM_002834.5(PTPN11):c.825C>T (p.Asn275=)Cardiovascular phenotype [RCV004673941]|RASopathy [RCV003655723]likely benign12112473012112473012Human1name
405059994CV2969877single nucleotide variantNM_002834.5(PTPN11):c.55C>G (p.Leu19Val)RASopathy [RCV003655713]uncertain significance12112446316112446316Human1name
405062252CV3021566single nucleotide variantNM_002834.5(PTPN11):c.645C>A (p.Pro215=)RASopathy [RCV003656040]likely benign12112455952112455952Human1name
405138442CV3125459single nucleotide variantNM_002834.5(PTPN11):c.948C>G (p.Thr316=)Cardiovascular phenotype [RCV005264516]|RASopathy [RCV003816566]likely benign12112477871112477871Human1name
405277921CV3191303single nucleotide variantNM_002834.5(PTPN11):c.906A>G (p.Ser302=)Cardiovascular phenotype [RCV004987146]|PTPN11-related disorder [RCV004539306]likely benign12112477703112477703Humanname , alternate_id
11615897CV330590single nucleotide variantNM_002834.5(PTPN11):c.951G>A (p.Lys317=)Cardiovascular phenotype [RCV002317829]|LEOPARD syndrome 1 [RCV000347113]|Metachondromatosis [RCV000382358]|Noonan syndrome 1 [RCV000289778]|Noonan syndrome and Noonan-related syndrome [RCV001813456]|PTPN11-related disorder [RCV004544527]|RASopathy [RCV000522223benign|likely benign|uncertain significance12112477874112477874Human6name , alternate_id
405675709CV3386471indelNM_002834.5(PTPN11):c.1713-6_1731delinsGCardiovascular phenotype [RCV004516217]uncertain significance12112504689112504713Humanname
597706626CV3585041single nucleotide variantNM_002834.5(PTPN11):c.837T>C (p.Tyr279=)Cardiovascular phenotype [RCV004989460]likely benign12112473024112473024Humanname
597836553CV3739791single nucleotide variantNM_002834.5(PTPN11):c.345A>T (p.Gly115=)RASopathy [RCV005064011]likely benign12112453207112453207Human1name
12833224CV374586single nucleotide variantNM_002834.5(PTPN11):c.537C>T (p.Tyr179=)Cardiovascular phenotype [RCV003168629]|RASopathy [RCV001081959]|not provided [RCV000418110]|not specified [RCV001797715]likely benign12112454575112454575Human1name
597938742CV3788345single nucleotide variantNM_002834.5(PTPN11):c.945A>G (p.Glu315=)RASopathy [RCV005133020]likely benign12112477868112477868Human1name
597835420CV3828214single nucleotide variantNM_002834.5(PTPN11):c.666T>C (p.Asn222=)RASopathy [RCV005171106]likely benign12112455973112455973Human1name
597974771CV3831831single nucleotide variantNM_002834.5(PTPN11):c.834A>G (p.Arg278=)RASopathy [RCV005168770]uncertain significance12112473021112473021Human1name
597928168CV3851744single nucleotide variantNM_002834.5(PTPN11):c.954C>T (p.Cys318=)RASopathy [RCV005206212]likely benign12112477877112477877Human1name
598126678CV3882133single nucleotide variantNM_002834.5(PTPN11):c.40G>T (p.Val14Leu)not provided [RCV005233684]uncertain significance12112446301112446301Humanname
598181373CV3904796single nucleotide variantNM_002834.5(PTPN11):c.558G>A (p.Arg186=)Cardiovascular phenotype [RCV005265190]likely benign12112454596112454596Humanname
598181381CV3904798single nucleotide variantNM_002834.5(PTPN11):c.483T>C (p.Asn161=)Cardiovascular phenotype [RCV005265192]likely benign12112453345112453345Humanname
598181415CV3904808single nucleotide variantNM_002834.5(PTPN11):c.615A>T (p.Thr205=)Cardiovascular phenotype [RCV005265202]likely benign12112454653112454653Humanname
598181416CV3904809single nucleotide variantNM_002834.5(PTPN11):c.897G>A (p.Glu299=)Cardiovascular phenotype [RCV005265203]likely benign12112477694112477694Humanname
598181418CV3904810single nucleotide variantNM_002834.5(PTPN11):c.852C>T (p.Pro284=)Cardiovascular phenotype [RCV005265204]likely benign12112473039112473039Humanname
598181435CV3904815single nucleotide variantNM_002834.5(PTPN11):c.840A>G (p.Lys280=)Cardiovascular phenotype [RCV005265209]likely benign12112473027112473027Humanname
598181444CV3904818single nucleotide variantNM_002834.5(PTPN11):c.804T>A (p.Gly268=)Cardiovascular phenotype [RCV005265212]likely benign12112472991112472991Humanname
598181467CV3904826single nucleotide variantNM_002834.5(PTPN11):c.366A>G (p.Ala122=)Cardiovascular phenotype [RCV005265220]likely benign12112453228112453228Humanname
13520287CV487331single nucleotide variantNM_002834.5(PTPN11):c.327T>G (p.Ser109=)Cardiovascular phenotype [RCV002448824]|Noonan syndrome 1 [RCV002491168]|RASopathy [RCV001432258]|not specified [RCV000587505]likely benign|uncertain significance12112450507112450507Human8name
8604452CV48951single nucleotide variantNM_002834.4(PTPN11):c.56T>G (p.Leu19Arg)Rasopathy [RCV000033449]uncertain significance12112446317112446317Humanname
8604484CV48985single nucleotide variantNM_002834.5(PTPN11):c.486C>T (p.Asp162=)Cardiovascular phenotype [RCV000244264]|Juvenile myelomonocytic leukemia [RCV003315535]|PTPN11-related disorder [RCV004532488]|RASopathy [RCV000033493]|not provided [RCV001711362]|not specified [RCV002265575]benign|likely benign|conflicting interpretations of pathogenicity12112453348112453348Human3name , alternate_id
8604501CV49004single nucleotide variantNM_002834.5(PTPN11):c.879C>T (p.His293=)Cardiovascular phenotype [RCV004018711]|Metachondromatosis [RCV005234826]|RASopathy [RCV000033515]|not provided [RCV001719720]|not specified [RCV000242514]benign|likely benign12112477676112477676Human2name
8604505CV49008single nucleotide variantNM_002834.5(PTPN11):c.990A>C (p.Thr330=)Cardiovascular phenotype [RCV002381281]|Juvenile myelomonocytic leukemia [RCV003315538]|Noonan syndrome and Noonan-related syndrome [RCV001813253]|RASopathy [RCV000033521]|not provided [RCV001711218]|not specified [RCV000220386]benign|likely benign|uncertain significance12112477913112477913Human3name
8604506CV49009single nucleotide variantNM_002834.5(PTPN11):c.996C>T (p.Gly332=)Cardiovascular phenotype [RCV002381282]|Juvenile myelomonocytic leukemia [RCV003315539]|Metachondromatosis [RCV005234827]|RASopathy [RCV000033522]|not provided [RCV001531173]|not specified [RCV001264432]benign|likely benign|conflicting interpretations of pathogenicity12112477919112477919Human4name
13530643CV497213single nucleotide variantNM_002834.5(PTPN11):c.519C>G (p.Arg173=)Cardiovascular phenotype [RCV005260249]|Noonan syndrome 1 [RCV002498983]|RASopathy [RCV001466747]|not specified [RCV000606201]likely benign12112453381112453381Human8name
13526126CV503545single nucleotide variantNM_002834.5(PTPN11):c.372A>G (p.Lys124=)Cardiovascular phenotype [RCV005260244]|not specified [RCV000603702]likely benign12112453234112453234Humanname
13533292CV510344single nucleotide variantNM_002834.5(PTPN11):c.426C>T (p.Ser142=)Cardiovascular phenotype [RCV000617336]|Noonan syndrome and Noonan-related syndrome [RCV001813532]|RASopathy [RCV001448239]|not provided [RCV001712724]|not specified [RCV004782475]likely benign|uncertain significance12112453288112453288Human1name
13533341CV510345single nucleotide variantNM_002834.5(PTPN11):c.874C>T (p.Leu292=)Cardiovascular phenotype [RCV000617412]|Noonan syndrome 1 [RCV002491334]|RASopathy [RCV003655149]likely benign12112477671112477671Human8name
8607427CV53773single nucleotide variantNM_002834.5(PTPN11):c.315A>T (p.Ala105=)not specified [RCV000037643]likely benign12112450495112450495Humanname
13829464CV579766single nucleotide variantNM_002834.5(PTPN11):c.438T>C (p.Asp146=)Cardiovascular phenotype [RCV002315314]likely benign12112453300112453300Humanname
15167611CV687880single nucleotide variantNM_002834.5(PTPN11):c.616T>C (p.Leu206=)Cardiovascular phenotype [RCV002352544]|Noonan syndrome 1 [RCV002501269]|PTPN11-related disorder [RCV004538257]|RASopathy [RCV001455888]|not provided [RCV000867523]likely benign12112454654112454654Human8name , alternate_id
15167436CV687881single nucleotide variantNM_002834.5(PTPN11):c.636C>G (p.Leu212=)RASopathy [RCV000865132]likely benign12112454674112454674Human1name
15170103CV753102single nucleotide variantNM_002834.5(PTPN11):c.393A>G (p.Lys131=)not provided [RCV000915735]likely benign12112453255112453255Humanname
15170223CV753103single nucleotide variantNM_002834.5(PTPN11):c.615A>G (p.Thr205=)Cardiovascular phenotype [RCV002354755]|RASopathy [RCV002065915]likely benign12112454653112454653Human1name
26914180CV839322single nucleotide variantNM_002834.5(PTPN11):c.28A>G (p.Asn10Asp)Cardiovascular phenotype [RCV002434455]|RASopathy [RCV001040499]|not provided [RCV002282433]uncertain significance12112446289112446289Human1name
38471142CV935921single nucleotide variantNM_002834.5(PTPN11):c.489C>T (p.Gly163=)RASopathy [RCV001210345]likely pathogenic12112453351112453351Human1name
38597840CV964372single nucleotide variantNM_002834.5(PTPN11):c.92C>G (p.Ala31Gly)LEOPARD syndrome 1 [RCV001253203]likely pathogenic12112446353112446353Human1name
40814692CV969665single nucleotide variantNM_002834.5(PTPN11):c.64A>G (p.Thr22Ala)Noonan syndrome 1 [RCV005012701]|Noonan syndrome [RCV001261096]|RASopathy [RCV003539390]uncertain significance12112446325112446325Human4name
126746411CV1015372single nucleotide variantNM_002834.5(PTPN11):c.1131A>C (p.Leu377=)Cardiovascular phenotype [RCV002322261]|Noonan syndrome 1 [RCV002493717]|RASopathy [RCV001456317]|not provided [RCV003456490]|not specified [RCV001328460]likely benign12112482112112482112Human8name
126730038CV1030664single nucleotide variantNM_002834.5(PTPN11):c.133G>A (p.Val45Ile)RASopathy [RCV001349203]uncertain significance12112446394112446394Human1name
127238484CV1100855single nucleotide variantNM_002834.5(PTPN11):c.1218T>C (p.Val406=)Cardiovascular phenotype [RCV003298716]|RASopathy [RCV001422915]likely benign12112482199112482199Human1name
127328629CV1122311single nucleotide variantNM_002834.5(PTPN11):c.1242G>T (p.Thr414=)Cardiovascular phenotype [RCV002384757]|RASopathy [RCV001469661]|not specified [RCV005405615]likely benign12112486492112486492Human1name
127296722CV1122312single nucleotide variantNM_002834.5(PTPN11):c.1575A>G (p.Leu525=)Cardiovascular phenotype [RCV004038513]|RASopathy [RCV001452814]likely benign12112489151112489151Human1name
127316711CV1143172single nucleotide variantNM_002834.5(PTPN11):c.1176C>T (p.Ala392=)Cardiovascular phenotype [RCV002329635]|RASopathy [RCV001503093]likely benign12112482157112482157Human1name
150426805CV1187835single nucleotide variantNM_002834.5(PTPN11):c.290A>T (p.Glu97Val)Cardiovascular phenotype [RCV004988685]|RASopathy [RCV003771714]|not provided [RCV001560047]uncertain significance12112450470112450470Human1name
150427222CV1187838single nucleotide variantNM_002834.5(PTPN11):c.1653C>T (p.Asp551=)not provided [RCV001560643]likely benign12112502197112502197Humanname
150459817CV1202977single nucleotide variantNM_002834.5(PTPN11):c.145G>A (p.Gly49Arg)not provided [RCV001586630]uncertain significance12112450325112450325Humanname
150451630CV1207244single nucleotide variantNM_002834.5(PTPN11):c.1365C>T (p.Val455=)Cardiovascular phenotype [RCV002386480]|not specified [RCV001582374]likely benign12112486615112486615Humanname
150453634CV1219861single nucleotide variantNM_002834.5(PTPN11):c.1362G>A (p.Pro454=)Cardiovascular phenotype [RCV002386491]|RASopathy [RCV002072907]|not provided [RCV001612242]likely benign12112486612112486612Human1name
150534878CV1311667single nucleotide variantNM_002834.5(PTPN11):c.1011G>C (p.Thr337=)not specified [RCV001779477]likely benign12112477934112477934Humanname
151352171CV1325126single nucleotide variantNM_002834.5(PTPN11):c.1662T>C (p.Ser554=)Noonan syndrome and Noonan-related syndrome [RCV001813682]uncertain significance12112502206112502206Humanname
151664387CV1332546single nucleotide variantNM_002834.5(PTPN11):c.127C>G (p.Leu43Val)LEOPARD syndrome 1 [RCV001829267]|Noonan syndrome 1 [RCV002503336]|RASopathy [RCV002542777]uncertain significance12112446388112446388Human4name
151748183CV1353155single nucleotide variantNM_002834.5(PTPN11):c.164A>G (p.Lys55Arg)RASopathy [RCV001912687]uncertain significance12112450344112450344Human1name
8688322CV138852single nucleotide variantNM_002834.5(PTPN11):c.148G>A (p.Ala50Thr)RASopathy [RCV001854672]|not specified [RCV000121912]uncertain significance|not provided12112450328112450328Human1name
151880871CV1406021single nucleotide variantNM_002834.5(PTPN11):c.281A>G (p.Asp94Gly)RASopathy [RCV001941013]uncertain significance12112450461112450461Human1name
151808951CV1407330single nucleotide variantNM_002834.5(PTPN11):c.276T>A (p.Asn92Lys)RASopathy [RCV002048672]uncertain significance12112450456112450456Human1name
8692574CV142543single nucleotide variantNM_002834.5(PTPN11):c.1404G>C (p.Thr468=)Cardiovascular phenotype [RCV002390292]|RASopathy [RCV002055763]|not specified [RCV000127654]benign|likely benign|conflicting interpretations of pathogenicity12112488467112488467Human1name
8692576CV142545single nucleotide variantNM_002834.5(PTPN11):c.1620C>T (p.His540=)Cardiovascular phenotype [RCV004019722]|Noonan syndrome [RCV000157005]|RASopathy [RCV001474997]|not specified [RCV000127656]benign|likely benign12112502164112502164Human2name
8692577CV142546single nucleotide variantNM_002834.5(PTPN11):c.1650G>A (p.Ala550=)Cardiovascular phenotype [RCV000241744]|LEOPARD syndrome 1 [RCV000405570]|Metachondromatosis [RCV000311634]|Noonan syndrome 1 [RCV000368773]|Noonan syndrome 1 [RCV002492485]|PTPN11-related disorder [RCV004532529]|RASopathy [RCV000519368]|not specified [RCV000127benign|likely benign|uncertain significance12112502194112502194Human8name , alternate_id
151745685CV1428192single nucleotide variantNM_002834.5(PTPN11):c.256G>A (p.Gly86Arg)Noonan syndrome 1 [RCV005002682]|RASopathy [RCV001926935]uncertain significance12112450436112450436Human3name
151814191CV1460512single nucleotide variantNM_002834.5(PTPN11):c.1302C>T (p.Gly434=)Cardiovascular phenotype [RCV004039644]|RASopathy [RCV001878573]likely benign|uncertain significance12112486552112486552Human1name
151878417CV1476041single nucleotide variantNM_002834.5(PTPN11):c.246G>C (p.Met82Ile)RASopathy [RCV002019827]uncertain significance12112450426112450426Human1name
151853774CV1485184single nucleotide variantNM_002834.5(PTPN11):c.283G>A (p.Val95Ile)RASopathy [RCV002033513]uncertain significance12112450463112450463Human1name
151854890CV1506458single nucleotide variantNM_002834.5(PTPN11):c.1098A>G (p.Lys366=)RASopathy [RCV001937823]|not provided [RCV003389887]likely benign|uncertain significance12112482079112482079Human1name
151742601CV1514791single nucleotide variantNM_002834.5(PTPN11):c.289G>A (p.Glu97Lys)Noonan syndrome 1 [RCV002492325]|RASopathy [RCV002022467]|not provided [RCV005414633]uncertain significance12112450469112450469Human3name
152098416CV1530744single nucleotide variantNM_002834.5(PTPN11):c.1635T>C (p.Ile545=)Cardiovascular phenotype [RCV003161586]|RASopathy [RCV002132941]likely benign12112502179112502179Human1name
152120040CV1547322single nucleotide variantNM_002834.5(PTPN11):c.1242G>C (p.Thr414=)RASopathy [RCV002081427]likely benign12112486492112486492Human1name
152158160CV1552826single nucleotide variantNM_002834.5(PTPN11):c.1233G>A (p.Thr411=)Cardiovascular phenotype [RCV004982884]|Noonan syndrome 1 [RCV002498174]|RASopathy [RCV002180444]likely benign12112486483112486483Human8name
152046721CV1561492single nucleotide variantNM_002834.5(PTPN11):c.1311C>T (p.Asp437=)Cardiovascular phenotype [RCV005264207]|RASopathy [RCV002108426]likely benign12112486561112486561Human1name
152102552CV1590824single nucleotide variantNM_002834.5(PTPN11):c.1659G>A (p.Thr553=)Cardiovascular phenotype [RCV002398232]|RASopathy [RCV002115533]likely benign12112502203112502203Human1name
152162933CV1600665single nucleotide variantNM_002834.5(PTPN11):c.1398A>G (p.Thr466=)Cardiovascular phenotype [RCV004982928]|RASopathy [RCV002141237]likely benign12112488461112488461Human1name
152052158CV1607192single nucleotide variantNM_002834.5(PTPN11):c.1008C>T (p.Asn336=)RASopathy [RCV002109108]likely benign12112477931112477931Human1name
152073496CV1638015single nucleotide variantNM_002834.5(PTPN11):c.1521A>G (p.Thr507=)RASopathy [RCV002192105]likely benign12112489097112489097Human1name
152039007CV1642507single nucleotide variantNM_002834.5(PTPN11):c.1731T>G (p.Ala577=)RASopathy [RCV002107456]likely benign12112504713112504713Human1name
152032342CV1643062single nucleotide variantNM_002834.5(PTPN11):c.1425T>C (p.Leu475=)RASopathy [RCV002204951]likely benign12112488488112488488Human1name
152050226CV1657159single nucleotide variantNM_002834.5(PTPN11):c.1356A>G (p.Ala452=)RASopathy [RCV002189319]likely benign12112486606112486606Human1name
153303951CV1690569single nucleotide variantNM_002834.5(PTPN11):c.281A>T (p.Asp94Val)RASopathy [RCV005095967]|not provided [RCV002269613]uncertain significance12112450461112450461Human1name
155265312CV1695504single nucleotide variantNM_002834.5(PTPN11):c.1224A>G (p.Gln408=)Cardiovascular phenotype [RCV004656914]|RASopathy [RCV005096013]|not provided [RCV002280236]likely benign|uncertain significance12112482205112482205Human1name
9692115CV175394single nucleotide variantNM_002834.5(PTPN11):c.206A>T (p.Glu69Val)LEOPARD syndrome 1 [RCV004562308]|Metachondromatosis [RCV004562307]|Noonan syndrome 1 [RCV004562306]|Noonan syndrome 3 [RCV000589756]|Noonan syndrome [RCV000151687]pathogenic|likely pathogenic|uncertain significance12112450386112450386Human5name
9690970CV175396single nucleotide variantNM_002834.5(PTPN11):c.1161C>T (p.Asn387=)Cardiovascular phenotype [RCV004019884]|RASopathy [RCV001469624]|not specified [RCV000156668]likely benign12112482142112482142Human1name
9690333CV175539single nucleotide variantNM_002834.5(PTPN11):c.182A>C (p.Asp61Ala)Noonan syndrome [RCV000156008]|RASopathy [RCV000780656]pathogenic|likely pathogenic12112450362112450362Human2name
9688972CV175540single nucleotide variantNM_002834.5(PTPN11):c.214G>A (p.Ala72Thr)Juvenile myelomonocytic leukemia [RCV000824740]|Noonan syndrome 1 [RCV000995620]|Noonan syndrome and Noonan-related syndrome [RCV001813395]|RASopathy [RCV000154367]|not provided [RCV000680626]pathogenic|likely pathogenic|uncertain significance12112450394112450394Human5name
9689103CV175543single nucleotide variantNM_002834.5(PTPN11):c.1551G>A (p.Ala517=)Cardiovascular phenotype [RCV002316978]|Metachondromatosis [RCV005235047]|Noonan syndrome 1 [RCV005003500]|RASopathy [RCV001359353]|not specified [RCV000154531]benign|likely benign|uncertain significance12112489127112489127Human8name
155716388CV1785163single nucleotide variantNM_002834.5(PTPN11):c.1129C>T (p.Leu377=)Cardiovascular phenotype [RCV002326023]|RASopathy [RCV003099199]likely benign12112482110112482110Human1name
9833400CV179443single nucleotide variantNM_002834.5(PTPN11):c.172A>T (p.Asn58Tyr)RASopathy [RCV001174933]|not provided [RCV000159042]pathogenic|likely pathogenic12112450352112450352Human1name
9833401CV179444single nucleotide variantNM_002834.5(PTPN11):c.211T>G (p.Phe71Val)Noonan syndrome 1 [RCV004593995]|not provided [RCV000159044]pathogenic12112450391112450391Human1name
9833402CV179445single nucleotide variantNM_002834.5(PTPN11):c.226G>C (p.Glu76Gln)Noonan syndrome 1 [RCV002288669]|Noonan syndrome and Noonan-related syndrome [RCV001813410]|RASopathy [RCV002281971]|not provided [RCV000159045]pathogenic|likely pathogenic12112450406112450406Human3name
155745384CV1834384single nucleotide variantNM_002834.5(PTPN11):c.1704C>T (p.Pro568=)Cardiovascular phenotype [RCV002414724]|RASopathy [RCV003539450]likely benign12112502248112502248Human1name
155693476CV1837161single nucleotide variantNM_002834.5(PTPN11):c.1530G>A (p.Gln510=)Cardiovascular phenotype [RCV002392559]|RASopathy [RCV003539446]likely benign12112489106112489106Human1name
155745758CV1838816single nucleotide variantNM_002834.5(PTPN11):c.185A>G (p.Tyr62Cys)Cardiovascular phenotype [RCV002414886]|RASopathy [RCV003539452]uncertain significance12112450365112450365Human1name
156128675CV1921472single nucleotide variantNM_002834.5(PTPN11):c.217A>G (p.Thr73Ala)RASopathy [RCV002623226]likely pathogenic12112450397112450397Human1name
156152266CV1934444single nucleotide variantNM_002834.5(PTPN11):c.1609A>C (p.Arg537=)RASopathy [RCV002663935]likely benign12112502153112502153Human1name
156411492CV1973430single nucleotide variantNM_002834.5(PTPN11):c.1578G>A (p.Gln526=)RASopathy [RCV002608267]likely benign12112489154112489154Human1name
156240595CV2028255single nucleotide variantNM_002834.5(PTPN11):c.1302C>A (p.Gly434=)RASopathy [RCV002745648]likely benign12112486552112486552Human1name
156084541CV2060438single nucleotide variantNM_002834.5(PTPN11):c.206A>C (p.Glu69Ala)RASopathy [RCV002823966]likely pathogenic12112450386112450386Human1name
156226869CV2081145single nucleotide variantNM_002834.5(PTPN11):c.237G>C (p.Gln79His)RASopathy [RCV002853422]likely pathogenic12112450417112450417Human1name
155980074CV2101666single nucleotide variantNM_002834.5(PTPN11):c.1458C>T (p.Cys486=)Cardiovascular phenotype [RCV004983166]|RASopathy [RCV002907661]likely benign12112489034112489034Human1name
156350712CV2157457single nucleotide variantNM_002834.5(PTPN11):c.1623A>G (p.Glu541=)Cardiovascular phenotype [RCV005264313]|RASopathy [RCV003030851]likely benign12112502167112502167Human1name
156194817CV2175447single nucleotide variantNM_002834.5(PTPN11):c.1410T>C (p.Ile470=)RASopathy [RCV003057957]likely benign12112488473112488473Human1name
11050653CV226150single nucleotide variantNM_002834.5(PTPN11):c.205G>A (p.Glu69Lys)Cardiovascular phenotype [RCV002415881]|Juvenile myelomonocytic leukemia [RCV005251095]|Noonan syndrome 1 [RCV001250211]|not provided [RCV000210038]likely pathogenic|uncertain significance12112450385112450385Human4name
11051369CV226151single nucleotide variantNM_002834.5(PTPN11):c.272A>G (p.Lys91Arg)not specified [RCV000210044]uncertain significance12112450452112450452Humanname
11090112CV230257single nucleotide variantNM_002834.5(PTPN11):c.181G>T (p.Asp61Tyr)Juvenile myelomonocytic leukemia [RCV000215649]|Noonan syndrome 1 [RCV003992237]|not provided [RCV001090939]pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112450361112450361Human3name
11551273CV254416single nucleotide variantNM_002834.5(PTPN11):c.1011G>A (p.Thr337=)Cardiovascular phenotype [RCV003362737]|Noonan syndrome 1 [RCV002500898]|RASopathy [RCV001410326]|not provided [RCV000680322]|not specified [RCV000252825]likely benign12112477934112477934Human8name
11547125CV254417single nucleotide variantNM_002834.5(PTPN11):c.1278C>T (p.His426=)Cardiovascular phenotype [RCV002374417]|RASopathy [RCV001484623]|not provided [RCV000680323]|not specified [RCV000247355]likely benign12112486528112486528Human1name
11550788CV258714single nucleotide variantNM_002834.5(PTPN11):c.1404G>A (p.Thr468=)Cardiovascular phenotype [RCV000252206]|RASopathy [RCV003765563]pathogenic|likely benign12112488467112488467Human1name
11636254CV264575single nucleotide variantNM_002834.5(PTPN11):c.115G>A (p.Gly39Arg)LEOPARD syndrome 1 [RCV001528118]|RASopathy [RCV002519051]|not provided [RCV000265572]likely pathogenic|uncertain significance12112446376112446376Human2name
329952192CV2668899single nucleotide variantNM_002834.5(PTPN11):c.1698G>A (p.Thr566=)Cardiovascular phenotype [RCV004985320]|not specified [RCV003230983]likely benign12112502242112502242Humanname
11643328CV272270single nucleotide variantNM_002834.5(PTPN11):c.175A>G (p.Thr59Ala)Cardiovascular phenotype [RCV004021238]|Noonan syndrome 1 [RCV005003613]|PTPN11-related disorder [RCV004529475]|RASopathy [RCV001349385]|not provided [RCV000390743]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112450355112450355Human8name , alternate_id
401769144CV2734640single nucleotide variantNM_002834.5(PTPN11):c.1692T>G (p.Thr564=)Cardiovascular phenotype [RCV003283492]likely benign12112502236112502236Humanname
11639581CV273762single nucleotide variantNM_002834.5(PTPN11):c.1740T>C (p.Tyr580=)Cardiovascular phenotype [RCV002411174]|PTPN11-related disorder [RCV004535430]|RASopathy [RCV001493011]|not provided [RCV000681310]likely benign|conflicting interpretations of pathogenicity|uncertain significance12112504722112504722Human1name , alternate_id
401875923CV2750141single nucleotide variantNM_002834.5(PTPN11):c.213T>A (p.Phe71Leu)LEOPARD syndrome 1 [RCV003333582]|Metachondromatosis [RCV003333581]|Noonan syndrome 1 [RCV003333580]likely pathogenic12112450393112450393Human3name
401919108CV2794763single nucleotide variantNM_002834.5(PTPN11):c.1506A>G (p.Ser502=)Cardiovascular phenotype [RCV005264405]|not specified [RCV003388438]likely benign12112489082112489082Humanname
401932433CV2816881single nucleotide variantNM_002834.5(PTPN11):c.1362G>C (p.Pro454=)not provided [RCV003392036]likely benign12112486612112486612Humanname
8599358CV28363single nucleotide variantNM_002834.5(PTPN11):c.214G>T (p.Ala72Ser)Noonan syndrome 1 [RCV000014252]|Noonan syndrome 1 [RCV000576667]|Noonan syndrome 1 [RCV000762883]|Noonan syndrome [RCV000157001]|Noonan syndrome and Noonan-related syndrome [RCV001813190]|RASopathy [RCV000033471]|not provided [RCV000212890]pathogenic12112450394112450394Human8name
8599359CV28364single nucleotide variantNM_002834.5(PTPN11):c.215C>G (p.Ala72Gly)Cardiovascular phenotype [RCV002426502]|Noonan syndrome 1 [RCV000014253]|Noonan syndrome 1 [RCV000515213]|Noonan syndrome 3 [RCV000587329]|Noonan syndrome [RCV000157006]|Noonan syndrome and Noonan-related syndrome [RCV001813191]|RASopathy [RCV000707460]|not provided [RCV000157679]pathogenic|likely pathogenic12112450395112450395Human9name
8599363CV28368single nucleotide variantNM_002834.5(PTPN11):c.184T>G (p.Tyr62Asp)Cardiovascular phenotype [RCV002408460]|Failure to thrive [RCV000590972]|Juvenile myelomonocytic leukemia [RCV000824739]|Noonan syndrome 1 [RCV000014257]|Noonan syndrome 1 [RCV000762882]|Noonan syndrome [RCV000156993]|Noonan syndrome and Noonan-related syndrome [RCV001813195]|PTPN11pathogenic|association12112450364112450364Human20name , alternate_id
8599364CV28369single nucleotide variantNM_002834.5(PTPN11):c.182A>G (p.Asp61Gly)Juvenile myelomonocytic leukemia [RCV000824738]|LEOPARD syndrome 1 [RCV001270166]|Metachondromatosis [RCV003147285]|Non-immune hydrops fetalis [RCV001376030]|Noonan syndrome 1 [RCV000014258]|Noonan syndrome 1 [RCV002490363]|Noonan syndrome and Noonan-related syndrome [RCV001813196]|PTPN11pathogenic|likely pathogenic12112450362112450362Human14name , alternate_id
8599367CV28372single nucleotide variantNM_002834.5(PTPN11):c.188A>G (p.Tyr63Cys)Hereditary cancer-predisposing syndrome [RCV005251036]|LEOPARD syndrome 1 [RCV003137518]|Lymphoma [RCV000722014]|Metachondromatosis [RCV003147286]|Noonan syndrome 1 [RCV000014261]|Noonan syndrome 1 [RCV000515408]|Noonan syndrome 1 [RCV001249667]|Noonan syndrome 3 [RCV000588678]|Noonan syndrome [RCV0pathogenic|conflicting interpretations of pathogenicity12112450368112450368Human12name , alternate_id
8599368CV28373single nucleotide variantNM_002834.5(PTPN11):c.218C>T (p.Thr73Ile)Cardiovascular phenotype [RCV002415414]|LEOPARD syndrome 1 [RCV003147288]|Metachondromatosis [RCV003147287]|Noonan syndrome 1 [RCV000014262]|Noonan syndrome 1 [RCV000515312]|Noonan syndrome [RCV000156985]|Noonan syndrome and Noonan-related syndrome [RCV001813199]|RASopathy [RCV000033475]|not providepathogenic|conflicting interpretations of pathogenicity12112450398112450398Human8name
8599370CV28375single nucleotide variantNM_002834.5(PTPN11):c.226G>A (p.Glu76Lys)Juvenile myelomonocytic leukemia [RCV000014264]|Malignant neoplastic disease [RCV001254876]|Noonan syndrome 1 [RCV004813039]|Noonan syndrome [RCV000156974]|PTPN11-related disorder [RCV004545728]|RASopathy [RCV000033476]|not provided [RCV000212892]pathogenic|likely pathogenic|uncertain significance|other12112450406112450406Human7name , alternate_id
8599371CV28376single nucleotide variantNM_002834.5(PTPN11):c.227A>T (p.Glu76Val)Juvenile myelomonocytic leukemia [RCV000014265]|Noonan syndrome and Noonan-related syndrome [RCV001813201]|RASopathy [RCV000781775]|not provided [RCV000788241]pathogenic|other12112450407112450407Human3name
8599372CV28377single nucleotide variantNM_002834.5(PTPN11):c.227A>G (p.Glu76Gly)Juvenile myelomonocytic leukemia [RCV000014266]|RASopathy [RCV002513040]|not provided [RCV000159046]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters|other12112450407112450407Human3name
8599373CV28378single nucleotide variantNM_002834.5(PTPN11):c.227A>C (p.Glu76Ala)Juvenile myelomonocytic leukemia [RCV000014267]|not provided [RCV000033477]pathogenic|likely pathogenic|other12112450407112450407Human2name
8599374CV28379single nucleotide variantNM_002834.5(PTPN11):c.236A>G (p.Gln79Arg)Cardiovascular phenotype [RCV002453257]|Noonan syndrome 1 [RCV000014268]|Noonan syndrome 1 [RCV000515381]|Noonan syndrome 3 [RCV000590740]|Noonan syndrome [RCV000037641]|Noonan syndrome and Noonan-related syndrome [RCV001813202]|PTPN11-related disorder [RCV00453pathogenic12112450416112450416Human9name , alternate_id
405158997CV2869527single nucleotide variantNM_002834.5(PTPN11):c.1104C>T (p.Val368=)RASopathy [RCV003539702]likely benign12112482085112482085Human1name
405160588CV2892788single nucleotide variantNM_002834.5(PTPN11):c.1017T>C (p.Asn339=)RASopathy [RCV003540078]likely benign12112477940112477940Human1name
405161892CV2895713single nucleotide variantNM_002834.5(PTPN11):c.104A>T (p.Lys35Ile)RASopathy [RCV003540187]uncertain significance12112446365112446365Human1name
405163580CV2897526single nucleotide variantNM_002834.5(PTPN11):c.1329C>T (p.His443=)RASopathy [RCV003540243]likely benign12112486579112486579Human1name
405161530CV2898972single nucleotide variantNM_002834.5(PTPN11):c.236A>C (p.Gln79Pro)RASopathy [RCV003540157]pathogenic12112450416112450416Human1name
405163937CV2910057single nucleotide variantNM_002834.5(PTPN11):c.185A>C (p.Tyr62Ser)RASopathy [RCV003540328]likely pathogenic12112450365112450365Human1name
405163322CV2916421single nucleotide variantNM_002834.5(PTPN11):c.1362G>T (p.Pro454=)RASopathy [RCV003540303]likely benign12112486612112486612Human1name
405164366CV2925497single nucleotide variantNM_002834.5(PTPN11):c.1320G>A (p.Glu440=)RASopathy [RCV003540387]likely benign12112486570112486570Human1name
405164564CV2931127single nucleotide variantNM_002834.5(PTPN11):c.1326G>A (p.Val442=)RASopathy [RCV003540379]uncertain significance12112486576112486576Human1name
405165704CV2931649single nucleotide variantNM_002834.5(PTPN11):c.1086A>G (p.Arg362=)RASopathy [RCV003540399]likely benign12112478009112478009Human1name
405054977CV2937814single nucleotide variantNM_002834.5(PTPN11):c.1290C>T (p.Ser430=)RASopathy [RCV003655470]likely benign12112486540112486540Human1name
405055449CV2945350single nucleotide variantNM_002834.5(PTPN11):c.1461T>C (p.Asp487=)RASopathy [RCV003655504]likely benign12112489037112489037Human1name
405056174CV2950604single nucleotide variantNM_002834.5(PTPN11):c.1533C>T (p.Tyr511=)RASopathy [RCV003655558]likely benign12112489109112489109Human1name
405056021CV2957098single nucleotide variantNM_002834.5(PTPN11):c.1338G>A (p.Gln446=)RASopathy [RCV003655545]likely benign12112486588112486588Human1name
405057726CV2969764single nucleotide variantNM_002834.5(PTPN11):c.1515C>T (p.Val505=)Cardiovascular phenotype [RCV005264472]|RASopathy [RCV003655702]likely benign12112489091112489091Human1name
405062038CV3010878single nucleotide variantNM_002834.5(PTPN11):c.1479C>T (p.Thr493=)RASopathy [RCV003656023]likely benign12112489055112489055Human1name
405051862CV3063155single nucleotide variantNM_002834.5(PTPN11):c.1242G>A (p.Thr414=)Cardiovascular phenotype [RCV004374257]|RASopathy [RCV003654804]likely benign12112486492112486492Human1name
405086436CV3122091single nucleotide variantNM_002834.5(PTPN11):c.1680C>T (p.Leu560=)PTPN11-related disorder [RCV004542281]|RASopathy [RCV003810846]likely benign12112502224112502224Human1name , alternate_id
405675695CV3386468single nucleotide variantNM_002834.5(PTPN11):c.1140T>C (p.Tyr380=)Cardiovascular phenotype [RCV004516214]likely benign12112482121112482121Humanname
407472448CV3468367single nucleotide variantNM_002834.5(PTPN11):c.1146C>T (p.Val382=)Cardiovascular phenotype [RCV004662507]|RASopathy [RCV005102403]likely benign12112482127112482127Human1name
407491656CV3496659single nucleotide variantNM_002834.5(PTPN11):c.184T>C (p.Tyr62His)Noonan syndrome [RCV004698371]likely pathogenic12112450364112450364Human1name
407573625CV3497992single nucleotide variantNM_002834.5(PTPN11):c.293T>C (p.Leu98Pro)not provided [RCV004701978]uncertain significance12112450473112450473Humanname
597706554CV3585024single nucleotide variantNM_002834.5(PTPN11):c.224C>A (p.Ala75Asp)Cardiovascular phenotype [RCV004989445]uncertain significance12112450404112450404Humanname
597706562CV3585026single nucleotide variantNM_002834.5(PTPN11):c.1326G>T (p.Val442=)Cardiovascular phenotype [RCV004989447]likely benign12112486576112486576Humanname
597706565CV3585027single nucleotide variantNM_002834.5(PTPN11):c.1332T>C (p.His444=)Cardiovascular phenotype [RCV004989448]likely benign12112486582112486582Humanname
597706571CV3585028single nucleotide variantNM_002834.5(PTPN11):c.1353T>C (p.Asp451=)Cardiovascular phenotype [RCV004989449]likely benign12112486603112486603Humanname
597706577CV3585030single nucleotide variantNM_002834.5(PTPN11):c.1551G>C (p.Ala517=)Cardiovascular phenotype [RCV004989450]likely benign12112489127112489127Humanname
597706587CV3585032single nucleotide variantNM_002834.5(PTPN11):c.1056G>A (p.Val352=)Cardiovascular phenotype [RCV004989452]likely benign12112477979112477979Humanname
597706602CV3585036single nucleotide variantNM_002834.5(PTPN11):c.1263G>A (p.Arg421=)Cardiovascular phenotype [RCV004989455]likely benign12112486513112486513Humanname
597706607CV3585037single nucleotide variantNM_002834.5(PTPN11):c.1272G>A (p.Pro424=)Cardiovascular phenotype [RCV004989456]likely benign12112486522112486522Humanname
597706618CV3585039single nucleotide variantNM_002834.5(PTPN11):c.1734A>G (p.Arg578=)Cardiovascular phenotype [RCV004989458]likely benign12112504716112504716Humanname
12742463CV360062single nucleotide variantNM_002834.5(PTPN11):c.178G>C (p.Gly60Arg)RASopathy [RCV001201204]|not provided [RCV000413720]pathogenic|likely pathogenic12112450358112450358Human1name
12742510CV360078single nucleotide variantNM_002834.5(PTPN11):c.173A>G (p.Asn58Ser)Cardiovascular phenotype [RCV002411277]|Noonan syndrome 1 [RCV005010309]|PTPN11-related disorder [RCV004735501]|RASopathy [RCV000691488]|not provided [RCV000413828]|not specified [RCV000780655]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112450353112450353Human8name , alternate_id
12840209CV363390single nucleotide variantNM_002834.5(PTPN11):c.215C>A (p.Ala72Asp)Acute myeloid leukemia [RCV000420417]|B-cell chronic lymphocytic leukemia [RCV000430256]|Neoplasm of brain [RCV000440942]|Neuroblastoma [RCV000441142]likely pathogenic12112450395112450395Human4name
597664825CV3732563single nucleotide variantNM_002834.5(PTPN11):c.124A>T (p.Thr42Ser)not provided [RCV005004032]likely pathogenic12112446385112446385Humanname
597835093CV3739615single nucleotide variantNM_002834.5(PTPN11):c.1626T>C (p.Tyr542=)RASopathy [RCV005063834]likely benign12112502170112502170Human1name
12838383CV374591single nucleotide variantNM_002834.5(PTPN11):c.1023T>C (p.Phe341=)Cardiovascular phenotype [RCV003298442]|RASopathy [RCV002059804]|not provided [RCV000426865]likely benign12112477946112477946Human1name
597851470CV3761897single nucleotide variantNM_002834.5(PTPN11):c.1509G>A (p.Gly503=)Cardiovascular phenotype [RCV005264592]|RASopathy [RCV005087994]likely benign12112489085112489085Human1name
597917931CV3767940single nucleotide variantNM_002834.5(PTPN11):c.155C>A (p.Thr52Asn)RASopathy [RCV005114741]uncertain significance12112450335112450335Human1name
597917938CV3767941single nucleotide variantNM_002834.5(PTPN11):c.254A>G (p.His85Arg)RASopathy [RCV005114742]uncertain significance12112450434112450434Human1name
597868329CV3787343deletionNM_002834.5(PTPN11):c.887del (p.Asp296fs)RASopathy [RCV005122228]pathogenic12112477684112477684Human1name
597890853CV3839808single nucleotide variantNM_002834.5(PTPN11):c.224C>G (p.Ala75Gly)RASopathy [RCV005179700]uncertain significance12112450404112450404Human1name
597924703CV3840456single nucleotide variantNM_002834.5(PTPN11):c.1137A>G (p.Glu379=)RASopathy [RCV005184926]likely benign12112482118112482118Human1name
597903908CV3846055single nucleotide variantNM_002834.5(PTPN11):c.1344C>T (p.Ser448=)RASopathy [RCV005181677]likely benign12112486594112486594Human1name
597937588CV3862733single nucleotide variantNM_002834.5(PTPN11):c.1020C>T (p.Asp340=)Cardiovascular phenotype [RCV005258048]|RASopathy [RCV005208005]likely benign12112477943112477943Human1name
598181391CV3904801single nucleotide variantNM_002834.5(PTPN11):c.1266C>T (p.Thr422=)Cardiovascular phenotype [RCV005265195]likely benign12112486516112486516Humanname
598181393CV3904802single nucleotide variantNM_002834.5(PTPN11):c.1611G>A (p.Arg537=)Cardiovascular phenotype [RCV005265196]likely benign12112502155112502155Humanname
598181422CV3904811single nucleotide variantNM_002834.5(PTPN11):c.1761A>G (p.Gln587=)Cardiovascular phenotype [RCV005265205]likely benign12112504743112504743Humanname
598181438CV3904816single nucleotide variantNM_002834.5(PTPN11):c.1725C>T (p.Asp575=)Cardiovascular phenotype [RCV005265210]likely benign12112504707112504707Humanname
598181455CV3904821single nucleotide variantNM_002834.5(PTPN11):c.1392C>T (p.Gly464=)Cardiovascular phenotype [RCV005265215]likely benign12112488455112488455Humanname
598181466CV3904825single nucleotide variantNM_002834.5(PTPN11):c.1770A>G (p.Lys590=)Cardiovascular phenotype [RCV005265219]likely benign12112504752112504752Humanname
616939976CV4014300single nucleotide variantNM_002834.5(PTPN11):c.1596G>A (p.Glu532=)not provided [RCV005413794]likely benign12112489172112489172Humanname
8602471CV40231single nucleotide variantNM_002834.5(PTPN11):c.295A>T (p.Lys99Ter)Metachondromatosis [RCV000024261]pathogenic12112450475112450475Human1name
13215022CV429364single nucleotide variantNM_002834.5(PTPN11):c.1221A>G (p.Gly407=)Cardiovascular phenotype [RCV002367691]|Juvenile myelomonocytic leukemia [RCV003316649]|LEOPARD syndrome 1 [RCV001112241]|Metachondromatosis [RCV001112243]|Noonan syndrome 1 [RCV001112242]|RASopathy [RCV000522823]|not specified [RCV000501992]benign|uncertain significance12112482202112482202Human8name
13491818CV461618single nucleotide variantNM_002834.5(PTPN11):c.213T>G (p.Phe71Leu)RASopathy [RCV000534502]|not provided [RCV000593077]pathogenic|likely pathogenic|uncertain significance12112450393112450393Human1name
13479479CV461622single nucleotide variantNM_002834.5(PTPN11):c.223G>C (p.Ala75Pro)RASopathy [RCV000528111]uncertain significance12112450403112450403Human1name
13489625CV461631single nucleotide variantNM_002834.5(PTPN11):c.1191G>T (p.Thr397=)Cardiovascular phenotype [RCV005260232]|RASopathy [RCV000555446]likely benign12112482172112482172Human1name
13487373CV462420single nucleotide variantNM_002834.5(PTPN11):c.167T>C (p.Ile56Thr)Noonan syndrome 1 [RCV004796235]|Noonan syndrome and Noonan-related syndrome [RCV000788007]|RASopathy [RCV000531774]likely pathogenic|uncertain significance12112450347112450347Human8name
8604453CV48952single nucleotide variantNM_002834.5(PTPN11):c.124A>G (p.Thr42Ala)Cardiovascular phenotype [RCV002399352]|Noonan syndrome 1 [RCV001330777]|Noonan syndrome 1 [RCV002482941]|Noonan syndrome [RCV000157002]|Noonan syndrome and Noonan-related syndrome [RCV001813241]|PTPN11-related disorder [RCV005222713]|RASopathy [RCV000227194]|nopathogenic|conflicting interpretations of pathogenicity12112446385112446385Human8name , alternate_id
8604455CV48954single nucleotide variantNM_002834.5(PTPN11):c.155C>T (p.Thr52Ile)Noonan syndrome 1 [RCV002287349]|Noonan syndrome [RCV000037621]|RASopathy [RCV000809051]|not provided [RCV000033452]likely pathogenic|uncertain significance12112450335112450335Human3name
8604456CV48955single nucleotide variantNM_002834.5(PTPN11):c.166A>G (p.Ile56Val)Noonan syndrome 1 [RCV000995619]|Noonan syndrome [RCV000154561]|Noonan syndrome and Noonan-related syndrome [RCV000788006]|PTPN11-related disorder [RCV004528152]|RASopathy [RCV000557839]|not provided [RCV000518841]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112450346112450346Human3name , alternate_id
8604457CV48956single nucleotide variantNM_002834.5(PTPN11):c.172A>C (p.Asn58His)Noonan syndrome 1 [RCV002470725]|Noonan syndrome [RCV000037626]|RASopathy [RCV000456871]|not provided [RCV000157676]pathogenic12112450352112450352Human3name
8604458CV48957single nucleotide variantNM_002834.5(PTPN11):c.172A>G (p.Asn58Asp)Cardiovascular phenotype [RCV002408493]|LEOPARD syndrome 1 [RCV003333002]|Male infertility with azoospermia or oligozoospermia due to single gene mutation [RCV003991571]|Metachondromatosis [RCV003333001]|Noonan syndrome 1 [RCV000768061]|Noonan syndrome 1 [RCV001283812]|Noonan syndrome [RCV000037627]pathogenic12112450352112450352Human9name , alternate_id
8604459CV48958single nucleotide variantNM_002834.5(PTPN11):c.174C>A (p.Asn58Lys)Noonan syndrome 1 [RCV001358687]|Noonan syndrome 1 [RCV004795945]|Noonan syndrome 3 [RCV000587067]|Noonan syndrome [RCV000037629]|Noonan syndrome and Noonan-related syndrome [RCV001813243]|RASopathy [RCV000556984]|not provided [RCV000157677]pathogenic|likely pathogenic12112450354112450354Human9name
8604460CV48959single nucleotide variantNM_002834.5(PTPN11):c.174C>G (p.Asn58Lys)Noonan syndrome 1 [RCV000037630]|Noonan syndrome 1 [RCV000515267]|Noonan syndrome [RCV000211846]|RASopathy [RCV000588173]|not provided [RCV000033457]pathogenic|likely pathogenic12112450354112450354Human4name
8604461CV48960single nucleotide variantNM_002834.5(PTPN11):c.178G>A (p.Gly60Ser)Noonan syndrome 1 [RCV002490444]|Noonan syndrome [RCV000151684]|PTPN11-related disorder [RCV004532484]|RASopathy [RCV001219186]|See cases [RCV003985264]|not provided [RCV000157700]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity12112450358112450358Human8name , alternate_id
8604463CV48963single nucleotide variantNM_002834.5(PTPN11):c.179G>C (p.Gly60Ala)Cardiovascular phenotype [RCV002408494]|Noonan syndrome 1 [RCV000416546]|Noonan syndrome [RCV000037631]|Noonan syndrome and Noonan-related syndrome [RCV001813244]|PTPN11-related disorder [RCV005229843]|RASopathy [RCV000459297]|not provided [RCV000033461]pathogenic12112450359112450359Human3name , alternate_id
8604464CV48964single nucleotide variantNM_002834.5(PTPN11):c.181G>C (p.Asp61His)Cardiovascular phenotype [RCV002408495]|Noonan syndrome 1 [RCV004698420]|Noonan syndrome 3 [RCV000589874]|PTPN11-related disorder [RCV004724759]|RASopathy [RCV005089335]|not provided [RCV000033462]pathogenic12112450361112450361Human4name , alternate_id
8604465CV48965single nucleotide variantNM_002834.5(PTPN11):c.181G>A (p.Asp61Asn)Cardiovascular phenotype [RCV002408496]|LEOPARD syndrome 1 [RCV003147305]|Metachondromatosis [RCV003147304]|Noonan syndrome 1 [RCV000576434]|Noonan syndrome 1 [RCV001775072]|Noonan syndrome 1 [RCV003224113]|Noonan syndrome [RCV000599619]|Noonan syndrome and Noonan-related syndrome [RCV001813245]|... (more)pathogenic12112450361112450361Human8name , alternate_id
8604466CV48966single nucleotide variantNM_002834.5(PTPN11):c.182A>T (p.Asp61Val)RASopathy [RCV000687319]pathogenic|uncertain significance12112450362112450362Human1name
8604467CV48967single nucleotide variantNM_002834.5(PTPN11):c.184T>A (p.Tyr62Asn)Noonan syndrome 1 [RCV002052009]|RASopathy [RCV002001115]pathogenic|likely pathogenic12112450364112450364Human2name
8604468CV48968single nucleotide variantNM_002834.5(PTPN11):c.205G>C (p.Glu69Gln)Cardiovascular phenotype [RCV002415446]|Noonan syndrome 1 [RCV004795946]|Noonan syndrome [RCV000037633]|RASopathy [RCV000033469]|not provided [RCV000212889]pathogenic12112450385112450385Human3name
8604469CV48969single nucleotide variantNM_002834.5(PTPN11):c.211T>C (p.Phe71Leu)Noonan syndrome 1 [RCV003150933]|Noonan syndrome 3 [RCV000586528]|Noonan syndrome [RCV000151689]|PTPN11-related disorder [RCV004532486]|RASopathy [RCV000686123]|not provided [RCV000033470]pathogenic|likely pathogenic12112450391112450391Human4name , alternate_id
8604470CV48970single nucleotide variantNM_002834.5(PTPN11):c.214G>C (p.Ala72Pro)Cardiovascular phenotype [RCV005259985]|Noonan syndrome [RCV000037635]|Noonan syndrome with multiple lentigines [RCV003103718]|RASopathy [RCV001852674]|not provided [RCV000033472]pathogenic|likely pathogenic12112450394112450394Human3name
8604471CV48971single nucleotide variantNM_002834.5(PTPN11):c.217A>C (p.Thr73Pro)Noonan syndrome 1 [RCV003152671]|RASopathy [RCV003654180]|not provided [RCV000033474]pathogenic|likely pathogenic12112450397112450397Human2name
8604472CV48972single nucleotide variantNM_002834.5(PTPN11):c.228G>T (p.Glu76Asp)Noonan syndrome 1 [RCV000762884]|Noonan syndrome 1 [RCV003150934]|Noonan syndrome [RCV000037639]|Noonan syndrome and Noonan-related syndrome [RCV001813246]|PTPN11-related disorder [RCV004734537]|RASopathy [RCV000033478]|not provided [RCV000254683]pathogenic12112450408112450408Human8name , alternate_id
8604473CV48973single nucleotide variantNM_002834.5(PTPN11):c.228G>C (p.Glu76Asp)Cardiovascular phenotype [RCV002453282]|Noonan syndrome 1 [RCV000856760]|Noonan syndrome [RCV000037638]|RASopathy [RCV000472904]|not provided [RCV000033479]pathogenic12112450408112450408Human3name
8604474CV48974single nucleotide variantNM_002834.5(PTPN11):c.244A>G (p.Met82Val)Noonan syndrome 1 [RCV002477045]|RASopathy [RCV000522529]|not provided [RCV000724722]uncertain significance12112450424112450424Human3name
8604475CV48975single nucleotide variantNM_002834.5(PTPN11):c.289G>C (p.Glu97Gln)Noonan syndrome 1 [RCV002496499]|RASopathy [RCV002513325]|not provided [RCV000033482]uncertain significance12112450469112450469Human3name
8604625CV49880single nucleotide variantNM_002834.5(PTPN11):c.178G>T (p.Gly60Cys)Cardiovascular phenotype [RCV002408501]|RASopathy [RCV002514147]|not provided [RCV000034327]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity12112450358112450358Human1name
8604626CV49881single nucleotide variantNM_002834.5(PTPN11):c.215C>T (p.Ala72Val)RASopathy [RCV003654183]|not provided [RCV000413699]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112450395112450395Human1name
13525323CV503898single nucleotide variantNM_002834.5(PTPN11):c.1281C>T (p.Gly427=)Cardiovascular phenotype [RCV003302940]|Noonan syndrome and Noonan-related syndrome [RCV001813522]|RASopathy [RCV000685929]|not provided [RCV003392447]|not specified [RCV000603003]likely benign|uncertain significance12112486531112486531Human1name
13538168CV503901single nucleotide variantNM_002834.5(PTPN11):c.1467C>T (p.Asp489=)Cardiovascular phenotype [RCV002395603]|RASopathy [RCV000869454]|not specified [RCV000611432]likely benign12112489043112489043Human1name
13540906CV504536single nucleotide variantNM_002834.5(PTPN11):c.1047C>T (p.Asn349=)Cardiovascular phenotype [RCV002404683]|Noonan syndrome 1 [RCV002506474]|RASopathy [RCV002531637]|not specified [RCV000615368]likely benign12112477970112477970Human8name
8607416CV53762single nucleotide variantNM_002834.5(PTPN11):c.119A>G (p.Asp40Gly)not specified [RCV000037607]uncertain significance12112446380112446380Humanname
8607419CV53765single nucleotide variantNM_002834.5(PTPN11):c.1449T>G (p.Gly483=)Cardiovascular phenotype [RCV000618095]|LEOPARD syndrome 1 [RCV000404739]|Metachondromatosis [RCV000335748]|Noonan syndrome 1 [RCV000297146]|RASopathy [RCV001030074]|not provided [RCV000726049]|not specified [RCV000037613]likely benign|conflicting interpretations of pathogenicity|uncertain significance12112489025112489025Human6name
8607421CV53767single nucleotide variantNM_002834.5(PTPN11):c.1683G>A (p.Pro561=)Cardiovascular phenotype [RCV004018842]|RASopathy [RCV002054674]|not specified [RCV000037624]likely benign12112502227112502227Human1name
8607423CV53769single nucleotide variantNM_002834.5(PTPN11):c.1746C>T (p.Asn582=)Cardiovascular phenotype [RCV000619648]|Noonan syndrome 1 [RCV002496597]|RASopathy [RCV000546916]|not provided [RCV001689592]|not specified [RCV000037628]benign|likely benign|conflicting interpretations of pathogenicity12112504728112504728Human8name
8607424CV53770single nucleotide variantNM_002834.5(PTPN11):c.209A>G (p.Lys70Arg)LEOPARD syndrome 1 [RCV002464090]|Noonan syndrome 1 [RCV003313932]|Noonan syndrome 1 [RCV005007952]|Noonan syndrome [RCV000037634]|RASopathy [RCV000206837]|not provided [RCV000405696]pathogenic|likely pathogenic12112450389112450389Human5name
8607426CV53772single nucleotide variantNM_002834.5(PTPN11):c.235C>A (p.Gln79Lys)Noonan syndrome [RCV000037640]|RASopathy [RCV003764672]|not provided [RCV005222722]likely pathogenic12112450415112450415Human2name
13797314CV552667single nucleotide variantNM_002834.5(PTPN11):c.103A>C (p.Lys35Gln)Cardiovascular phenotype [RCV004026167]|not provided [RCV000681118]uncertain significance12112446364112446364Humanname
13796843CV552668single nucleotide variantNM_002834.5(PTPN11):c.127C>T (p.Leu43Phe)Cardiovascular phenotype [RCV004985065]|Noonan syndrome 1 [RCV002493124]|RASopathy [RCV000805888]|not provided [RCV000680807]|not specified [RCV001193111]likely pathogenic|uncertain significance12112446388112446388Human8name
13797790CV552674deletionNM_002834.5(PTPN11):c.505del (p.His169fs)not provided [RCV000681427]pathogenic12112453365112453365Humanname
13796555CV552680single nucleotide variantNM_002834.5(PTPN11):c.1173C>T (p.Ser391=)Cardiovascular phenotype [RCV002331314]|PTPN11-related disorder [RCV004535695]|RASopathy [RCV001402324]|not provided [RCV000680642]likely benign12112482154112482154Human1name , alternate_id
14732783CV640639single nucleotide variantNM_002834.5(PTPN11):c.1041A>G (p.Gln347=)Noonan syndrome 1 [RCV002501074]|RASopathy [RCV000802012]likely benign|uncertain significance12112477964112477964Human3name
15168102CV693143single nucleotide variantNM_002834.5(PTPN11):c.1143C>T (p.Gly381=)Cardiovascular phenotype [RCV002454027]|Noonan syndrome and Noonan-related syndrome [RCV001813562]|RASopathy [RCV001458618]|not provided [RCV000874210]likely benign|uncertain significance12112482124112482124Human1name
15168408CV693144single nucleotide variantNM_002834.5(PTPN11):c.1212A>C (p.Ser404=)not provided [RCV000878881]likely benign12112482193112482193Humanname
15167912CV693145single nucleotide variantNM_002834.5(PTPN11):c.1266C>G (p.Thr422=)Cardiovascular phenotype [RCV002442864]|PTPN11-related disorder [RCV004735847]|RASopathy [RCV000871655]likely benign12112486516112486516Human1name , alternate_id
8616632CV70453single nucleotide variantNM_002834.5(PTPN11):c.179G>T (p.Gly60Val)Noonan syndrome 1 [RCV000414941]|Noonan syndrome 1 [RCV003224860]|Noonan syndrome and Noonan-related syndrome [RCV001813372]|RASopathy [RCV002513672]|See cases [RCV002287357]|not provided [RCV000049228]pathogenic|likely pathogenic12112450359112450359Human5name
15169209CV738453single nucleotide variantNM_002834.5(PTPN11):c.1479C>G (p.Thr493=)Cardiovascular phenotype [RCV005262135]|not provided [RCV000896973]likely benign12112489055112489055Humanname
15170778CV768893single nucleotide variantNM_002834.5(PTPN11):c.1071G>C (p.Thr357=)RASopathy [RCV001430141]likely benign12112477994112477994Human1name
8627183CV82327single nucleotide variantNM_002834.5(PTPN11):c.1296T>G (p.Pro432=)Cardiovascular phenotype [RCV004989439]likely benign|not provided12112486546112486546Humanname
38469055CV935920single nucleotide variantNM_002834.5(PTPN11):c.103A>G (p.Lys35Glu)RASopathy [RCV001204608]uncertain significance12112446364112446364Human1name
38463971CV947789deletionNM_002834.5(PTPN11):c.409del (p.Val137fs)RASopathy [RCV001235274]pathogenic12112453271112453271Human1name
40814694CV969666single nucleotide variantNM_002834.5(PTPN11):c.171G>T (p.Gln57His)Noonan syndrome [RCV001261097]likely pathogenic12112450351112450351Human1name
40903925CV975717single nucleotide variantNM_002834.5(PTPN11):c.179G>A (p.Gly60Asp)Noonan syndrome 1 [RCV001268963]|not provided [RCV001815530]pathogenic|likely pathogenic12112450359112450359Human1name
126728872CV985624single nucleotide variantNM_002834.5(PTPN11):c.1089A>G (p.Gly363=)not specified [RCV001293559]likely benign12112478012112478012Humanname
126773311CV1010126single nucleotide variantNM_002834.5(PTPN11):c.470A>G (p.Lys157Arg)Cardiovascular phenotype [RCV002341673]|RASopathy [RCV001324259]uncertain significance12112453332112453332Human1name
126753518CV1010127single nucleotide variantNM_002834.5(PTPN11):c.733C>G (p.Gln245Glu)Cardiovascular phenotype [RCV005262380]|RASopathy [RCV001316496]uncertain significance12112456040112456040Human1name
150419599CV1180934single nucleotide variantNM_002834.5(PTPN11):c.575A>G (p.Asp192Gly)Cardiovascular phenotype [RCV002343723]|not provided [RCV001551137]uncertain significance12112454613112454613Humanname
150425164CV1184624single nucleotide variantNM_002834.5(PTPN11):c.865A>G (p.Arg289Gly)Cardiovascular phenotype [RCV004656627]|Noonan syndrome 1 [RCV002495890]|RASopathy [RCV003120628]|not provided [RCV001557643]likely pathogenic|uncertain significance12112477662112477662Human8name
150411355CV1191330single nucleotide variantNM_002834.5(PTPN11):c.855T>A (p.Phe285Leu)not provided [RCV001566530]pathogenic12112477652112477652Humanname
150546028CV1291628single nucleotide variantNM_002834.5(PTPN11):c.862A>G (p.Thr288Ala)not specified [RCV001732823]uncertain significance12112477659112477659Humanname
150529866CV1293232single nucleotide variantNM_002834.5(PTPN11):c.460G>A (p.Gly154Ser)not provided [RCV001756451]uncertain significance12112453322112453322Humanname
150552910CV1295582single nucleotide variantNM_002834.5(PTPN11):c.502A>T (p.Thr168Ser)RASopathy [RCV005057569]|not provided [RCV001768514]uncertain significance12112453364112453364Human1name
150556567CV1303264single nucleotide variantNM_002834.5(PTPN11):c.587A>G (p.His196Arg)RASopathy [RCV005095028]|not provided [RCV001774457]uncertain significance12112454625112454625Human1name
151233509CV1317843single nucleotide variantNM_002834.5(PTPN11):c.565T>G (p.Ser189Ala)not provided [RCV001787610]uncertain significance12112454603112454603Humanname
151234293CV1318176single nucleotide variantNM_002834.5(PTPN11):c.860A>C (p.His287Pro)Noonan syndrome [RCV001789834]|RASopathy [RCV002034638]uncertain significance12112477657112477657Human2name
153301481CV1324488single nucleotide variantNM_002834.5(PTPN11):c.793C>G (p.Arg265Gly)Werner syndrome [RCV002265033]|not provided [RCV004728829]risk factor|uncertain significance12112472980112472980Human1name
151352078CV1325059single nucleotide variantNM_002834.5(PTPN11):c.991C>T (p.Gln331Ter)Metachondromatosis [RCV003128275]likely pathogenic12112477914112477914Human1name
151663146CV1330957single nucleotide variantNM_002834.5(PTPN11):c.329A>G (p.Glu110Gly)Noonan syndrome 1 [RCV002478072]|PTPN11-related disorder [RCV004536350]|not specified [RCV001825135]likely pathogenic|uncertain significance12112450509112450509Human7name , alternate_id
151803193CV1364686single nucleotide variantNM_002834.5(PTPN11):c.879C>A (p.His293Gln)RASopathy [RCV001991141]uncertain significance12112477676112477676Human1name
151821204CV1391099single nucleotide variantNM_002834.5(PTPN11):c.983T>C (p.Ile328Thr)Noonan syndrome 1 [RCV005006294]|RASopathy [RCV001992792]|not provided [RCV003128835]uncertain significance12112477906112477906Human3name
151712089CV1401649single nucleotide variantNM_002834.5(PTPN11):c.691C>T (p.Arg231Ter)Noonan syndrome 1 [RCV002503431]|RASopathy [RCV001964503]pathogenic|likely pathogenic12112455998112455998Human3name
151726474CV1416063single nucleotide variantNM_002834.5(PTPN11):c.770A>G (p.Gln257Arg)Cardiovascular phenotype [RCV004656742]|Noonan syndrome 1 [RCV002503618]|RASopathy [RCV001945584]uncertain significance12112472957112472957Human8name
151726499CV1416080single nucleotide variantNM_002834.5(PTPN11):c.563A>G (p.Asp188Gly)Cardiovascular phenotype [RCV004044150]|Noonan syndrome 1 [RCV002479440]|RASopathy [RCV001945587]uncertain significance12112454601112454601Human8name
151888075CV1434046single nucleotide variantNM_002834.5(PTPN11):c.583G>A (p.Glu195Lys)RASopathy [RCV002038323]uncertain significance12112454621112454621Human1name
151777981CV1449696single nucleotide variantNM_002834.5(PTPN11):c.967C>A (p.Pro323Thr)Cardiovascular phenotype [RCV003303633]|RASopathy [RCV002009470]|not provided [RCV004763309]uncertain significance12112477890112477890Human1name
151806486CV1453449single nucleotide variantNM_002834.5(PTPN11):c.658C>T (p.Arg220Cys)RASopathy [RCV001877848]uncertain significance12112455965112455965Human1name
151750096CV1457165single nucleotide variantNM_002834.5(PTPN11):c.947C>T (p.Thr316Ile)RASopathy [RCV001912897]uncertain significance12112477870112477870Human1name
151850361CV1464910single nucleotide variantNM_002834.5(PTPN11):c.557G>C (p.Arg186Pro)RASopathy [RCV001995881]uncertain significance12112454595112454595Human1name
151716353CV1470611single nucleotide variantNM_002834.5(PTPN11):c.955A>G (p.Asn319Asp)Cardiovascular phenotype [RCV002370487]|RASopathy [RCV001909027]uncertain significance12112477878112477878Human1name
151721813CV1491788single nucleotide variantNM_002834.5(PTPN11):c.479G>A (p.Ser160Asn)Cardiovascular phenotype [RCV002335019]|RASopathy [RCV002003785]uncertain significance12112453341112453341Human1name
152156764CV1668727single nucleotide variantNM_002834.5(PTPN11):c.561T>G (p.Phe187Leu)not specified [RCV002222953]uncertain significance12112454599112454599Humanname
152977912CV1671270deletionNM_002834.5(PTPN11):c.1070del (p.Thr357fs)Metachondromatosis [RCV002226944]likely pathogenic12112477993112477993Human1name
155642767CV1706382single nucleotide variantNM_002834.5(PTPN11):c.612A>T (p.Glu204Asp)LEOPARD syndrome 1 [RCV002287238]|RASopathy [RCV003097717]|not provided [RCV002509826]uncertain significance12112454650112454650Human2name
9692116CV175541single nucleotide variantNM_002834.5(PTPN11):c.598A>T (p.Asn200Tyr)Noonan syndrome [RCV000151696]|PTPN11-related disorder [RCV004734709]|RASopathy [RCV000654965]|not provided [RCV000380092]pathogenic|likely pathogenic12112454636112454636Human2name , alternate_id
155695367CV1793732single nucleotide variantNM_002834.5(PTPN11):c.397G>A (p.Gly133Ser)Cardiovascular phenotype [RCV002357735]uncertain significance12112453259112453259Humanname
9833403CV179446single nucleotide variantNM_002834.5(PTPN11):c.487G>A (p.Gly163Ser)Cardiovascular phenotype [RCV002336367]|Noonan syndrome [RCV001261106]|RASopathy [RCV000159047]|not provided [RCV003480068]uncertain significance12112453349112453349Human2name
9833404CV179447single nucleotide variantNM_002834.5(PTPN11):c.661A>G (p.Ile221Val)Noonan syndrome 1 [RCV005003506]|RASopathy [RCV005089786]|not provided [RCV000159048]pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112455968112455968Human3name
9833696CV179448single nucleotide variantNM_002834.5(PTPN11):c.701G>A (p.Ser234Asn)not provided [RCV000159506]uncertain significance12112456008112456008Humanname
9833405CV179449single nucleotide variantNM_002834.5(PTPN11):c.854T>A (p.Phe285Tyr)Cardiovascular phenotype [RCV002408715]|Noonan syndrome [RCV001261017]|RASopathy [RCV001526955]|not provided [RCV000159051]pathogenic|likely pathogenic|uncertain significance12112477651112477651Human2name
9833406CV179450single nucleotide variantNM_002834.5(PTPN11):c.893A>G (p.Asn298Ser)Cardio-facio-cutaneous syndrome [RCV000208167]|Cardiovascular phenotype [RCV002372037]|Noonan syndrome 1 [RCV002492630]|RASopathy [RCV001850234]|not provided [RCV000159053]|not specified [RCV001844054]likely benign|uncertain significance12112477690112477690Human9name
9833410CV179451single nucleotide variantNM_002834.5(PTPN11):c.913A>G (p.Ile305Val)not provided [RCV000159058]uncertain significance12112477710112477710Humanname
9833407CV179453single nucleotide variantNM_002834.5(PTPN11):c.997T>A (p.Cys333Ser)RASopathy [RCV001850235]|not provided [RCV000159054]uncertain significance12112477920112477920Human1name
155724548CV1799443single nucleotide variantNM_002834.5(PTPN11):c.517C>T (p.Arg173Cys)Cardiovascular phenotype [RCV002338436]uncertain significance12112453379112453379Humanname
155743179CV1806663single nucleotide variantNM_002834.5(PTPN11):c.557G>A (p.Arg186Gln)Cardiovascular phenotype [RCV002344744]|Noonan syndrome 1 [RCV005002830]|RASopathy [RCV005096814]uncertain significance12112454595112454595Human8name
155722823CV1814576single nucleotide variantNM_002834.5(PTPN11):c.880G>A (p.Asp294Asn)Cardiovascular phenotype [RCV002449795]|RASopathy [RCV003100032]|not provided [RCV003738229]|not specified [RCV003491100]uncertain significance12112477677112477677Human1name
155670593CV1819216single nucleotide variantNM_002834.5(PTPN11):c.710C>T (p.Ala237Val)Cardiovascular phenotype [RCV002367396]|RASopathy [RCV003776352]uncertain significance12112456017112456017Human1name
155723933CV1820983single nucleotide variantNM_002834.5(PTPN11):c.898C>A (p.Pro300Thr)Cardiovascular phenotype [RCV002449935]|RASopathy [RCV003774146]|not provided [RCV003156383]|not specified [RCV004700743]uncertain significance12112477695112477695Human1name
155692189CV1821548single nucleotide variantNM_002834.5(PTPN11):c.950A>G (p.Lys317Arg)Cardiovascular phenotype [RCV002374168]uncertain significance12112477873112477873Humanname
155698987CV1824510single nucleotide variantNM_002834.5(PTPN11):c.889C>G (p.Pro297Ala)Cardiovascular phenotype [RCV002376025]|RASopathy [RCV003539436]uncertain significance12112477686112477686Human1name
155797949CV1860561single nucleotide variantNM_002834.5(PTPN11):c.323C>T (p.Thr108Ile)not provided [RCV002467203]uncertain significance12112450503112450503Humanname
156175697CV1874569single nucleotide variantNM_002834.5(PTPN11):c.784C>T (p.Leu262Phe)Noonan syndrome 1 [RCV004786806]|RASopathy [RCV003041175]likely pathogenic12112472971112472971Human2name
156353112CV1923798single nucleotide variantNM_002834.5(PTPN11):c.500T>C (p.Val167Ala)Noonan syndrome 1 [RCV003985114]|RASopathy [RCV002651052]uncertain significance12112453362112453362Human2name
156166501CV1930000single nucleotide variantNM_002834.5(PTPN11):c.877C>T (p.His293Tyr)Cardiovascular phenotype [RCV004985255]|RASopathy [RCV002624569]uncertain significance12112477674112477674Human1name
156450258CV1942618single nucleotide variantNM_002834.5(PTPN11):c.487G>T (p.Gly163Cys)RASopathy [RCV003122410]uncertain significance12112453349112453349Human1name
10053001CV195646single nucleotide variantNM_002834.5(PTPN11):c.806A>G (p.Gln269Arg)not provided [RCV000179850]uncertain significance12112472993112472993Humanname
156395938CV1958945single nucleotide variantNM_002834.5(PTPN11):c.583G>C (p.Glu195Gln)RASopathy [RCV002584359]uncertain significance12112454621112454621Human1name
156053247CV2006889single nucleotide variantNM_002834.5(PTPN11):c.653C>T (p.Thr218Met)RASopathy [RCV002659435]uncertain significance12112455960112455960Human1name
156345703CV2051861single nucleotide variantNM_002834.5(PTPN11):c.554A>T (p.Glu185Val)RASopathy [RCV002811452]uncertain significance12112454592112454592Human1name
155994080CV2063920single nucleotide variantNM_002834.5(PTPN11):c.972A>C (p.Lys324Asn)RASopathy [RCV002843098]uncertain significance12112477895112477895Human1name
156245861CV2086206single nucleotide variantNM_002834.5(PTPN11):c.745G>T (p.Glu249Ter)RASopathy [RCV002876768]pathogenic12112456052112456052Human1name
156251792CV2098076single nucleotide variantNM_002834.5(PTPN11):c.604A>T (p.Met202Leu)RASopathy [RCV002895288]uncertain significance12112454642112454642Human1name
156264711CV2129006single nucleotide variantNM_002834.5(PTPN11):c.538G>A (p.Asp180Asn)RASopathy [RCV002934010]|not provided [RCV003154264]uncertain significance12112454576112454576Human1name
156204782CV2134929single nucleotide variantNM_002834.5(PTPN11):c.712G>A (p.Glu238Lys)RASopathy [RCV002985356]|not provided [RCV003314748]uncertain significance12112456019112456019Human1name
156095875CV2135793single nucleotide variantNM_002834.5(PTPN11):c.575A>C (p.Asp192Ala)RASopathy [RCV003002018]uncertain significance12112454613112454613Human1name
155934311CV2153449single nucleotide variantNM_002834.5(PTPN11):c.416A>G (p.Glu139Gly)RASopathy [RCV003013822]likely pathogenic12112453278112453278Human1name
155945925CV2154762single nucleotide variantNM_002834.5(PTPN11):c.641A>T (p.Gln214Leu)RASopathy [RCV003014558]uncertain significance12112454679112454679Human1name
243051014CV2413600single nucleotide variantNM_002834.5(PTPN11):c.521G>A (p.Cys174Tyr)Noonan syndrome 1 [RCV005003020]|not provided [RCV003130351]uncertain significance12112453383112453383Human2name
329381403CV2423771single nucleotide variantNM_002834.5(PTPN11):c.934C>A (p.Pro312Thr)Cardiovascular phenotype [RCV003188015]uncertain significance12112477857112477857Humanname
329395019CV2473004single nucleotide variantNM_002834.5(PTPN11):c.443T>C (p.Val148Ala)not provided [RCV003218987]uncertain significance12112453305112453305Humanname
329847435CV2524271single nucleotide variantNM_002834.5(PTPN11):c.301C>T (p.Pro101Ser)not provided [RCV003227163]uncertain significance12112450481112450481Humanname
11633581CV264502single nucleotide variantNM_002834.5(PTPN11):c.845T>C (p.Ile282Thr)not provided [RCV000349409]pathogenic12112473032112473032Humanname
11639444CV264507single nucleotide variantNM_002834.5(PTPN11):c.879C>G (p.His293Gln)Noonan syndrome and Noonan-related syndrome [RCV001813443]|RASopathy [RCV001322233]|not provided [RCV000320986]uncertain significance12112477676112477676Human1name
11637607CV264667single nucleotide variantNM_002834.5(PTPN11):c.369G>T (p.Glu123Asp)RASopathy [RCV000810975]|not provided [RCV000288839]uncertain significance12112453231112453231Human1name
11581055CV264670single nucleotide variantNM_002834.5(PTPN11):c.782T>G (p.Leu261Arg)Neurofibromatosis-Noonan syndrome [RCV001261108]|RASopathy [RCV000805075]|not provided [RCV000354323]likely pathogenic|uncertain significance12112472969112472969Human2name
329953621CV2668505single nucleotide variantNM_002834.5(PTPN11):c.868G>C (p.Val290Leu)not provided [RCV003230158]uncertain significance12112477665112477665Humanname
401733405CV2736845single nucleotide variantNM_002834.5(PTPN11):c.867G>C (p.Arg289Ser)not provided [RCV003313607]uncertain significance12112477664112477664Humanname
401722658CV2737718single nucleotide variantNM_002834.5(PTPN11):c.760C>G (p.Leu254Val)not provided [RCV003314890]uncertain significance12112472947112472947Humanname
401798838CV2742606single nucleotide variantNM_002834.5(PTPN11):c.692G>A (p.Arg231Gln)not provided [RCV003325050]uncertain significance12112455999112455999Humanname
401830695CV2748343single nucleotide variantNM_002834.5(PTPN11):c.488G>A (p.Gly163Asp)not provided [RCV003329952]uncertain significance12112453350112453350Humanname
401873340CV2749744single nucleotide variantNM_002834.5(PTPN11):c.449C>G (p.Ser150Cys)Cardiovascular phenotype [RCV005264404]|not provided [RCV003332873]uncertain significance12112453311112453311Humanname
401855222CV2764070single nucleotide variantNM_002834.5(PTPN11):c.302C>T (p.Pro101Leu)Cardiovascular phenotype [RCV003339289]|Noonan syndrome 1 [RCV005012882]|RASopathy [RCV003655420]uncertain significance12112450482112450482Human8name
8599360CV28365single nucleotide variantNM_002834.5(PTPN11):c.922A>G (p.Asn308Asp)Abnormal bleeding [RCV001270562]|Cardiovascular phenotype [RCV000621227]|Hereditary cancer-predisposing syndrome [RCV001293867]|LEOPARD syndrome 1 [RCV001253546]|Male infertility with azoospermia or oligozoospermia due to single gene mutation [RCV003991568]|Metachondromatosis [RCV003147284]|Noonan spathogenic|likely pathogenic12112477719112477719Human14name , alternate_id
8599361CV28366single nucleotide variantNM_002834.5(PTPN11):c.923A>G (p.Asn308Ser)LEOPARD syndrome 1 [RCV001197417]|Noonan syndrome 1 [RCV000014255]|Noonan syndrome 1 [RCV000515421]|Noonan syndrome 1 [RCV001027696]|Noonan syndrome 3 [RCV000588570]|Noonan syndrome [RCV000037669]|Noonan syndrome and Noonan-related syndrome [RCV001813193]|PTPN11pathogenic12112477720112477720Human9name , alternate_id
8599362CV28367single nucleotide variantNM_002834.5(PTPN11):c.836A>G (p.Tyr279Cys)CBL-related disorder [RCV000492270]|Cardiovascular phenotype [RCV000617951]|LEOPARD syndrome 1 [RCV000055890]|Noonan syndrome 1 [RCV000577894]|Noonan syndrome 1 [RCV000768062]|Noonan syndrome and Noonan-related syndrome [RCV001813194]|Noonan syndrome with multiple lentigines [RCV000030620]|Noonan sypathogenic|likely pathogenic|conflicting interpretations of pathogenicity12112473023112473023Human9name , alternate_id
8599369CV28374single nucleotide variantNM_002834.5(PTPN11):c.854T>C (p.Phe285Ser)Early T cell progenitor acute lymphoblastic leukemia [RCV000190417]|LEOPARD syndrome 1 [RCV004562208]|Metachondromatosis [RCV004562207]|Non-immune hydrops fetalis [RCV001376066]|Noonan syndrome 1 [RCV000014263]|Noonan syndrome [RCV000037663]|Noonan syndrome and Noonan-related syndrome [RCV001813200]pathogenic12112477651112477651Human9name , alternate_id
8599380CV28387single nucleotide variantNM_002834.5(PTPN11):c.412C>T (p.Arg138Ter)Metachondromatosis [RCV000014276]|RASopathy [RCV001205820]pathogenic12112453274112453274Human2name
405717444CV2847042single nucleotide variantNM_002834.5(PTPN11):c.362A>C (p.Glu121Ala)Male infertility with azoospermia or oligozoospermia due to single gene mutation [RCV003991596]likely pathogenic12112453224112453224Human1name
405717448CV2847043single nucleotide variantNM_002834.5(PTPN11):c.518G>T (p.Arg173Leu)Male infertility with azoospermia or oligozoospermia due to single gene mutation [RCV003991597]likely pathogenic12112453380112453380Human1name
405158133CV2874676single nucleotide variantNM_002834.5(PTPN11):c.965A>G (p.Lys322Arg)RASopathy [RCV003539636]uncertain significance12112477888112477888Human1name
405160200CV2885596single nucleotide variantNM_002834.5(PTPN11):c.466G>T (p.Asp156Tyr)RASopathy [RCV003540044]uncertain significance12112453328112453328Human1name
405164983CV2932799single nucleotide variantNM_002834.5(PTPN11):c.473G>T (p.Gly158Val)RASopathy [RCV003540438]uncertain significance12112453335112453335Human1name
405055110CV2938173single nucleotide variantNM_002834.5(PTPN11):c.776G>A (p.Cys259Tyr)RASopathy [RCV003655481]uncertain significance12112472963112472963Human1name
405055462CV2945400single nucleotide variantNM_002834.5(PTPN11):c.574G>A (p.Asp192Asn)RASopathy [RCV003655505]uncertain significance12112454612112454612Human1name
405056595CV2958997single nucleotide variantNM_002834.5(PTPN11):c.956A>G (p.Asn319Ser)RASopathy [RCV003655590]uncertain significance12112477879112477879Human1name
405058513CV2968530single nucleotide variantNM_002834.5(PTPN11):c.611A>T (p.Glu204Val)RASopathy [RCV003655675]uncertain significance12112454649112454649Human1name
405061976CV3017212single nucleotide variantNM_002834.5(PTPN11):c.628C>A (p.Leu210Ile)RASopathy [RCV003656018]uncertain significance12112454666112454666Human1name
405050967CV3058147single nucleotide variantNM_002834.5(PTPN11):c.880G>T (p.Asp294Tyr)Cardiovascular phenotype [RCV004985567]|RASopathy [RCV003654734]uncertain significance12112477677112477677Human1name
405004422CV3184549single nucleotide variantNM_002834.5(PTPN11):c.787T>A (p.Tyr263Asn)Noonan syndrome 1 [RCV003883338]likely pathogenic12112472974112472974Human2name
405281109CV3223893single nucleotide variantNM_002834.5(PTPN11):c.318T>A (p.Asp106Glu)not specified [RCV003988271]uncertain significance12112450498112450498Humanname
405688704CV3318306single nucleotide variantNM_002834.5(PTPN11):c.848T>A (p.Leu283Gln)Cardiovascular phenotype [RCV004444939]uncertain significance12112473035112473035Humanname
405673660CV3380076single nucleotide variantNM_002834.5(PTPN11):c.763C>T (p.Gln255Ter)Metachondromatosis [RCV004515745]likely pathogenic12112472950112472950Human1name
405675716CV3386473single nucleotide variantNM_002834.5(PTPN11):c.772G>C (p.Glu258Gln)Cardiovascular phenotype [RCV004516219]uncertain significance12112472959112472959Humanname
407472438CV3468364single nucleotide variantNM_002834.5(PTPN11):c.555A>C (p.Glu185Asp)Cardiovascular phenotype [RCV004662504]uncertain significance12112454593112454593Humanname
407472445CV3468366single nucleotide variantNM_002834.5(PTPN11):c.754G>A (p.Glu252Lys)Cardiovascular phenotype [RCV004662506]uncertain significance12112456061112456061Humanname
407506594CV3496160single nucleotide variantNM_002834.5(PTPN11):c.886G>C (p.Asp296His)not provided [RCV004698001]uncertain significance12112477683112477683Humanname
408378542CV3505326single nucleotide variantNM_002834.5(PTPN11):c.646C>T (p.Leu216Phe)Cardiovascular phenotype [RCV005264554]|PTPN11-related disorder [RCV004728016]uncertain significance12112455953112455953Humanname , alternate_id
408387207CV3524447single nucleotide variantNM_002834.5(PTPN11):c.847C>G (p.Leu283Val)not provided [RCV004768321]uncertain significance12112473034112473034Humanname
596931360CV3531696single nucleotide variantNM_002834.5(PTPN11):c.899C>T (p.Pro300Leu)not provided [RCV004781258]uncertain significance12112477696112477696Humanname
596921691CV3535317single nucleotide variantNM_002834.5(PTPN11):c.841A>G (p.Asn281Asp)Noonan syndrome 1 [RCV004784872]|not provided [RCV005001476]likely pathogenic12112473028112473028Human1name
12742233CV360023single nucleotide variantNM_002834.5(PTPN11):c.827A>G (p.Lys276Arg)Cardiovascular phenotype [RCV003298421]|Noonan syndrome [RCV001261109]|not provided [RCV000413183]|not specified [RCV000781774]likely pathogenic|uncertain significance12112473014112473014Human1name
12740668CV360063single nucleotide variantNM_002834.5(PTPN11):c.931A>G (p.Met311Val)Cardiovascular phenotype [RCV002318367]|Noonan syndrome 1 [RCV002481274]|PTPN11-related disorder [RCV004544723]|RASopathy [RCV000701867]|not specified [RCV000412738]likely benign|uncertain significance12112477728112477728Human8name , alternate_id
597685169CV3707174single nucleotide variantNM_002834.5(PTPN11):c.467A>G (p.Asp156Gly)Noonan syndrome 1 [RCV005006806]uncertain significance12112453329112453329Human2name
597670370CV3713698single nucleotide variantNM_002834.5(PTPN11):c.503C>T (p.Thr168Ile)Noonan syndrome 1 [RCV005004820]|not provided [RCV005410004]uncertain significance12112453365112453365Human2name
597670377CV3713699single nucleotide variantNM_002834.5(PTPN11):c.513G>C (p.Met171Ile)Noonan syndrome 1 [RCV005004821]|RASopathy [RCV005112539]uncertain significance12112453375112453375Human3name
597670387CV3713700single nucleotide variantNM_002834.5(PTPN11):c.529C>G (p.Leu177Val)Noonan syndrome 1 [RCV005004822]uncertain significance12112454567112454567Human2name
597685177CV3713701single nucleotide variantNM_002834.5(PTPN11):c.570G>T (p.Leu190Phe)Noonan syndrome 1 [RCV005006807]uncertain significance12112454608112454608Human2name
597685189CV3713702single nucleotide variantNM_002834.5(PTPN11):c.585A>C (p.Glu195Asp)Noonan syndrome 1 [RCV005006808]uncertain significance12112454623112454623Human2name
597670414CV3713705single nucleotide variantNM_002834.5(PTPN11):c.709G>A (p.Ala237Thr)Noonan syndrome 1 [RCV005004825]uncertain significance12112456016112456016Human2name
597670422CV3713706single nucleotide variantNM_002834.5(PTPN11):c.881A>G (p.Asp294Gly)Noonan syndrome 1 [RCV005004826]uncertain significance12112477678112477678Human2name
597884669CV3745476single nucleotide variantNM_002834.5(PTPN11):c.779A>G (p.Lys260Arg)Cardiovascular phenotype [RCV005264586]|RASopathy [RCV005070312]uncertain significance12112472966112472966Human1name
597917943CV3767942single nucleotide variantNM_002834.5(PTPN11):c.349C>G (p.Leu117Val)RASopathy [RCV005114743]uncertain significance12112453211112453211Human1name
597917955CV3767944single nucleotide variantNM_002834.5(PTPN11):c.451G>C (p.Val151Leu)RASopathy [RCV005114745]uncertain significance12112453313112453313Human1name
597917960CV3767945single nucleotide variantNM_002834.5(PTPN11):c.530T>G (p.Leu177Arg)RASopathy [RCV005114746]uncertain significance12112454568112454568Human1name
597917970CV3767947single nucleotide variantNM_002834.5(PTPN11):c.589T>C (p.Tyr197His)RASopathy [RCV005114748]uncertain significance12112454627112454627Human1name
597917976CV3767948single nucleotide variantNM_002834.5(PTPN11):c.606G>A (p.Met202Ile)RASopathy [RCV005114749]uncertain significance12112454644112454644Human1name
597911179CV3778226single nucleotide variantNM_002834.5(PTPN11):c.811C>T (p.Gln271Ter)RASopathy [RCV005128765]pathogenic12112472998112472998Human1name
597921101CV3811829single nucleotide variantNM_002834.5(PTPN11):c.574G>T (p.Asp192Tyr)RASopathy [RCV005155660]uncertain significance12112454612112454612Human1name
598125580CV3885813single nucleotide variantNM_002834.5(PTPN11):c.344G>A (p.Gly115Glu)not provided [RCV005241616]uncertain significance12112453206112453206Humanname
598181362CV3904792single nucleotide variantNM_002834.5(PTPN11):c.572C>G (p.Thr191Arg)Cardiovascular phenotype [RCV005265186]uncertain significance12112454610112454610Humanname
598181406CV3904806single nucleotide variantNM_002834.5(PTPN11):c.348T>G (p.His116Gln)Cardiovascular phenotype [RCV005265200]uncertain significance12112453210112453210Humanname
598181424CV3904812single nucleotide variantNM_002834.5(PTPN11):c.805C>G (p.Gln269Glu)Cardiovascular phenotype [RCV005265206]uncertain significance12112472992112472992Humanname
598181427CV3904813single nucleotide variantNM_002834.5(PTPN11):c.931A>T (p.Met311Leu)Cardiovascular phenotype [RCV005265207]uncertain significance12112477728112477728Humanname
598181441CV3904817single nucleotide variantNM_002834.5(PTPN11):c.968C>T (p.Pro323Leu)Cardiovascular phenotype [RCV005265211]uncertain significance12112477891112477891Humanname
598181459CV3904822single nucleotide variantNM_002834.5(PTPN11):c.477G>T (p.Glu159Asp)Cardiovascular phenotype [RCV005265216]uncertain significance12112453339112453339Humanname
598181460CV3904823single nucleotide variantNM_002834.5(PTPN11):c.815A>G (p.Glu272Gly)Cardiovascular phenotype [RCV005265217]uncertain significance12112473002112473002Humanname
598181475CV3904829single nucleotide variantNM_002834.5(PTPN11):c.718A>G (p.Thr240Ala)Cardiovascular phenotype [RCV005265223]uncertain significance12112456025112456025Humanname
12889127CV398831single nucleotide variantNM_002834.5(PTPN11):c.418A>T (p.Ser140Cys)RASopathy [RCV000472224]uncertain significance12112453280112453280Human1name
8602469CV40229deletionNM_002834.5(PTPN11):c.1315del (p.Leu439fs)Metachondromatosis [RCV000024259]pathogenic12112486564112486564Human1name
13480175CV444914single nucleotide variantNM_002834.5(PTPN11):c.461G>C (p.Gly154Ala)Cardiovascular phenotype [RCV003302760]|Noonan syndrome 1 [RCV003444566]|RASopathy [RCV001245865]|not provided [RCV000521157]uncertain significance12112453323112453323Human3name
13480335CV444915single nucleotide variantNM_002834.5(PTPN11):c.518G>C (p.Arg173Pro)not provided [RCV000521204]likely pathogenic12112453380112453380Humanname
13485074CV444916single nucleotide variantNM_002834.5(PTPN11):c.562G>C (p.Asp188His)not provided [RCV000522506]uncertain significance12112454600112454600Humanname
13506313CV481135single nucleotide variantNM_002834.5(PTPN11):c.473G>C (p.Gly158Ala)LEOPARD syndrome 1 [RCV000577992]|Metachondromatosis [RCV000578050]|Noonan syndrome 1 [RCV000578106]likely pathogenic|uncertain significance12112453335112453335Human3name
13521745CV487552single nucleotide variantNM_002834.5(PTPN11):c.868G>A (p.Val290Ile)not provided [RCV000590078]uncertain significance12112477665112477665Humanname
13521509CV487578single nucleotide variantNM_002834.5(PTPN11):c.652A>T (p.Thr218Ser)RASopathy [RCV001860131]|not provided [RCV000589400]uncertain significance12112455959112455959Human1name
8604476CV48976single nucleotide variantNM_002834.5(PTPN11):c.317A>C (p.Asp106Ala)Noonan syndrome 1 [RCV001261998]|Noonan syndrome [RCV000157021]|Noonan syndrome and Noonan-related syndrome [RCV001813247]|RASopathy [RCV000033483]|not provided [RCV000212893]pathogenic|likely pathogenic12112450497112450497Human3name
8604477CV48977single nucleotide variantNM_002834.5(PTPN11):c.328G>A (p.Glu110Lys)Cardiovascular phenotype [RCV004984651]|Noonan syndrome 1 [RCV004771457]|Noonan syndrome 3 [RCV000589214]|Noonan syndrome [RCV000037645]|Noonan syndrome and Noonan-related syndrome [RCV001813248]|RASopathy [RCV000815390]|not provided [RCV000033484]pathogenic|likely pathogenic12112450508112450508Human4name
8604478CV48978single nucleotide variantNM_002834.5(PTPN11):c.329A>C (p.Glu110Ala)LEOPARD syndrome 1 [RCV003333004]|Metachondromatosis [RCV003333003]|Noonan syndrome 1 [RCV001089572]|RASopathy [RCV001221785]|not provided [RCV000033485]|not specified [RCV001002539]pathogenic|likely pathogenic12112450509112450509Human4name
8604481CV48982single nucleotide variantNM_002834.5(PTPN11):c.417G>T (p.Glu139Asp)Inborn genetic diseases [RCV001267275]|Juvenile myelomonocytic leukemia [RCV000824742]|Noonan syndrome 1 [RCV000995621]|RASopathy [RCV000033490]|not provided [RCV000212894]pathogenic12112453279112453279Human5name
8604482CV48983single nucleotide variantNM_002834.5(PTPN11):c.417G>C (p.Glu139Asp)Cardiovascular phenotype [RCV000617179]|Hypertrophic cardiomyopathy [RCV000626830]|Juvenile myelomonocytic leukemia [RCV000824741]|LEOPARD syndrome 1 [RCV003147307]|Metachondromatosis [RCV003147306]|Noonan syndrome 1 [RCV000357736]|Noonan syndrome 1 [RCV000515221]|Noonan syndrome 3 [RCV000585988]|Nopathogenic|likely pathogenic12112453279112453279Human21name , alternate_id
8604483CV48984single nucleotide variantNM_002834.5(PTPN11):c.455G>A (p.Arg152His)Cardiovascular phenotype [RCV003352752]|Metachondromatosis [RCV000988913]|Noonan syndrome 1 [RCV002477046]|Noonan syndrome [RCV001261105]|RASopathy [RCV001852675]|not provided [RCV000680299]|not specified [RCV000121913]likely pathogenic|uncertain significance|not provided12112453317112453317Human8name
8604486CV48988single nucleotide variantNM_002834.5(PTPN11):c.767A>G (p.Gln256Arg)Cardiovascular phenotype [RCV002399353]|Noonan syndrome 1 [RCV000585640]|Noonan syndrome with multiple lentigines [RCV000824743]|RASopathy [RCV000033497]|not provided [RCV000157681]|not specified [RCV000506790]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity12112472954112472954Human4name
8604488CV48990single nucleotide variantNM_002834.5(PTPN11):c.781C>T (p.Leu261Phe)Noonan syndrome 1 [RCV002496500]|Noonan syndrome [RCV000037657]|RASopathy [RCV000522926]|not provided [RCV000157701]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity12112472968112472968Human4name
8604489CV48991single nucleotide variantNM_002834.5(PTPN11):c.785T>G (p.Leu262Arg)Noonan syndrome 1 [RCV000106324]|RASopathy [RCV000526885]pathogenic|not provided12112472972112472972Human2name
8604490CV48992single nucleotide variantNM_002834.5(PTPN11):c.794G>A (p.Arg265Gln)Cardiovascular phenotype [RCV002415447]|LEOPARD syndrome 1 [RCV001253554]|Metachondromatosis [RCV000988915]|Noonan syndrome 1 [RCV000234910]|Noonan syndrome 1 [RCV001536068]|Noonan syndrome [RCV000037658]|PTPN11-related disorder [RCV000723292]|RASopathy [RCV0004pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112472981112472981Human8name , alternate_id
8604491CV48993single nucleotide variantNM_002834.5(PTPN11):c.802G>T (p.Gly268Cys)Cardiovascular phenotype [RCV004658964]|LEOPARD syndrome 1 [RCV003147309]|Metachondromatosis [RCV003147308]|Noonan syndrome 1 [RCV001729355]|Noonan syndrome [RCV000037660]|Noonan syndrome with multiple lentigines [RCV004700300]|PTPN11-related disorder [RCV004545pathogenic|likely pathogenic12112472989112472989Human6name , alternate_id
8604492CV48994single nucleotide variantNM_002834.5(PTPN11):c.824A>C (p.Asn275Thr)Cardiovascular phenotype [RCV003298038]|LEOPARD syndrome 1 [RCV001109483]|Metachondromatosis [RCV001109482]|Noonan syndrome 1 [RCV001111779]|RASopathy [RCV001294974]|not specified [RCV001264525]benign|uncertain significance12112473011112473011Human6name
8604493CV48995single nucleotide variantNM_002834.5(PTPN11):c.844A>G (p.Ile282Val)Cardiovascular phenotype [RCV002444453]|Neurodevelopmental abnormality [RCV001731328]|Noonan syndrome 1 [RCV001283770]|Noonan syndrome 1 [RCV002054539]|Noonan syndrome 1 [RCV003153317]|Noonan syndrome [RCV002273940]|Noonan syndrome and Noonan-related syndrome [RCV001813250]|Noonan syndrome with multpathogenic12112473031112473031Human10name , alternate_id
8604494CV48996single nucleotide variantNM_002834.5(PTPN11):c.846C>G (p.Ile282Met)Cardiovascular phenotype [RCV002444454]|Noonan syndrome 1 [RCV001027860]|Noonan syndrome [RCV000037661]|PTPN11-related disorder [RCV004734538]|RASopathy [RCV001852676]|not provided [RCV000033506]pathogenic|likely pathogenic12112473033112473033Human3name , alternate_id
8604495CV48997single nucleotide variantNM_002834.5(PTPN11):c.853T>G (p.Phe285Val)Noonan syndrome 1 [RCV001027842]|Noonan syndrome 1 [RCV003224796]|Noonan syndrome 1 [RCV004593977]|PTPN11-related disorder [RCV004532489]|RASopathy [RCV003539766]|not provided [RCV002508779]pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112473040112473040Human8name , alternate_id
8604496CV48998single nucleotide variantNM_002834.5(PTPN11):c.853T>C (p.Phe285Leu)Cardiovascular phenotype [RCV004018710]|LEOPARD syndrome 1 [RCV002288529]|Metachondromatosis [RCV004562222]|Noonan syndrome 1 [RCV000762885]|Noonan syndrome 1 [RCV000856809]|Noonan syndrome 3 [RCV000586058]|Noonan syndrome [RCV000037662]|PTPN11-related disorder pathogenic|likely pathogenic12112473040112473040Human9name , alternate_id
8604500CV49003single nucleotide variantNM_002834.5(PTPN11):c.854T>G (p.Phe285Cys)Noonan syndrome [RCV000037664]|RASopathy [RCV000033513]|not provided [RCV000212895]pathogenic|likely pathogenic12112477651112477651Human2name
8604502CV49005single nucleotide variantNM_002834.5(PTPN11):c.923A>C (p.Asn308Thr)Cardiovascular phenotype [RCV002371807]|LEOPARD syndrome 1 [RCV004795947]|Noonan syndrome 1 [RCV002482942]|Noonan syndrome 1 [RCV004668747]|Noonan syndrome [RCV000037668]|Noonan syndrome and Noonan-related syndrome [RCV001813251]|PTPN11-related disorder [RCV0045pathogenic|likely pathogenic12112477720112477720Human8name , alternate_id
8604503CV49006single nucleotide variantNM_002834.5(PTPN11):c.925A>G (p.Ile309Val)Cardiovascular phenotype [RCV000252493]|LEOPARD syndrome 1 [RCV001111780]|Metachondromatosis [RCV000988916]|Noonan syndrome 1 [RCV001111781]|Noonan syndrome [RCV000761037]|Noonan syndrome and Noonan-related syndrome [RCV001813252]|PTPN11-related disorder [RCV004benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance12112477722112477722Human6name , alternate_id
13515467CV494971single nucleotide variantNM_002834.5(PTPN11):c.348T>A (p.His116Gln)Cardiovascular phenotype [RCV005260238]|not provided [RCV004701697]|not specified [RCV000594318]likely pathogenic|uncertain significance12112453210112453210Humanname
13518399CV494972single nucleotide variantNM_002834.5(PTPN11):c.652A>G (p.Thr218Ala)Inborn genetic diseases [RCV001267343]|not provided [RCV005409682]|not specified [RCV000597366]uncertain significance12112455959112455959Human1name
13528084CV513319single nucleotide variantNM_002834.5(PTPN11):c.959A>G (p.Asn320Ser)Noonan syndrome [RCV000625873]likely pathogenic12112477882112477882Human1name
13705757CV536828single nucleotide variantNM_002834.5(PTPN11):c.683G>T (p.Ser228Ile)Cardiovascular phenotype [RCV005260317]|Noonan syndrome 1 [RCV005010640]|RASopathy [RCV005091893]|not provided [RCV000658340]uncertain significance12112455990112455990Human8name
8607428CV53774single nucleotide variantNM_002834.5(PTPN11):c.392A>G (p.Lys131Arg)Cardiovascular phenotype [RCV000621552]|Noonan syndrome 1 [RCV002496598]|Noonan syndrome [RCV000678902]|Noonan syndrome and Noonan-related syndrome [RCV001813328]|PTPN11-related disorder [RCV004534799]|RASopathy [RCV000654924]|not provided [RCV000680297]|not spelikely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided12112453254112453254Human8name , alternate_id
8607430CV53776single nucleotide variantNM_002834.5(PTPN11):c.556C>T (p.Arg186Trp)Cardiovascular phenotype [RCV002345295]|Noonan syndrome and Noonan-related syndrome [RCV001813330]|RASopathy [RCV001852783]|not provided [RCV001569121]|not specified [RCV000037651]likely benign|conflicting interpretations of pathogenicity|uncertain significance12112454594112454594Human1name
8607431CV53777single nucleotide variantNM_002834.5(PTPN11):c.661A>T (p.Ile221Leu)not specified [RCV000037653]uncertain significance12112455968112455968Humanname
8607434CV53780single nucleotide variantNM_002834.5(PTPN11):c.774G>T (p.Glu258Asp)Noonan syndrome [RCV000037656]|not provided [RCV000159049]|not specified [RCV001002142]pathogenic|likely pathogenic12112472961112472961Human1name
8607435CV53781single nucleotide variantNM_002834.5(PTPN11):c.802G>A (p.Gly268Ser)Cardiovascular phenotype [RCV002415470]|LEOPARD syndrome 1 [RCV001330780]|Noonan syndrome 1 [RCV002504894]|Noonan syndrome 1 [RCV003338391]|Noonan syndrome [RCV000037659]|RASopathy [RCV000587886]|not provided [RCV000159050]pathogenic|likely pathogenic12112472989112472989Human8name
8607436CV53782single nucleotide variantNM_002834.5(PTPN11):c.855T>G (p.Phe285Leu)Noonan syndrome 1 [RCV002288537]|Noonan syndrome 3 [RCV000587757]|Noonan syndrome [RCV000037665]|RASopathy [RCV000687570]|not provided [RCV000159052]pathogenic12112477652112477652Human4name
8607437CV53783single nucleotide variantNM_002834.5(PTPN11):c.858T>A (p.Asp286Glu)not specified [RCV000037666]likely pathogenic|uncertain significance12112477655112477655Humanname
13797327CV552670single nucleotide variantNM_002834.5(PTPN11):c.330A>C (p.Glu110Asp)not provided [RCV000681127]likely pathogenic|uncertain significance12112450510112450510Humanname
13797081CV552672single nucleotide variantNM_002834.5(PTPN11):c.346C>A (p.His116Asn)not provided [RCV000680951]uncertain significance12112453208112453208Humanname
13797427CV552673single nucleotide variantNM_002834.5(PTPN11):c.440T>G (p.Phe147Cys)Cardiovascular phenotype [RCV005260321]|RASopathy [RCV001861894]|not provided [RCV000681211]uncertain significance12112453302112453302Human1name
13796844CV552676single nucleotide variantNM_002834.5(PTPN11):c.766C>A (p.Gln256Lys)RASopathy [RCV002531416]|not provided [RCV000680808]pathogenic|likely pathogenic12112472953112472953Human1name
13797343CV552677single nucleotide variantNM_002834.5(PTPN11):c.788A>G (p.Tyr263Cys)Cardiovascular phenotype [RCV002406523]|Noonan syndrome 1 [RCV002493128]|RASopathy [RCV003768042]|not provided [RCV000681136]uncertain significance12112472975112472975Human8name
13797318CV552678single nucleotide variantNM_002834.5(PTPN11):c.794G>T (p.Arg265Leu)Cardiovascular phenotype [RCV002422462]|PTPN11-related disorder [RCV004527734]|RASopathy [RCV002544702]|not provided [RCV000681121]likely pathogenic|uncertain significance12112472981112472981Human1name , alternate_id
13822465CV571258single nucleotide variantNM_002834.5(PTPN11):c.782T>A (p.Leu261His)RASopathy [RCV000697357]pathogenic|likely pathogenic12112472969112472969Human1name
14396241CV612014single nucleotide variantNM_002834.5(PTPN11):c.940T>C (p.Phe314Leu)Cardiovascular phenotype [RCV005260382]|Noonan syndrome [RCV000761000]uncertain significance12112477863112477863Human1name
14691010CV621369single nucleotide variantNM_002834.5(PTPN11):c.562G>A (p.Asp188Asn)not specified [RCV000781777]uncertain significance12112454600112454600Humanname
14698307CV624453single nucleotide variantNM_002834.5(PTPN11):c.853T>A (p.Phe285Ile)not provided [RCV000788225]pathogenic12112473040112473040Humanname
8621822CV76574single nucleotide variantNM_002834.5(PTPN11):c.836A>C (p.Tyr279Ser)LEOPARD syndrome 1 [RCV000055889]|RASopathy [RCV001064303]pathogenic|not provided12112473023112473023Human2name
15173049CV784275single nucleotide variantNM_002834.5(PTPN11):c.932T>C (p.Met311Thr)RASopathy [RCV002548437]likely benign12112477729112477729Human1name
25314996CV818296deletionNM_002834.5(PTPN11):c.1339del (p.Glu447fs)Metachondromatosis [RCV001029946]pathogenic12112486588112486588Human1name
26888478CV839323single nucleotide variantNM_002834.5(PTPN11):c.502A>G (p.Thr168Ala)RASopathy [RCV001067112]|not provided [RCV001545213]likely pathogenic|uncertain significance12112453364112453364Human1name
26922179CV839324single nucleotide variantNM_002834.5(PTPN11):c.518G>A (p.Arg173His)Cardiovascular phenotype [RCV005262223]|Noonan syndrome 1 [RCV005051851]|RASopathy [RCV001061667]|not provided [RCV001547358]uncertain significance12112453380112453380Human3name
34896357CV917102single nucleotide variantNM_002834.5(PTPN11):c.971A>G (p.Lys324Arg)RASopathy [RCV005094029]|not specified [RCV001193712]uncertain significance12112477894112477894Human1name
38465364CV947790duplicationNM_002834.5(PTPN11):c.1147dup (p.Met383fs)RASopathy [RCV001238086]pathogenic12112482127112482128Human1name
38466955CV956748single nucleotide variantNM_002834.5(PTPN11):c.569T>A (p.Leu190Ter)RASopathy [RCV001241165]pathogenic12112454607112454607Human1name
40814115CV966979single nucleotide variantNM_002834.5(PTPN11):c.317A>G (p.Asp106Gly)Autism spectrum disorder [RCV001257614]|Noonan syndrome [RCV001261101]likely pathogenic12112450497112450497Human3name
40814701CV969670single nucleotide variantNM_002834.5(PTPN11):c.325T>C (p.Ser109Pro)Noonan syndrome [RCV001261102]|Noonan syndrome and Noonan-related syndrome [RCV001813586]uncertain significance12112450505112450505Human1name
40814702CV969671single nucleotide variantNM_002834.5(PTPN11):c.387A>C (p.Lys129Asn)Noonan syndrome [RCV001261103]uncertain significance12112453249112453249Human1name
40814704CV969672single nucleotide variantNM_002834.5(PTPN11):c.395A>C (p.His132Pro)Noonan syndrome [RCV001261104]uncertain significance12112453257112453257Human1name
40814706CV969673single nucleotide variantNM_002834.5(PTPN11):c.663A>G (p.Ile221Met)LEOPARD syndrome 1 [RCV002246254]|Noonan syndrome 1 [RCV003152757]|Noonan syndrome [RCV001261107]|Proportionate short stature [RCV001779145]pathogenic|likely pathogenic|uncertain significance12112455970112455970Human5name
40815903CV970539single nucleotide variantNM_002834.5(PTPN11):c.772G>A (p.Glu258Lys)Cardiovascular phenotype [RCV004987013]|Noonan syndrome 1 [RCV001262011]|RASopathy [RCV005094247]pathogenic|likely pathogenic|uncertain significance12112472959112472959Human3name
8688320CV138850single nucleotide variantNM_002834.5(PTPN11):c.1594G>A (p.Glu532Lys)Cardiovascular phenotype [RCV003298143]|Noonan syndrome 1 [RCV002483228]|Noonan syndrome 1 [RCV004783747]|Noonan syndrome and Noonan-related syndrome [RCV001813380]|RASopathy [RCV001854671]|not provided [RCV004017410]|not specified [RCV000121910]uncertain significance|not provided12112489170112489170Human8name
152156861CV1668787single nucleotide variantNM_002834.5(PTPN11):c.1660A>G (p.Ser554Gly)not specified [RCV002223013]uncertain significance12112502204112502204Humanname
152039816CV1669634single nucleotide variantNM_002834.5(PTPN11):c.1459G>A (p.Asp487Asn)not provided [RCV002224535]uncertain significance12112489035112489035Humanname
153000234CV1682926single nucleotide variantNM_002834.5(PTPN11):c.1742A>C (p.Glu581Ala)Noonan syndrome 1 [RCV005008489]|RASopathy [RCV003655350]|See cases [RCV002252936]uncertain significance12112504724112504724Human3name
153301522CV1685777single nucleotide variantNM_002834.5(PTPN11):c.1483C>A (p.Gln495Lys)not provided [RCV002260754]uncertain significance12112489059112489059Humanname
153347592CV1692108single nucleotide variantNM_002834.5(PTPN11):c.1480A>G (p.Ile494Val)not provided [RCV002273593]uncertain significance12112489056112489056Humanname
155642577CV1707493single nucleotide variantNM_002834.5(PTPN11):c.1495T>C (p.Ser499Pro)Noonan syndrome 1 [RCV002288423]likely pathogenic12112489071112489071Human1name
9687225CV172138single nucleotide variantNM_002834.5(PTPN11):c.1508G>C (p.Gly503Ala)RASopathy [RCV000149849]pathogenic12112489084112489084Human1name
9689128CV175397single nucleotide variantNM_002834.5(PTPN11):c.1374C>A (p.His458Gln)Noonan syndrome 1 [RCV004593994]|not specified [RCV000154559]uncertain significance12112486624112486624Human1name
9689109CV175398single nucleotide variantNM_002834.5(PTPN11):c.1682C>T (p.Pro561Leu)Cardiovascular phenotype [RCV002399540]|Noonan syndrome 1 [RCV000515184]|RASopathy [RCV000690056]|not provided [RCV000680301]|not specified [RCV000154538]likely benign|conflicting interpretations of pathogenicity|uncertain significance12112502226112502226Human8name
155703901CV1771244single nucleotide variantNM_002834.5(PTPN11):c.1078G>A (p.Val360Met)RASopathy [RCV002295745]uncertain significance12112478001112478001Human1name
155711648CV1775861single nucleotide variantNM_002834.5(PTPN11):c.1303G>T (p.Val435Leu)Cardiovascular phenotype [RCV004047666]|RASopathy [RCV002296225]uncertain significance12112486553112486553Human1name
155690821CV1777960single nucleotide variantNM_002834.5(PTPN11):c.1331A>G (p.His444Arg)RASopathy [RCV002299281]|not provided [RCV004729150]uncertain significance12112486581112486581Human1name
9693656CV178356single nucleotide variantNM_002834.5(PTPN11):c.1277A>C (p.His426Pro)Noonan syndrome [RCV000157022]uncertain significance12112486527112486527Human1name
9833697CV179454single nucleotide variantNM_002834.5(PTPN11):c.1028G>A (p.Arg343Gln)Cardiovascular phenotype [RCV002381524]|RASopathy [RCV000519427]|not provided [RCV000159507]benign|likely benign|uncertain significance12112477951112477951Human1name
9833408CV179455single nucleotide variantNM_002834.5(PTPN11):c.1460A>G (p.Asp487Gly)not provided [RCV000159055]likely pathogenic|uncertain significance12112489036112489036Humanname
9833409CV179456single nucleotide variantNM_002834.5(PTPN11):c.1471C>G (p.Pro491Ala)Astrocytic tumor [RCV003764999]|Noonan syndrome 1 [RCV001002766]|Noonan syndrome 1 [RCV005008065]|Noonan syndrome [RCV001261020]|Noonan syndrome and Noonan-related syndrome [RCV001813411]|RASopathy [RCV002515083]|not provided [RCV000159056]pathogenic|likely pathogenic|uncertain significance|no classifications from unflagged records12112489047112489047Human9name
155719542CV1830589single nucleotide variantNM_002834.5(PTPN11):c.1566T>G (p.Ile522Met)Cardiovascular phenotype [RCV002405545]uncertain significance12112489142112489142Humanname
155745529CV1831345single nucleotide variantNM_002834.5(PTPN11):c.1720G>A (p.Glu574Lys)Cardiovascular phenotype [RCV002414791]uncertain significance12112504702112504702Humanname
155670616CV1832389single nucleotide variantNM_002834.5(PTPN11):c.1320G>C (p.Glu440Asp)Cardiovascular phenotype [RCV002385687]uncertain significance12112486570112486570Humanname
155708953CV1833674single nucleotide variantNM_002834.5(PTPN11):c.1552G>T (p.Val518Phe)Cardiovascular phenotype [RCV002403401]|RASopathy [RCV005097589]uncertain significance12112489128112489128Human1name
155702264CV1838271single nucleotide variantNM_002834.5(PTPN11):c.1763A>G (p.Gln588Arg)Cardiovascular phenotype [RCV002401692]|RASopathy [RCV003097222]uncertain significance12112504745112504745Human1name
155795670CV1861436single nucleotide variantNM_002834.5(PTPN11):c.1648G>A (p.Ala550Thr)Noonan syndrome 1 [RCV005002842]|RASopathy [RCV003775501]|not provided [RCV002469718]uncertain significance12112502192112502192Human3name
155798516CV1862041single nucleotide variantNM_002834.5(PTPN11):c.1493G>A (p.Arg498Gln)Noonan syndrome 1 [RCV002471444]|not provided [RCV005051976]likely pathogenic12112489069112489069Human1name
155799259CV1862428single nucleotide variantNM_002834.5(PTPN11):c.1205A>C (p.Lys402Thr)Noonan syndrome 1 [RCV002471834]|not provided [RCV005235662]uncertain significance12112482186112482186Human1name
156165282CV1866856single nucleotide variantNM_002834.5(PTPN11):c.1204A>G (p.Lys402Glu)not provided [RCV002508408]uncertain significance12112482185112482185Humanname
156142720CV1898664single nucleotide variantNM_002834.5(PTPN11):c.1358G>A (p.Gly453Glu)RASopathy [RCV003082264]uncertain significance12112486608112486608Human1name
156202500CV1916867single nucleotide variantNM_002834.5(PTPN11):c.1727G>A (p.Ser576Asn)RASopathy [RCV002595755]uncertain significance12112504709112504709Human1name
156107487CV2008453single nucleotide variantNM_002834.5(PTPN11):c.1432A>G (p.Ile478Val)Cardiovascular phenotype [RCV004983088]|RASopathy [RCV002695536]uncertain significance12112488495112488495Human1name
156157079CV2049351single nucleotide variantNM_002834.5(PTPN11):c.1177G>A (p.Ala393Thr)RASopathy [RCV002801491]uncertain significance12112482158112482158Human1name
156192696CV2099063single nucleotide variantNM_002834.5(PTPN11):c.1198G>A (p.Glu400Lys)RASopathy [RCV002917501]|not provided [RCV003151904]uncertain significance12112482179112482179Human1name
156046991CV2144232single nucleotide variantNM_002834.5(PTPN11):c.1464T>G (p.Ile488Met)RASopathy [RCV002999741]uncertain significance12112489040112489040Human1name
155915675CV2149842single nucleotide variantNM_002834.5(PTPN11):c.1183G>T (p.Asp395Tyr)RASopathy [RCV003012579]uncertain significance12112482164112482164Human1name
155915689CV2149843single nucleotide variantNM_002834.5(PTPN11):c.1186T>C (p.Tyr396His)RASopathy [RCV003012580]uncertain significance12112482167112482167Human1name
243051810CV2404123single nucleotide variantNM_002834.5(PTPN11):c.1444A>C (p.Lys482Gln)RASopathy [RCV003655403]|not provided [RCV003129149]uncertain significance12112488507112488507Human1name
243051019CV2413601single nucleotide variantNM_002834.5(PTPN11):c.1241C>T (p.Thr414Met)Cardiovascular phenotype [RCV004985306]|RASopathy [RCV003539470]|not provided [RCV003130352]uncertain significance12112486491112486491Human1name
329381400CV2423769single nucleotide variantNM_002834.5(PTPN11):c.1540A>G (p.Ile514Val)Cardiovascular phenotype [RCV003188013]uncertain significance12112489116112489116Humanname
329848800CV2523548single nucleotide variantNM_002834.5(PTPN11):c.1553T>G (p.Val518Gly)RASopathy [RCV005102420]|not provided [RCV003225562]uncertain significance12112489129112489129Human1name
401730558CV2729575single nucleotide variantNM_002834.5(PTPN11):c.1546A>G (p.Met516Val)Cardiovascular phenotype [RCV003297536]|not provided [RCV003313327]uncertain significance12112489122112489122Humanname
401740184CV2738684single nucleotide variantNM_002834.5(PTPN11):c.1607A>G (p.Lys536Arg)not provided [RCV003318078]uncertain significance12112502151112502151Humanname
401796258CV2740464single nucleotide variantNM_002834.5(PTPN11):c.1189A>G (p.Thr397Ala)not provided [RCV003321134]uncertain significance12112482170112482170Humanname
401830164CV2744161single nucleotide variantNM_002834.5(PTPN11):c.1095T>A (p.Ser365Arg)Noonan syndrome 1 [RCV003327358]uncertain significance12112482076112482076Human1name
401864098CV2764071single nucleotide variantNM_002834.5(PTPN11):c.1676C>T (p.Pro559Leu)Cardiovascular phenotype [RCV003344188]|RASopathy [RCV003655421]uncertain significance12112502220112502220Human1name
401855225CV2764073single nucleotide variantNM_002834.5(PTPN11):c.1495T>G (p.Ser499Ala)Cardiovascular phenotype [RCV003339291]uncertain significance12112489071112489071Humanname
401935073CV2799815single nucleotide variantNM_002834.5(PTPN11):c.1411G>T (p.Val471Leu)PTPN11-related disorder [RCV004536722]uncertain significance12112488474112488474Humanname , trait , alternate_id
401912951CV2800792single nucleotide variantNM_002834.5(PTPN11):c.1643C>G (p.Ser548Cys)PTPN11-related disorder [RCV004529824]uncertain significance12112502187112502187Humanname , trait , alternate_id
8599365CV28370single nucleotide variantNM_002834.5(PTPN11):c.1403C>T (p.Thr468Met)Cardiovascular phenotype [RCV002390104]|Hypertrophic cardiomyopathy [RCV000853462]|LEOPARD syndrome 1 [RCV000055884]|Noonan syndrome 1 [RCV000106323]|Noonan syndrome 1 [RCV000515406]|Noonan syndrome [RCV000157014]|Noonan syndrome and Noonan-related syndrome [RCV001813197]|Noonan syndrome with multippathogenic|likely pathogenic|likely benign|conflicting interpretations of pathogenicity|uncertain significance|not provided12112488466112488466Human10name , alternate_id
8599366CV28371single nucleotide variantNM_002834.5(PTPN11):c.1504T>A (p.Ser502Thr)Cardiovascular phenotype [RCV004984639]|Juvenile myelomonocytic leukemia [RCV000033543]|Noonan syndrome 1 [RCV000014260]|Noonan syndrome 1 [RCV002490364]|Noonan syndrome [RCV000156995]|PTPN11-related disorder [RCV004532342]|RASopathy [RCV001851849]|not provided pathogenic12112489080112489080Human8name , alternate_id
8599375CV28380single nucleotide variantNM_002834.5(PTPN11):c.1232C>T (p.Thr411Met)Acute megakaryoblastic leukemia in down syndrome [RCV001293768]|Cardiovascular phenotype [RCV002362582]|Noonan syndrome 1 [RCV000014269]|RASopathy [RCV001030087]|not provided [RCV001091427]pathogenic|likely pathogenic|uncertain significance12112486482112486482Human4name
8599376CV28381single nucleotide variantNM_002834.5(PTPN11):c.1381G>A (p.Ala461Thr)LEOPARD syndrome 1 [RCV000055882]|Noonan syndrome 1 [RCV001089941]|Noonan syndrome with multiple lentigines [RCV000037611]|PTPN11-related disorder [RCV004532345]|RASopathy [RCV000529342]|not provided [RCV000033530]|not specified [RCV001002017]pathogenic|conflicting interpretations of pathogenicity12112488444112488444Human5name , alternate_id
8599377CV28382single nucleotide variantNM_002834.5(PTPN11):c.1391G>C (p.Gly464Ala)Cardiovascular phenotype [RCV002390105]|LEOPARD syndrome 1 [RCV000055883]|Noonan syndrome 1 [RCV001281363]|Noonan syndrome and Noonan-related syndrome [RCV001813203]|Noonan syndrome with multiple lentigines [RCV000824746]|PTPN11-related disorder [RCV004532346]|Rpathogenic12112488454112488454Human5name , alternate_id
8599378CV28383single nucleotide variantNM_002834.5(PTPN11):c.1529A>C (p.Gln510Pro)LEOPARD syndrome 1 [RCV000014272]|Noonan syndrome 1 [RCV001254107]|Noonan syndrome 1 [RCV002286696]|Noonan syndrome 3 [RCV000586289]|Noonan syndrome with multiple lentigines [RCV000520822]|Noonan syndrome with multiple lentigines [RCV000824752]|PTPN11-related dipathogenic12112489105112489105Human6name , alternate_id
8599379CV28384single nucleotide variantNM_002834.5(PTPN11):c.1529A>G (p.Gln510Arg)Cardiovascular phenotype [RCV004018624]|LEOPARD syndrome 1 [RCV001002770]|Noonan syndrome 1 [RCV000014273]|PTPN11-related disorder [RCV004734518]|RASopathy [RCV000780654]|not provided [RCV000414743]pathogenic|likely pathogenic12112489105112489105Human5name , alternate_id
404981517CV2850875single nucleotide variantNM_002834.5(PTPN11):c.1165A>C (p.Lys389Gln)not provided [RCV003488315]uncertain significance12112482146112482146Humanname
405007839CV2853572single nucleotide variantNM_002834.5(PTPN11):c.1187A>G (p.Tyr396Cys)Noonan syndrome 1 [RCV003514654]likely pathogenic12112482168112482168Human1name
405158333CV2871738single nucleotide variantNM_002834.5(PTPN11):c.1117G>A (p.Asp373Asn)Cardiovascular phenotype [RCV005264429]|RASopathy [RCV003539651]|not provided [RCV004765873]uncertain significance12112482098112482098Human1name
405160778CV2886624single nucleotide variantNM_002834.5(PTPN11):c.1343G>A (p.Ser448Asn)RASopathy [RCV003540095]|not provided [RCV005255765]uncertain significance12112486593112486593Human1name
405056261CV2957890single nucleotide variantNM_002834.5(PTPN11):c.1121A>G (p.Glu374Gly)RASopathy [RCV003655565]uncertain significance12112482102112482102Human1name
405059165CV2987171single nucleotide variantNM_002834.5(PTPN11):c.1294C>G (p.Pro432Ala)Cardiovascular phenotype [RCV004985490]|RASopathy [RCV003655820]uncertain significance12112486544112486544Human1name
405059729CV2995160single nucleotide variantNM_002834.5(PTPN11):c.1712A>C (p.Glu571Ala)RASopathy [RCV003655861]|not provided [RCV005415674]uncertain significance12112502256112502256Human1name
405060565CV3000413single nucleotide variantNM_002834.5(PTPN11):c.1657A>T (p.Thr553Ser)RASopathy [RCV003655905]uncertain significance12112502201112502201Human1name
405060906CV3004428single nucleotide variantNM_002834.5(PTPN11):c.1172G>A (p.Ser391Asn)RASopathy [RCV003655932]uncertain significance12112482153112482153Human1name
405061112CV3008216single nucleotide variantNM_002834.5(PTPN11):c.1604G>A (p.Ser535Asn)RASopathy [RCV003655948]uncertain significance12112502148112502148Human1name
405047310CV3026606single nucleotide variantNM_002834.5(PTPN11):c.1708G>T (p.Ala570Ser)RASopathy [RCV003654473]uncertain significance12112502252112502252Human1name
405051429CV3062300single nucleotide variantNM_002834.5(PTPN11):c.1594G>C (p.Glu532Gln)RASopathy [RCV003654770]uncertain significance12112489170112489170Human1name
405051034CV3068521single nucleotide variantNM_002834.5(PTPN11):c.1496C>G (p.Ser499Cys)RASopathy [RCV003654739]uncertain significance12112489072112489072Human1name
405115972CV3134258single nucleotide variantNM_002834.5(PTPN11):c.1348A>T (p.Met450Leu)Cardiovascular phenotype [RCV005264525]|RASopathy [RCV003836860]uncertain significance12112486598112486598Human1name
405212988CV3169836single nucleotide variantNM_002834.5(PTPN11):c.1387A>G (p.Ile463Val)RASopathy [RCV003862435]|not provided [RCV004719401]uncertain significance12112488450112488450Human1name
405256213CV3222063single nucleotide variantNM_002834.5(PTPN11):c.1565T>C (p.Ile522Thr)Duane retraction syndrome [RCV004577406]|RASopathy [RCV005103148]uncertain significance12112489141112489141Human3name
405688702CV3318305single nucleotide variantNM_002834.5(PTPN11):c.1045A>G (p.Asn349Asp)Cardiovascular phenotype [RCV004444938]|RASopathy [RCV005104649]uncertain significance12112477968112477968Human1name
405675699CV3386469single nucleotide variantNM_002834.5(PTPN11):c.1213A>G (p.Lys405Glu)Cardiovascular phenotype [RCV004516215]uncertain significance12112482194112482194Humanname
405675705CV3386470single nucleotide variantNM_002834.5(PTPN11):c.1615G>T (p.Gly539Trp)Cardiovascular phenotype [RCV004516216]uncertain significance12112502159112502159Humanname
405867942CV3401331single nucleotide variantNM_002834.5(PTPN11):c.1420A>G (p.Ile474Val)Noonan syndrome 1 [RCV004577642]likely benign12112488483112488483Human1name
407472440CV3468365single nucleotide variantNM_002834.5(PTPN11):c.1690A>T (p.Thr564Ser)Cardiovascular phenotype [RCV004662505]|RASopathy [RCV005102402]uncertain significance12112502234112502234Human1name
408381123CV3501823single nucleotide variantNM_002834.5(PTPN11):c.1393C>T (p.Arg465Trp)not provided [RCV004729351]uncertain significance12112488456112488456Humanname
408390152CV3524951single nucleotide variantNM_002834.5(PTPN11):c.1357G>T (p.Gly453Trp)not provided [RCV004769846]uncertain significance12112486607112486607Humanname
597706532CV3585018single nucleotide variantNM_002834.5(PTPN11):c.1000C>A (p.Leu334Met)Cardiovascular phenotype [RCV004989440]|RASopathy [RCV005107772]uncertain significance12112477923112477923Human1name
597706535CV3585019single nucleotide variantNM_002834.5(PTPN11):c.1054G>C (p.Val352Leu)Cardiovascular phenotype [RCV004989441]uncertain significance12112477977112477977Humanname
597706541CV3585020single nucleotide variantNM_002834.5(PTPN11):c.1753C>A (p.Leu585Met)Cardiovascular phenotype [RCV004989442]likely benign12112504735112504735Humanname
597706547CV3585022single nucleotide variantNM_002834.5(PTPN11):c.1228A>C (p.Asn410His)Cardiovascular phenotype [RCV004989444]uncertain significance12112486478112486478Humanname
597706621CV3585040single nucleotide variantNM_002834.5(PTPN11):c.1729G>A (p.Ala577Thr)Cardiovascular phenotype [RCV004989459]|RASopathy [RCV005061536]uncertain significance12112504711112504711Human1name
597685209CV3713707single nucleotide variantNM_002834.5(PTPN11):c.1070C>T (p.Thr357Met)Noonan syndrome 1 [RCV005006810]uncertain significance12112477993112477993Human2name
597917981CV3767949single nucleotide variantNM_002834.5(PTPN11):c.1232C>A (p.Thr411Lys)RASopathy [RCV005114750]uncertain significance12112486482112486482Human1name
597917987CV3767950single nucleotide variantNM_002834.5(PTPN11):c.1400G>T (p.Gly467Val)RASopathy [RCV005114751]uncertain significance12112488463112488463Human1name
597918001CV3767952single nucleotide variantNM_002834.5(PTPN11):c.1552G>A (p.Val518Ile)RASopathy [RCV005114753]uncertain significance12112489128112489128Human1name
597918006CV3767953single nucleotide variantNM_002834.5(PTPN11):c.1559A>G (p.His520Arg)RASopathy [RCV005114754]uncertain significance12112489135112489135Human1name
597918021CV3767955single nucleotide variantNM_002834.5(PTPN11):c.1643C>T (p.Ser548Phe)RASopathy [RCV005114756]|not provided [RCV005412721]uncertain significance12112502187112502187Human1name
597918029CV3767956single nucleotide variantNM_002834.5(PTPN11):c.1645C>G (p.Leu549Val)RASopathy [RCV005114757]uncertain significance12112502189112502189Human1name
597952640CV3815403single nucleotide variantNM_002834.5(PTPN11):c.1163T>C (p.Val388Ala)RASopathy [RCV005161353]uncertain significance12112482144112482144Human1name
597930162CV3826925single nucleotide variantNM_002834.5(PTPN11):c.1700C>T (p.Pro567Leu)RASopathy [RCV005156938]uncertain significance12112502244112502244Human1name
597906401CV3853450single nucleotide variantNM_002834.5(PTPN11):c.1601A>G (p.Lys534Arg)RASopathy [RCV005202928]uncertain significance12112502145112502145Human1name
597966057CV3859030single nucleotide variantNM_002834.5(PTPN11):c.1641T>A (p.Tyr547Ter)RASopathy [RCV005194425]pathogenic12112502185112502185Human1name
597865623CV3861246single nucleotide variantNM_002834.5(PTPN11):c.1782A>G (p.Ter594Trp)RASopathy [RCV005196594]uncertain significance12112504764112504764Human1name
598123006CV3890156single nucleotide variantNM_002834.5(PTPN11):c.1330C>T (p.His444Tyr)not provided [RCV005250675]uncertain significance12112486580112486580Humanname
598181385CV3904799single nucleotide variantNM_002834.5(PTPN11):c.1445A>G (p.Lys482Arg)Cardiovascular phenotype [RCV005265193]uncertain significance12112488508112488508Humanname
598181387CV3904800single nucleotide variantNM_002834.5(PTPN11):c.1153G>A (p.Val385Ile)Cardiovascular phenotype [RCV005265194]uncertain significance12112482134112482134Humanname
598181397CV3904803single nucleotide variantNM_002834.5(PTPN11):c.1580G>T (p.Arg527Leu)Cardiovascular phenotype [RCV005265197]uncertain significance12112489156112489156Humanname
598181447CV3904819single nucleotide variantNM_002834.5(PTPN11):c.1662T>A (p.Ser554Arg)Cardiovascular phenotype [RCV005265213]uncertain significance12112502206112502206Humanname
598181463CV3904824single nucleotide variantNM_002834.5(PTPN11):c.1243G>T (p.Val415Phe)Cardiovascular phenotype [RCV005265218]uncertain significance12112486493112486493Humanname
598181470CV3904827single nucleotide variantNM_002834.5(PTPN11):c.1652A>G (p.Asp551Gly)Cardiovascular phenotype [RCV005265221]uncertain significance12112502196112502196Humanname
598176311CV4008105single nucleotide variantNM_002834.5(PTPN11):c.1276C>A (p.His426Asn)Noonan syndrome 1 [RCV005393621]uncertain significance12112486526112486526Human2name
598176319CV4008106single nucleotide variantNM_002834.5(PTPN11):c.1667A>G (p.Asp556Gly)Noonan syndrome 1 [RCV005393622]uncertain significance12112502211112502211Human2name
616936446CV4010514single nucleotide variantNM_002834.5(PTPN11):c.1507G>T (p.Gly503Trp)Cardiovascular phenotype [RCV005403860]likely pathogenic12112489083112489083Humanname
8602468CV40228single nucleotide variantNM_002834.5(PTPN11):c.1516C>T (p.Gln506Ter)Metachondromatosis [RCV000024258]pathogenic12112489092112489092Human1name
8604507CV49010single nucleotide variantNM_002834.5(PTPN11):c.1048T>G (p.Ser350Ala)Cardiovascular phenotype [RCV004018712]|Noonan syndrome 1 [RCV000763793]|RASopathy [RCV003539767]|not provided [RCV000033523]likely benign|uncertain significance12112477971112477971Human8name
8604508CV49011single nucleotide variantNM_002834.5(PTPN11):c.1052G>A (p.Arg351Gln)Cardiovascular phenotype [RCV002399354]|Juvenile myelomonocytic leukemia [RCV003315540]|Metachondromatosis [RCV005234828]|PTPN11-related disorder [RCV004541059]|RASopathy [RCV000521244]|not provided [RCV000373942]|not specified [RCV001582506]benign|conflicting interpretations of pathogenicity|uncertain significance12112477975112477975Human4name , alternate_id
8604510CV49013single nucleotide variantNM_002834.4(PTPN11):c.1120G>C (p.Glu374Gln)Rasopathy [RCV000033526]uncertain significance12112482101112482101Humanname
8604511CV49014single nucleotide variantNM_002834.5(PTPN11):c.1124A>G (p.Tyr375Cys)Cardiovascular phenotype [RCV004017275]|Noonan syndrome 1 [RCV002477047]|RASopathy [RCV001042982]|not specified [RCV000037606]uncertain significance12112482105112482105Human8name
8604512CV49015single nucleotide variantNM_002834.5(PTPN11):c.1282G>A (p.Val428Met)Cardiovascular phenotype [RCV004018713]|Noonan syndrome 1 [RCV001725940]|Noonan syndrome and Noonan-related syndrome [RCV001813255]|RASopathy [RCV001852677]|not provided [RCV000033528]|not specified [RCV001818207]likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112486532112486532Human3name
8604513CV49016single nucleotide variantNM_002834.5(PTPN11):c.1381G>T (p.Ala461Ser)LEOPARD syndrome 1 [RCV001729356]|Noonan syndrome with multiple lentigines [RCV000037612]|RASopathy [RCV001060541]|not provided [RCV000033529]pathogenic12112488444112488444Human3name
8604514CV49017single nucleotide variantNM_002834.5(PTPN11):c.1402A>C (p.Thr468Pro)Cardiovascular phenotype [RCV002390129]|Noonan syndrome and Noonan-related syndrome [RCV001813256]|Noonan syndrome with multiple lentigines [RCV001804754]|RASopathy [RCV000231162]|not provided [RCV000033532]pathogenic12112488465112488465Human2name
8604515CV49018single nucleotide variantNM_002834.5(PTPN11):c.1453G>T (p.Asp485Tyr)RASopathy [RCV003655574]likely pathogenic|uncertain significance12112489029112489029Human1name
8604516CV49019single nucleotide variantNM_002834.5(PTPN11):c.1471C>A (p.Pro491Thr)Cardiovascular phenotype [RCV004018714]|Noonan syndrome 1 [RCV000660240]|Noonan syndrome 1 [RCV002490445]|Noonan syndrome [RCV000208219]|RASopathy [RCV000694590]|not provided [RCV000033535]pathogenic|likely pathogenic12112489047112489047Human8name
8604517CV49020single nucleotide variantNM_002834.5(PTPN11):c.1471C>T (p.Pro491Ser)Noonan syndrome 1 [RCV000984919]|Noonan syndrome 1 [RCV004795948]|Noonan syndrome [RCV000157010]|Noonan syndrome and Noonan-related syndrome [RCV001813257]|RASopathy [RCV000033536]|not provided [RCV000254684]pathogenic12112489047112489047Human8name
8604518CV49021single nucleotide variantNM_002834.5(PTPN11):c.1472C>A (p.Pro491His)Cardiovascular phenotype [RCV002390130]|Noonan syndrome 1 [RCV002490446]|Noonan syndrome [RCV000037617]|RASopathy [RCV001378165]|Short stature [RCV001730478]|not provided [RCV000033537]pathogenic|likely pathogenic12112489048112489048Human13name
8604519CV49022single nucleotide variantNM_002834.5(PTPN11):c.1472C>T (p.Pro491Leu)LEOPARD syndrome 1 [RCV001335067]|Noonan syndrome 1 [RCV001002769]|Noonan syndrome 1 [RCV002504856]|Noonan syndrome [RCV000156989]|Noonan syndrome and Noonan-related syndrome [RCV001813258]|PTPN11-related disorder [RCV004532492]|RASopathy [RCV000033538]|not provpathogenic|likely pathogenic12112489048112489048Human8name , alternate_id
8604520CV49023single nucleotide variantNM_002834.5(PTPN11):c.1492C>T (p.Arg498Trp)Cardiovascular phenotype [RCV004018715]|LEOPARD syndrome 1 [RCV000055885]|Metachondromatosis [RCV004558285]|Noonan syndrome 1 [RCV000722171]|Noonan syndrome 1 [RCV002490447]|Noonan syndrome and Noonan-related syndrome [RCV001813259]|Noonan syndrome with multiple lentigines [RCV000824747]|PTPN11pathogenic|likely pathogenic|drug response12112489068112489068Human8name , alternate_id
8604521CV49024single nucleotide variantNM_002834.5(PTPN11):c.1493G>T (p.Arg498Leu)LEOPARD syndrome 1 [RCV000055886]|Noonan syndrome 1 [RCV000494687]|Noonan syndrome and Noonan-related syndrome [RCV001813260]|Noonan syndrome with multiple lentigines [RCV000824748]|Noonan syndrome with multiple lentigines [RCV005406769]|RASopathy [RCV000033540]|Scoliosis [RCV000626828]|not providedpathogenic|likely pathogenic12112489069112489069Human14name
8604522CV49025single nucleotide variantNM_002834.5(PTPN11):c.1502G>A (p.Arg501Lys)Cardiovascular phenotype [RCV004018716]|Epicanthus [RCV001800333]|Noonan syndrome 1 [RCV002260947]|Noonan syndrome 1 [RCV004795949]|Noonan syndrome [RCV000037618]|RASopathy [RCV000466382]|not provided [RCV000033541]pathogenic|likely pathogenic12112489078112489078Human18name
8604523CV49026single nucleotide variantNM_002834.5(PTPN11):c.1504T>G (p.Ser502Ala)Juvenile myelomonocytic leukemia [RCV000033542]|RASopathy [RCV001731329]|not provided [RCV000212898]pathogenic12112489080112489080Human3name
8604524CV49027single nucleotide variantNM_002834.5(PTPN11):c.1505C>T (p.Ser502Leu)Noonan syndrome 1 [RCV002227049]|Noonan syndrome [RCV000037619]|RASopathy [RCV000781773]|not provided [RCV000033544]pathogenic|likely pathogenic12112489081112489081Human3name
8604525CV49028single nucleotide variantNM_002834.5(PTPN11):c.1507G>C (p.Gly503Arg)Cardiovascular phenotype [RCV002390131]|Juvenile myelomonocytic leukemia [RCV000824750]|Neurodevelopmental disorder [RCV001374913]|Noonan syndrome 1 [RCV000515165]|Noonan syndrome 1 [RCV001028095]|PTPN11-related disorder [RCV004532494]|RASopathy [RCV000033545]|npathogenic12112489083112489083Human9name , alternate_id
8604526CV49029single nucleotide variantNM_002834.5(PTPN11):c.1507G>A (p.Gly503Arg)Cardiovascular phenotype [RCV000618529]|Juvenile myelomonocytic leukemia [RCV000824749]|LEOPARD syndrome 1 [RCV003147311]|Metachondromatosis [RCV003147310]|Noonan syndrome 1 [RCV000660241]|Noonan syndrome 1 [RCV000762886]|Noonan syndrome [RCV000157015]|Noonan syndrome and Noonan-related syndrome [RCpathogenic12112489083112489083Human8name , alternate_id
8604527CV49030single nucleotide variantNM_002834.5(PTPN11):c.1508G>T (p.Gly503Val)Embryonal rhabdomyosarcoma [RCV000505671]pathogenic|likely pathogenic|other12112489084112489084Human2name
8604528CV49031single nucleotide variantNM_002834.5(PTPN11):c.1508G>A (p.Gly503Glu)LEOPARD syndrome 1 [RCV000677651]|Metachondromatosis [RCV003450655]|Noonan syndrome 1 [RCV001330778]|Noonan syndrome 1 [RCV002490448]|RASopathy [RCV000532971]|not provided [RCV000033548]pathogenic|likely pathogenic12112489084112489084Human5name
8604529CV49032single nucleotide variantNM_002834.5(PTPN11):c.1510A>G (p.Met504Val)Cardiovascular phenotype [RCV002390132]|Male infertility with azoospermia or oligozoospermia due to single gene mutation [RCV003991572]|Noonan syndrome 1 [RCV000677652]|Noonan syndrome 1 [RCV000762887]|Noonan syndrome 1 [RCV001027841]|Noonan syndrome [RCV000156983]|PTPN11pathogenic|likely pathogenic12112489086112489086Human9name , alternate_id
8604530CV49033single nucleotide variantNM_002834.5(PTPN11):c.1517A>C (p.Gln506Pro)Cardiovascular phenotype [RCV002390133]|Congenital long QT syndrome [RCV004732584]|LEOPARD syndrome 1 [RCV000055887]|Noonan syndrome 1 [RCV004554638]|Noonan syndrome [RCV001849289]|Noonan syndrome with multiple lentigines [RCV000154371]|PTPN11-related disorder [pathogenic|likely pathogenic|not provided12112489093112489093Human8name , alternate_id
8604531CV49035single nucleotide variantNM_002834.4(PTPN11):c.1528C>A (p.Gln510Lys)Rasopathy [RCV000033552]pathogenic12112489104112489104Humanname
8604532CV49036single nucleotide variantNM_002834.5(PTPN11):c.1528C>G (p.Gln510Glu)Cardiovascular phenotype [RCV000619738]|LEOPARD syndrome 1 [RCV000055888]|Noonan syndrome 1 [RCV000679882]|Noonan syndrome 3 [RCV000589512]|Noonan syndrome with multiple lentigines [RCV000824751]|PTPN11-related disorder [RCV004545736]|RASopathy [RCV000033553]|Sepathogenic|not provided12112489104112489104Human6name , alternate_id
8570863CV49037single nucleotide variantNM_002834.5(PTPN11):c.1530G>C (p.Gln510His)Cardiovascular phenotype [RCV002399355]|LEOPARD syndrome 1 [RCV003147314]|Metachondromatosis [RCV003147313]|Noonan syndrome 1 [RCV002490449]|Noonan syndrome 1 [RCV003147312]|PTPN11-related disorder [RCV004532497]|RASopathy [RCV000521890]|not provided [RCV0000778pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112489106112489106Human8name , alternate_id
8604533CV49038single nucleotide variantNM_002834.3(PTPN11):c.1595A>G (p.Glu532Gly)Rasopathy [RCV000033556]likely pathogenic12112489171112489171Humanname
8604534CV49040single nucleotide variantNM_002834.5(PTPN11):c.1658C>T (p.Thr553Met)Cardiovascular phenotype [RCV000254003]|Metachondromatosis [RCV000988917]|Noonan syndrome 1 [RCV000755651]|Noonan syndrome [RCV000156990]|Noonan syndrome and Noonan-related syndrome [RCV001813262]|PTPN11-related disorder [RCV004532498]|Primary dilated cardiomyoplikely pathogenic|benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance|conflicting data from submitters12112502202112502202Human10name , alternate_id
8604535CV49041single nucleotide variantNM_002834.5(PTPN11):c.1697C>T (p.Thr566Met)Noonan syndrome 1 [RCV002470726]|RASopathy [RCV001321672]|not provided [RCV000033559]|not specified [RCV003155047]uncertain significance12112502241112502241Human2name
8607417CV53763single nucleotide variantNM_002834.5(PTPN11):c.1226G>C (p.Gly409Ala)Cardiovascular phenotype [RCV002362629]|Neurofibroma [RCV000626827]|Noonan syndrome 1 [RCV002477095]|Noonan syndrome and Noonan-related syndrome [RCV001813326]|RASopathy [RCV001296596]|not provided [RCV004696650]|not specified [RCV000037608]pathogenic|uncertain significance12112486476112486476Human10name
8607418CV53764single nucleotide variantNM_002834.5(PTPN11):c.1366G>A (p.Val456Met)Noonan syndrome 1 [RCV005007951]|RASopathy [RCV000461820]|not specified [RCV000037610]uncertain significance12112486616112486616Human3name
8607420CV53766single nucleotide variantNM_002834.5(PTPN11):c.1678C>T (p.Leu560Phe)Cardiovascular phenotype [RCV002399376]|Metachondromatosis [RCV000988918]|Noonan syndrome 1 [RCV000515375]|Noonan syndrome and Noonan-related syndrome [RCV001813327]|PTPN11-related disorder [RCV004534798]|RASopathy [RCV000159057]|not provided [RCV000157702]|not likely benign|conflicting interpretations of pathogenicity|uncertain significance12112502222112502222Human8name , alternate_id
8607422CV53768single nucleotide variantNM_002834.5(PTPN11):c.1724A>G (p.Asp575Gly)RASopathy [RCV002513481]|not specified [RCV000037625]uncertain significance12112504706112504706Human1name
8616633CV70454single nucleotide variantNM_002834.5(PTPN11):c.1382C>G (p.Ala461Gly)LEOPARD syndrome 1 [RCV002269822]|PTPN11-related disorder [RCV004537234]|not specified [RCV000614347]pathogenic|likely pathogenic|uncertain significance12112488445112488445Human2name , alternate_id
21074842CV798651single nucleotide variantNM_002834.5(PTPN11):c.1271C>T (p.Pro424Leu)Noonan syndrome 1 [RCV000995622]likely pathogenic12112486521112486521Human1name
21406037CV799666single nucleotide variantNM_002834.5(PTPN11):c.1530G>T (p.Gln510His)Noonan syndrome 1 [RCV003989616]|Noonan syndrome [RCV001261024]|PTPN11-related disorder [RCV004528333]|not provided [RCV001171895]|not specified [RCV001001798]pathogenic|likely pathogenic12112489106112489106Human2name , alternate_id
26917145CV839325single nucleotide variantNM_002834.5(PTPN11):c.1282G>T (p.Val428Leu)Noonan syndrome 1 [RCV003514461]|Noonan syndrome 1 [RCV005012502]|RASopathy [RCV001056808]|not provided [RCV001788413]pathogenic|likely pathogenic|uncertain significance12112486532112486532Human3name
26912670CV839326single nucleotide variantNM_002834.5(PTPN11):c.1715T>C (p.Met572Thr)Cardiovascular phenotype [RCV005262210]|Noonan syndrome 1 [RCV005012497]|RASopathy [RCV001053742]uncertain significance12112504697112504697Human8name
34891129CV905932single nucleotide variantNM_002834.5(PTPN11):c.1669C>A (p.Gln557Lys)Cardiovascular phenotype [RCV005262259]|not specified [RCV001174786]uncertain significance12112502213112502213Humanname
38466236CV919411single nucleotide variantNM_002834.5(PTPN11):c.1739A>G (p.Tyr580Cys)LEOPARD syndrome 1 [RCV001198644]|Noonan syndrome 1 [RCV005005064]uncertain significance12112504721112504721Human3name
38472323CV926468single nucleotide variantNM_002834.5(PTPN11):c.1547T>C (p.Met516Thr)Cardiovascular phenotype [RCV005262287]|RASopathy [RCV001214373]uncertain significance12112489123112489123Human1name
38468199CV935923single nucleotide variantNM_002834.5(PTPN11):c.1385G>T (p.Gly462Val)RASopathy [RCV001203190]uncertain significance12112488448112488448Human1name
38472186CV935924single nucleotide variantNM_002834.5(PTPN11):c.1426A>G (p.Ile476Val)RASopathy [RCV001213640]uncertain significance12112488489112488489Human1name
40814114CV966980single nucleotide variantNM_002834.5(PTPN11):c.1040A>G (p.Gln347Arg)Intellectual disability [RCV001257613]uncertain significance12112477963112477963Human2name
40814113CV966981single nucleotide variantNM_002834.5(PTPN11):c.1282G>C (p.Val428Leu)Intellectual disability [RCV001257612]|Noonan syndrome 1 [RCV002471063]|RASopathy [RCV001879977]|not provided [RCV004762028]pathogenic|likely pathogenic|uncertain significance12112486532112486532Human4name
40814685CV969674single nucleotide variantNM_002834.5(PTPN11):c.1402A>T (p.Thr468Ser)Noonan syndrome [RCV001261018]likely benign12112488465112488465Human1name
40814687CV969675single nucleotide variantNM_002834.5(PTPN11):c.1496C>T (p.Ser499Phe)Noonan syndrome [RCV001261021]|RASopathy [RCV005094239]|not specified [RCV001526964]likely pathogenic|uncertain significance12112489072112489072Human2name
40814688CV969676single nucleotide variantNM_002834.5(PTPN11):c.1500G>T (p.Gln500His)Noonan syndrome [RCV001261022]uncertain significance12112489076112489076Human1name
40814690CV969677single nucleotide variantNM_002834.5(PTPN11):c.1529A>T (p.Gln510Leu)Noonan syndrome [RCV001261023]|Noonan syndrome and Noonan-related syndrome [RCV001813585]likely pathogenic12112489105112489105Human1name
40815891CV970540single nucleotide variantNM_002834.5(PTPN11):c.1409T>C (p.Ile470Thr)Noonan syndrome 1 [RCV001261995]likely pathogenic12112488472112488472Human1name
40889428CV972585single nucleotide variantNM_002834.5(PTPN11):c.1499A>G (p.Gln500Arg)Cardiovascular phenotype [RCV004035417]|RASopathy [RCV002537668]|not specified [RCV001264424]uncertain significance12112489075112489075Human1name
41404990CV981770single nucleotide variantNM_002834.5(PTPN11):c.1402A>G (p.Thr468Ala)not provided [RCV001577287]likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance12112488465112488465Humanname
401934860CV2800534indelNM_002834.5(PTPN11):c.717delinsAGATAAAGTTTG (p.Thr240fs)PTPN11-related disorder [RCV004529793]likely pathogenic12112456024112456024Humantrait , alternate_id
12742302CV360079single nucleotide variantNM_002834.5(PTPN11):c.1051C>T (p.Arg351Ter)PTPN11-related disorder [RCV004725202]|not provided [RCV000413347]pathogenic|likely pathogenic12112477974112477974Humanalternate_id
13489537CV444918single nucleotide variantNM_002834.5(PTPN11):c.1261C>T (p.Arg421Trp)Cardiovascular phenotype [RCV003278863]|Noonan syndrome 1 [RCV002481692]|PTPN11-related disorder [RCV004735590]|RASopathy [RCV001343021]|not provided [RCV000523921]uncertain significance12112486511112486511Human8alternate_id
21076025CV792557microsatelliteNM_002834.5(PTPN11):c.762ACA[2] (p.Gln257del)Noonan syndrome 1 [RCV000991102]|Noonan syndrome 1 [RCV002489463]|PTPN11-related disorder [RCV004544990]|RASopathy [RCV002549756]|not provided [RCV003229002]likely pathogenic|uncertain significance12112472949112472951Humanalternate_id